id	sid	tid	token	lemma	pos
iajs-3571	1	1	223	223	NUM
iajs-3571	1	2	©	©	ADP
iajs-3571	1	3	2025	2025	NUM
iajs-3571	1	4	the	the	DET
iajs-3571	1	5	author(s	author(s	NOUN
iajs-3571	1	6	)	)	PUNCT
iajs-3571	1	7	.	.	PUNCT
iajs-3571	2	1	published	publish	VERB
iajs-3571	2	2	by	by	ADP
iajs-3571	2	3	college	college	NOUN
iajs-3571	2	4	of	of	ADP
iajs-3571	2	5	education	education	NOUN
iajs-3571	2	6	for	for	ADP
iajs-3571	2	7	pure	pure	ADJ
iajs-3571	2	8	science	science	NOUN
iajs-3571	2	9	(	(	PUNCT
iajs-3571	2	10	ibn	ibn	PROPN
iajs-3571	2	11	al	al	PROPN
iajs-3571	2	12	-	-	PUNCT
iajs-3571	2	13	haitham	haitham	PROPN
iajs-3571	2	14	)	)	PUNCT
iajs-3571	2	15	,	,	PUNCT
iajs-3571	2	16	university	university	NOUN
iajs-3571	2	17	of	of	ADP
iajs-3571	2	18	baghdad	baghdad	PROPN
iajs-3571	2	19	.	.	PUNCT
iajs-3571	3	1	this	this	PRON
iajs-3571	3	2	is	be	AUX
iajs-3571	3	3	an	an	DET
iajs-3571	3	4	open	open	ADJ
iajs-3571	3	5	-	-	PUNCT
iajs-3571	3	6	access	access	NOUN
iajs-3571	3	7	article	article	NOUN
iajs-3571	3	8	distributed	distribute	VERB
iajs-3571	3	9	under	under	ADP
iajs-3571	3	10	the	the	DET
iajs-3571	3	11	terms	term	NOUN
iajs-3571	3	12	of	of	ADP
iajs-3571	3	13	the	the	DET
iajs-3571	3	14	creative	creative	ADJ
iajs-3571	3	15	commons	common	NOUN
iajs-3571	3	16	attribution	attribution	NOUN
iajs-3571	3	17	4.0	4.0	NUM
iajs-3571	3	18	international	international	ADJ
iajs-3571	3	19	license	license	NOUN
iajs-3571	3	20	comparison	comparison	NOUN
iajs-3571	3	21	of	of	ADP
iajs-3571	3	22	serum	serum	NOUN
iajs-3571	3	23	apelin-36	apelin-36	PROPN
iajs-3571	3	24	and	and	CCONJ
iajs-3571	3	25	insulin	insulin	NOUN
iajs-3571	3	26	resistance	resistance	NOUN
iajs-3571	3	27	between	between	ADP
iajs-3571	3	28	male	male	ADJ
iajs-3571	3	29	and	and	CCONJ
iajs-3571	3	30	female	female	ADJ
iajs-3571	3	31	type	type	NOUN
iajs-3571	3	32	2	2	NUM
iajs-3571	3	33	diabetics	diabetic	NOUN
iajs-3571	3	34	maryam	maryam	NOUN
iajs-3571	3	35	moayd	moayd	PROPN
iajs-3571	3	36	mohammed1	mohammed1	PROPN
iajs-3571	3	37	*	*	PUNCT
iajs-3571	3	38	and	and	CCONJ
iajs-3571	3	39	fayhaa	fayhaa	PROPN
iajs-3571	3	40	m.	m.	NOUN
iajs-3571	3	41	khaleel2	khaleel2	PROPN
iajs-3571	4	1	1,2department	1,2department	NUM
iajs-3571	4	2	of	of	ADP
iajs-3571	4	3	chemistry	chemistry	NOUN
iajs-3571	4	4	,	,	PUNCT
iajs-3571	4	5	college	college	NOUN
iajs-3571	4	6	of	of	ADP
iajs-3571	4	7	science	science	NOUN
iajs-3571	4	8	for	for	ADP
iajs-3571	4	9	women	woman	NOUN
iajs-3571	4	10	,	,	PUNCT
iajs-3571	4	11	university	university	NOUN
iajs-3571	4	12	of	of	ADP
iajs-3571	4	13	baghdad	baghdad	PROPN
iajs-3571	4	14	,	,	PUNCT
iajs-3571	4	15	baghdad	baghdad	PROPN
iajs-3571	4	16	,	,	PUNCT
iajs-3571	4	17	iraq	iraq	PROPN
iajs-3571	4	18	.	.	PUNCT
iajs-3571	5	1	*	*	PUNCT
iajs-3571	5	2	corresponding	correspond	VERB
iajs-3571	5	3	author	author	NOUN
iajs-3571	5	4	.	.	PUNCT
iajs-3571	6	1	received	receive	VERB
iajs-3571	6	2	:	:	PUNCT
iajs-3571	6	3	3	3	NUM
iajs-3571	6	4	june	june	PROPN
iajs-3571	6	5	2023	2023	NUM
iajs-3571	6	6	accepted	accept	VERB
iajs-3571	6	7	:	:	PUNCT
iajs-3571	6	8	19	19	NUM
iajs-3571	6	9	november	november	PROPN
iajs-3571	6	10	2023	2023	NUM
iajs-3571	6	11	published	publish	VERB
iajs-3571	6	12	:	:	PUNCT
iajs-3571	6	13	20	20	NUM
iajs-3571	6	14	april	april	PROPN
iajs-3571	6	15	2025	2025	NUM
iajs-3571	6	16	doi.org/10.30526/38.2.3571	doi.org/10.30526/38.2.3571	ADJ
iajs-3571	6	17	abstract	abstract	ADJ
iajs-3571	6	18	diabetes	diabetes	NOUN
iajs-3571	6	19	mellitus	mellitus	NOUN
iajs-3571	6	20	(	(	PUNCT
iajs-3571	6	21	dm	dm	PROPN
iajs-3571	6	22	)	)	PUNCT
iajs-3571	6	23	is	be	AUX
iajs-3571	6	24	a	a	DET
iajs-3571	6	25	chronic	chronic	ADJ
iajs-3571	6	26	metabolic	metabolic	NOUN
iajs-3571	6	27	disorder	disorder	NOUN
iajs-3571	6	28	characterized	characterize	VERB
iajs-3571	6	29	by	by	ADP
iajs-3571	6	30	persistent	persistent	ADJ
iajs-3571	6	31	hyperglycemia	hyperglycemia	NOUN
iajs-3571	6	32	.	.	PUNCT
iajs-3571	7	1	it	it	PRON
iajs-3571	7	2	may	may	AUX
iajs-3571	7	3	be	be	AUX
iajs-3571	7	4	due	due	ADJ
iajs-3571	7	5	to	to	ADP
iajs-3571	7	6	impaired	impair	VERB
iajs-3571	7	7	insulin	insulin	NOUN
iajs-3571	7	8	secretion	secretion	NOUN
iajs-3571	7	9	,	,	PUNCT
iajs-3571	7	10	resistance	resistance	NOUN
iajs-3571	7	11	to	to	ADP
iajs-3571	7	12	insulin	insulin	NOUN
iajs-3571	7	13	's	's	PART
iajs-3571	7	14	peripheral	peripheral	ADJ
iajs-3571	7	15	actions	action	NOUN
iajs-3571	7	16	,	,	PUNCT
iajs-3571	7	17	or	or	CCONJ
iajs-3571	7	18	both	both	PRON
iajs-3571	7	19	.	.	PUNCT
iajs-3571	8	1	the	the	DET
iajs-3571	8	2	aim	aim	NOUN
iajs-3571	8	3	of	of	ADP
iajs-3571	8	4	this	this	DET
iajs-3571	8	5	study	study	NOUN
iajs-3571	8	6	was	be	AUX
iajs-3571	8	7	to	to	PART
iajs-3571	8	8	estimate	estimate	VERB
iajs-3571	8	9	the	the	DET
iajs-3571	8	10	percentage	percentage	NOUN
iajs-3571	8	11	impact	impact	NOUN
iajs-3571	8	12	of	of	ADP
iajs-3571	8	13	obesity	obesity	NOUN
iajs-3571	8	14	on	on	ADP
iajs-3571	8	15	the	the	DET
iajs-3571	8	16	incidence	incidence	NOUN
iajs-3571	8	17	of	of	ADP
iajs-3571	8	18	dm	dm	NOUN
iajs-3571	8	19	,	,	PUNCT
iajs-3571	8	20	as	as	ADV
iajs-3571	8	21	well	well	ADV
iajs-3571	8	22	as	as	ADP
iajs-3571	8	23	compare	compare	VERB
iajs-3571	8	24	the	the	DET
iajs-3571	8	25	levels	level	NOUN
iajs-3571	8	26	of	of	ADP
iajs-3571	8	27	apelin-36	apelin-36	PROPN
iajs-3571	8	28	,	,	PUNCT
iajs-3571	8	29	glutathione	glutathione	NOUN
iajs-3571	8	30	-	-	PUNCT
iajs-3571	8	31	s	s	NOUN
iajs-3571	8	32	-	-	PUNCT
iajs-3571	8	33	transferase	transferase	NOUN
iajs-3571	8	34	,	,	PUNCT
iajs-3571	8	35	and	and	CCONJ
iajs-3571	8	36	insulin	insulin	NOUN
iajs-3571	8	37	resistance	resistance	NOUN
iajs-3571	8	38	(	(	PUNCT
iajs-3571	8	39	ir	ir	NOUN
iajs-3571	8	40	)	)	PUNCT
iajs-3571	8	41	in	in	ADP
iajs-3571	8	42	subjects	subject	NOUN
iajs-3571	8	43	with	with	ADP
iajs-3571	8	44	and	and	CCONJ
iajs-3571	8	45	without	without	ADP
iajs-3571	8	46	dm	dm	PROPN
iajs-3571	8	47	for	for	ADP
iajs-3571	8	48	both	both	DET
iajs-3571	8	49	sexes	sex	NOUN
iajs-3571	8	50	.	.	PUNCT
iajs-3571	9	1	this	this	DET
iajs-3571	9	2	study	study	NOUN
iajs-3571	9	3	included	include	VERB
iajs-3571	9	4	120	120	NUM
iajs-3571	9	5	subjects	subject	NOUN
iajs-3571	9	6	,	,	PUNCT
iajs-3571	9	7	divided	divide	VERB
iajs-3571	9	8	into	into	ADP
iajs-3571	9	9	60	60	NUM
iajs-3571	9	10	as	as	ADP
iajs-3571	9	11	a	a	DET
iajs-3571	9	12	control	control	NOUN
iajs-3571	9	13	group	group	NOUN
iajs-3571	9	14	and	and	CCONJ
iajs-3571	9	15	60	60	NUM
iajs-3571	9	16	as	as	ADP
iajs-3571	9	17	a	a	DET
iajs-3571	9	18	patient	patient	ADJ
iajs-3571	9	19	group	group	NOUN
iajs-3571	9	20	of	of	ADP
iajs-3571	9	21	both	both	DET
iajs-3571	9	22	sexes	sex	NOUN
iajs-3571	9	23	;	;	PUNCT
iajs-3571	9	24	all	all	PRON
iajs-3571	9	25	were	be	AUX
iajs-3571	9	26	adults	adult	NOUN
iajs-3571	9	27	between	between	ADP
iajs-3571	9	28	the	the	DET
iajs-3571	9	29	ages	age	NOUN
iajs-3571	9	30	of	of	ADP
iajs-3571	9	31	30	30	NUM
iajs-3571	9	32	and	and	CCONJ
iajs-3571	9	33	65	65	NUM
iajs-3571	9	34	.	.	PUNCT
iajs-3571	10	1	the	the	DET
iajs-3571	10	2	participants	participant	NOUN
iajs-3571	10	3	with	with	ADP
iajs-3571	10	4	fasting	fast	VERB
iajs-3571	10	5	blood	blood	NOUN
iajs-3571	10	6	sugar	sugar	NOUN
iajs-3571	10	7	,	,	PUNCT
iajs-3571	10	8	lipid	lipid	NOUN
iajs-3571	10	9	profile	profile	NOUN
iajs-3571	10	10	,	,	PUNCT
iajs-3571	10	11	glycated	glycate	VERB
iajs-3571	10	12	hemoglobin	hemoglobin	NOUN
iajs-3571	10	13	(	(	PUNCT
iajs-3571	10	14	hba1c	hba1c	PROPN
iajs-3571	10	15	)	)	PUNCT
iajs-3571	10	16	,	,	PUNCT
iajs-3571	10	17	apelin-36	apelin-36	PROPN
iajs-3571	10	18	,	,	PUNCT
iajs-3571	10	19	body	body	NOUN
iajs-3571	10	20	mass	mass	PROPN
iajs-3571	10	21	index	index	NOUN
iajs-3571	10	22	,	,	PUNCT
iajs-3571	10	23	insulin	insulin	NOUN
iajs-3571	10	24	hormone	hormone	NOUN
iajs-3571	10	25	,	,	PUNCT
iajs-3571	10	26	and	and	CCONJ
iajs-3571	10	27	ir	ir	PROPN
iajs-3571	10	28	were	be	AUX
iajs-3571	10	29	tested	test	VERB
iajs-3571	10	30	.	.	PUNCT
iajs-3571	11	1	the	the	DET
iajs-3571	11	2	results	result	NOUN
iajs-3571	11	3	showed	show	VERB
iajs-3571	11	4	a	a	DET
iajs-3571	11	5	significant	significant	ADJ
iajs-3571	11	6	difference	difference	NOUN
iajs-3571	11	7	in	in	ADP
iajs-3571	11	8	the	the	DET
iajs-3571	11	9	males	male	NOUN
iajs-3571	11	10	'	'	PART
iajs-3571	11	11	age	age	NOUN
iajs-3571	11	12	and	and	CCONJ
iajs-3571	11	13	body	body	NOUN
iajs-3571	11	14	mass	mass	NOUN
iajs-3571	11	15	index	index	NOUN
iajs-3571	11	16	but	but	CCONJ
iajs-3571	11	17	a	a	DET
iajs-3571	11	18	non	non	ADJ
iajs-3571	11	19	-	-	ADJ
iajs-3571	11	20	significant	significant	ADJ
iajs-3571	11	21	difference	difference	NOUN
iajs-3571	11	22	for	for	ADP
iajs-3571	11	23	females	female	NOUN
iajs-3571	11	24	.	.	PUNCT
iajs-3571	12	1	fasting	fast	VERB
iajs-3571	12	2	blood	blood	NOUN
iajs-3571	12	3	sugar	sugar	NOUN
iajs-3571	12	4	,	,	PUNCT
iajs-3571	12	5	hba1c	hba1c	PROPN
iajs-3571	12	6	and	and	CCONJ
iajs-3571	12	7	apelin-36	apelin-36	PROPN
iajs-3571	12	8	,	,	PUNCT
iajs-3571	12	9	insulin	insulin	NOUN
iajs-3571	12	10	hormone	hormone	NOUN
iajs-3571	12	11	,	,	PUNCT
iajs-3571	12	12	and	and	CCONJ
iajs-3571	12	13	ir	ir	PROPN
iajs-3571	12	14	for	for	ADP
iajs-3571	12	15	both	both	DET
iajs-3571	12	16	sexes	sex	NOUN
iajs-3571	12	17	have	have	VERB
iajs-3571	12	18	a	a	DET
iajs-3571	12	19	significant	significant	ADJ
iajs-3571	12	20	difference	difference	NOUN
iajs-3571	12	21	(	(	PUNCT
iajs-3571	12	22	p	p	NOUN
iajs-3571	12	23	≤	≤	NOUN
iajs-3571	12	24	0.05	0.05	NUM
iajs-3571	12	25	)	)	PUNCT
iajs-3571	12	26	.	.	PUNCT
iajs-3571	13	1	there	there	PRON
iajs-3571	13	2	is	be	VERB
iajs-3571	13	3	no	no	DET
iajs-3571	13	4	relation	relation	NOUN
iajs-3571	13	5	between	between	ADP
iajs-3571	13	6	glutathione	glutathione	NOUN
iajs-3571	13	7	-	-	PUNCT
iajs-3571	13	8	s	s	NOUN
iajs-3571	13	9	-	-	PUNCT
iajs-3571	13	10	transferase	transferase	NOUN
iajs-3571	13	11	activity	activity	NOUN
iajs-3571	13	12	,	,	PUNCT
iajs-3571	13	13	insulin	insulin	NOUN
iajs-3571	13	14	,	,	PUNCT
iajs-3571	13	15	and	and	CCONJ
iajs-3571	13	16	ir	ir	PROPN
iajs-3571	13	17	for	for	ADP
iajs-3571	13	18	both	both	DET
iajs-3571	13	19	sexes	sex	NOUN
iajs-3571	13	20	'	'	PART
iajs-3571	13	21	correlation	correlation	NOUN
iajs-3571	13	22	;	;	PUNCT
iajs-3571	13	23	the	the	DET
iajs-3571	13	24	area	area	NOUN
iajs-3571	13	25	under	under	ADP
iajs-3571	13	26	the	the	DET
iajs-3571	13	27	curve	curve	NOUN
iajs-3571	13	28	in	in	ADP
iajs-3571	13	29	the	the	DET
iajs-3571	13	30	study=	study=	NUM
iajs-3571	13	31	0.993	0.993	NUM
iajs-3571	13	32	,	,	PUNCT
iajs-3571	13	33	indicating	indicate	VERB
iajs-3571	13	34	a	a	DET
iajs-3571	13	35	perfect	perfect	ADJ
iajs-3571	13	36	roc	roc	NOUN
iajs-3571	13	37	test	test	NOUN
iajs-3571	13	38	for	for	ADP
iajs-3571	13	39	correctly	correctly	ADV
iajs-3571	13	40	identifying	identify	VERB
iajs-3571	13	41	individuals	individual	NOUN
iajs-3571	13	42	.	.	PUNCT
iajs-3571	14	1	an	an	DET
iajs-3571	14	2	important	important	ADJ
iajs-3571	14	3	role	role	NOUN
iajs-3571	14	4	is	be	AUX
iajs-3571	14	5	played	play	VERB
iajs-3571	14	6	by	by	ADP
iajs-3571	14	7	higher	high	ADJ
iajs-3571	14	8	levels	level	NOUN
iajs-3571	14	9	of	of	ADP
iajs-3571	14	10	apelin-36	apelin-36	PROPN
iajs-3571	14	11	,	,	PUNCT
iajs-3571	14	12	which	which	PRON
iajs-3571	14	13	directly	directly	ADV
iajs-3571	14	14	increase	increase	VERB
iajs-3571	14	15	obesity	obesity	NOUN
iajs-3571	14	16	and	and	CCONJ
iajs-3571	14	17	dm	dm	NOUN
iajs-3571	14	18	.	.	PUNCT
iajs-3571	15	1	this	this	DET
iajs-3571	15	2	study	study	NOUN
iajs-3571	15	3	concluded	conclude	VERB
iajs-3571	15	4	that	that	SCONJ
iajs-3571	15	5	apelin-36	apelin-36	PROPN
iajs-3571	15	6	serves	serve	VERB
iajs-3571	15	7	as	as	ADP
iajs-3571	15	8	a	a	DET
iajs-3571	15	9	reliable	reliable	ADJ
iajs-3571	15	10	indicator	indicator	NOUN
iajs-3571	15	11	for	for	ADP
iajs-3571	15	12	both	both	CCONJ
iajs-3571	15	13	male	male	ADJ
iajs-3571	15	14	and	and	CCONJ
iajs-3571	15	15	female	female	ADJ
iajs-3571	15	16	patients	patient	NOUN
iajs-3571	15	17	with	with	ADP
iajs-3571	15	18	type	type	NOUN
iajs-3571	15	19	2	2	NUM
iajs-3571	15	20	dm	dm	PROPN
iajs-3571	15	21	(	(	PUNCT
iajs-3571	15	22	t2	t2	NOUN
iajs-3571	15	23	dm	dm	PROPN
iajs-3571	15	24	)	)	PUNCT
iajs-3571	15	25	;	;	PUNCT
iajs-3571	15	26	while	while	SCONJ
iajs-3571	15	27	women	woman	NOUN
iajs-3571	15	28	are	be	AUX
iajs-3571	15	29	less	less	ADV
iajs-3571	15	30	likely	likely	ADJ
iajs-3571	15	31	to	to	PART
iajs-3571	15	32	develop	develop	VERB
iajs-3571	15	33	dm	dm	NUM
iajs-3571	15	34	,	,	PUNCT
iajs-3571	15	35	they	they	PRON
iajs-3571	15	36	are	be	AUX
iajs-3571	15	37	more	more	ADV
iajs-3571	15	38	likely	likely	ADJ
iajs-3571	15	39	to	to	PART
iajs-3571	15	40	experience	experience	VERB
iajs-3571	15	41	common	common	ADJ
iajs-3571	15	42	complications	complication	NOUN
iajs-3571	15	43	such	such	ADJ
iajs-3571	15	44	as	as	ADP
iajs-3571	15	45	cardiovascular	cardiovascular	ADJ
iajs-3571	15	46	disease	disease	NOUN
iajs-3571	15	47	.	.	PUNCT
iajs-3571	16	1	men	man	NOUN
iajs-3571	16	2	are	be	AUX
iajs-3571	16	3	more	more	ADV
iajs-3571	16	4	likely	likely	ADJ
iajs-3571	16	5	to	to	PART
iajs-3571	16	6	develop	develop	VERB
iajs-3571	16	7	t2	t2	NOUN
iajs-3571	16	8	dm	dm	NOUN
iajs-3571	16	9	due	due	ADP
iajs-3571	16	10	to	to	ADP
iajs-3571	16	11	their	their	PRON
iajs-3571	16	12	age	age	NOUN
iajs-3571	16	13	and	and	CCONJ
iajs-3571	16	14	higher	high	ADJ
iajs-3571	16	15	weight	weight	NOUN
iajs-3571	16	16	than	than	ADP
iajs-3571	16	17	women	woman	NOUN
iajs-3571	16	18	.	.	PUNCT
iajs-3571	17	1	keywords	keyword	NOUN
iajs-3571	17	2	:	:	PUNCT
iajs-3571	17	3	apelin-36	apelin-36	NOUN
iajs-3571	17	4	,	,	PUNCT
iajs-3571	17	5	glutathione	glutathione	NOUN
iajs-3571	17	6	-	-	PUNCT
iajs-3571	17	7	s	s	NOUN
iajs-3571	17	8	-	-	PUNCT
iajs-3571	17	9	transferase	transferase	NOUN
iajs-3571	17	10	,	,	PUNCT
iajs-3571	17	11	insulin	insulin	NOUN
iajs-3571	17	12	,	,	PUNCT
iajs-3571	17	13	insulin	insulin	NOUN
iajs-3571	17	14	resistance	resistance	NOUN
iajs-3571	17	15	,	,	PUNCT
iajs-3571	17	16	type	type	NOUN
iajs-3571	17	17	2	2	NUM
iajs-3571	17	18	diabetes	diabetes	NOUN
iajs-3571	17	19	mellitus	mellitus	NOUN
iajs-3571	17	20	.	.	PUNCT
iajs-3571	18	1	1	1	X
iajs-3571	18	2	.	.	X
iajs-3571	18	3	introduction	introduction	NOUN
iajs-3571	18	4	type	type	NOUN
iajs-3571	18	5	2	2	NUM
iajs-3571	18	6	diabetes	diabetes	NOUN
iajs-3571	18	7	mellitus	mellitus	NOUN
iajs-3571	18	8	(	(	PUNCT
iajs-3571	18	9	t2	t2	NOUN
iajs-3571	18	10	dm	dm	NOUN
iajs-3571	18	11	)	)	PUNCT
iajs-3571	18	12	is	be	AUX
iajs-3571	18	13	previously	previously	ADV
iajs-3571	18	14	known	know	VERB
iajs-3571	18	15	as	as	ADP
iajs-3571	18	16	adult	adult	NOUN
iajs-3571	18	17	-	-	PUNCT
iajs-3571	18	18	onset	onset	NOUN
iajs-3571	18	19	diabetes	diabetes	NOUN
iajs-3571	18	20	,	,	PUNCT
iajs-3571	18	21	maturity	maturity	NOUN
iajs-3571	18	22	onset	onset	NOUN
iajs-3571	18	23	diabetes	diabetes	NOUN
iajs-3571	18	24	,	,	PUNCT
iajs-3571	18	25	or	or	CCONJ
iajs-3571	18	26	non	non	ADJ
iajs-3571	18	27	-	-	ADJ
iajs-3571	18	28	insulin	insulin	ADJ
iajs-3571	18	29	dependent	dependent	ADJ
iajs-3571	18	30	diabetes	diabetes	NOUN
iajs-3571	18	31	mellitus	mellitus	NOUN
iajs-3571	18	32	(	(	PUNCT
iajs-3571	18	33	niddm	niddm	PROPN
iajs-3571	18	34	)	)	PUNCT
iajs-3571	18	35	.	.	PUNCT
iajs-3571	19	1	this	this	DET
iajs-3571	19	2	disease	disease	NOUN
iajs-3571	19	3	results	result	VERB
iajs-3571	19	4	from	from	ADP
iajs-3571	19	5	loss	loss	NOUN
iajs-3571	19	6	of	of	ADP
iajs-3571	19	7	responsiveness	responsiveness	NOUN
iajs-3571	19	8	(	(	PUNCT
iajs-3571	19	9	sensitivity	sensitivity	NOUN
iajs-3571	19	10	)	)	PUNCT
iajs-3571	19	11	of	of	ADP
iajs-3571	19	12	target	target	NOUN
iajs-3571	19	13	tissues	tissue	NOUN
iajs-3571	19	14	to	to	ADP
iajs-3571	19	15	insulin	insulin	NOUN
iajs-3571	19	16	;	;	PUNCT
iajs-3571	19	17	impaired	impaired	ADJ
iajs-3571	19	18	removal	removal	NOUN
iajs-3571	19	19	of	of	ADP
iajs-3571	19	20	glucose	glucose	NOUN
iajs-3571	19	21	from	from	ADP
iajs-3571	19	22	blood	blood	NOUN
iajs-3571	19	23	produces	produce	VERB
iajs-3571	19	24	hyperglycemia	hyperglycemia	NOUN
iajs-3571	19	25	even	even	ADV
iajs-3571	19	26	in	in	ADP
iajs-3571	19	27	the	the	DET
iajs-3571	19	28	presence	presence	NOUN
iajs-3571	19	29	of	of	ADP
iajs-3571	19	30	higher	high	ADJ
iajs-3571	19	31	insulin	insulin	NOUN
iajs-3571	19	32	levels	level	NOUN
iajs-3571	19	33	(	(	PUNCT
iajs-3571	19	34	1	1	NUM
iajs-3571	19	35	)	)	PUNCT
iajs-3571	19	36	.	.	PUNCT
iajs-3571	20	1	the	the	DET
iajs-3571	20	2	main	main	ADJ
iajs-3571	20	3	risk	risk	NOUN
iajs-3571	20	4	factor	factor	NOUN
iajs-3571	20	5	for	for	ADP
iajs-3571	20	6	the	the	DET
iajs-3571	20	7	development	development	NOUN
iajs-3571	20	8	of	of	ADP
iajs-3571	20	9	t2	t2	NOUN
iajs-3571	20	10	dm	dm	PROPN
iajs-3571	20	11	is	be	AUX
iajs-3571	20	12	obesity	obesity	NOUN
iajs-3571	20	13	because	because	SCONJ
iajs-3571	20	14	of	of	ADP
iajs-3571	20	15	a	a	DET
iajs-3571	20	16	variety	variety	NOUN
iajs-3571	20	17	of	of	ADP
iajs-3571	20	18	variables	variable	NOUN
iajs-3571	20	19	,	,	PUNCT
iajs-3571	20	20	including	include	VERB
iajs-3571	20	21	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3571	20	22	https://creativecommons.org/licenses/by/4.0/	https://creativecommons.org/licenses/by/4.0/	PROPN
iajs-3571	20	23	https://orcid.org/0009-0006-1767-5743	https://orcid.org/0009-0006-1767-5743	PROPN
iajs-3571	20	24	mailto:maryam1996moayad@gmail.com	mailto:maryam1996moayad@gmail.com	PROPN
iajs-3571	20	25	https://orcid.org/0000-0002-9951-2086	https://orcid.org/0000-0002-9951-2086	PROPN
iajs-3571	20	26	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	mailto:fayhaamk_chem@csw.uobaghdad.edu.iq	ADJ
iajs-3571	20	27	ihjpas	ihjpa	NOUN
iajs-3571	20	28	.	.	PUNCT
iajs-3571	21	1	2025	2025	NUM
iajs-3571	21	2	,	,	PUNCT
iajs-3571	21	3	38(2	38(2	NUM
iajs-3571	21	4	)	)	PUNCT
iajs-3571	21	5	224	224	NUM
iajs-3571	21	6	age	age	NOUN
iajs-3571	21	7	and	and	CCONJ
iajs-3571	21	8	genetics	genetic	NOUN
iajs-3571	21	9	,	,	PUNCT
iajs-3571	21	10	which	which	PRON
iajs-3571	21	11	can	can	AUX
iajs-3571	21	12	induce	induce	VERB
iajs-3571	21	13	risk	risk	NOUN
iajs-3571	21	14	for	for	ADP
iajs-3571	21	15	t2	t2	NOUN
iajs-3571	21	16	dm	dm	NOUN
iajs-3571	21	17	.	.	PUNCT
iajs-3571	22	1	there	there	PRON
iajs-3571	22	2	is	be	VERB
iajs-3571	22	3	a	a	DET
iajs-3571	22	4	wide	wide	ADJ
iajs-3571	22	5	range	range	NOUN
iajs-3571	22	6	of	of	ADP
iajs-3571	22	7	body	body	NOUN
iajs-3571	22	8	mass	mass	NOUN
iajs-3571	22	9	at	at	ADP
iajs-3571	22	10	diagnosis	diagnosis	NOUN
iajs-3571	22	11	(	(	PUNCT
iajs-3571	22	12	2	2	NUM
iajs-3571	22	13	)	)	PUNCT
iajs-3571	22	14	.	.	PUNCT
iajs-3571	23	1	properly	properly	ADV
iajs-3571	23	2	the	the	DET
iajs-3571	23	3	number	number	NOUN
iajs-3571	23	4	of	of	ADP
iajs-3571	23	5	people	people	NOUN
iajs-3571	23	6	with	with	ADP
iajs-3571	23	7	t2	t2	NOUN
iajs-3571	23	8	dm	dm	NUM
iajs-3571	23	9	has	have	AUX
iajs-3571	23	10	tripled	triple	VERB
iajs-3571	23	11	due	due	ADP
iajs-3571	23	12	to	to	ADP
iajs-3571	23	13	the	the	DET
iajs-3571	23	14	rise	rise	NOUN
iajs-3571	23	15	of	of	ADP
iajs-3571	23	16	obesity	obesity	NOUN
iajs-3571	23	17	,	,	PUNCT
iajs-3571	23	18	idle	idle	ADJ
iajs-3571	23	19	lives	life	NOUN
iajs-3571	23	20	,	,	PUNCT
iajs-3571	23	21	high	high	ADJ
iajs-3571	23	22	-	-	PUNCT
iajs-3571	23	23	calorie	calorie	NOUN
iajs-3571	23	24	foods	food	NOUN
iajs-3571	23	25	,	,	PUNCT
iajs-3571	23	26	and	and	CCONJ
iajs-3571	23	27	the	the	DET
iajs-3571	23	28	aging	aging	NOUN
iajs-3571	23	29	of	of	ADP
iajs-3571	23	30	the	the	DET
iajs-3571	23	31	population	population	NOUN
iajs-3571	23	32	(	(	PUNCT
iajs-3571	23	33	3	3	NUM
iajs-3571	23	34	,	,	PUNCT
iajs-3571	23	35	4	4	NUM
iajs-3571	23	36	)	)	PUNCT
iajs-3571	23	37	.	.	PUNCT
iajs-3571	24	1	in	in	ADP
iajs-3571	24	2	obesity	obesity	NOUN
iajs-3571	24	3	,	,	PUNCT
iajs-3571	24	4	fat	fat	ADJ
iajs-3571	24	5	cells	cell	NOUN
iajs-3571	24	6	reach	reach	VERB
iajs-3571	24	7	a	a	DET
iajs-3571	24	8	limit	limit	NOUN
iajs-3571	24	9	in	in	ADP
iajs-3571	24	10	storing	store	VERB
iajs-3571	24	11	excess	excess	ADJ
iajs-3571	24	12	energy	energy	NOUN
iajs-3571	24	13	,	,	PUNCT
iajs-3571	24	14	leading	lead	VERB
iajs-3571	24	15	to	to	ADP
iajs-3571	24	16	increased	increase	VERB
iajs-3571	24	17	release	release	NOUN
iajs-3571	24	18	of	of	ADP
iajs-3571	24	19	free	free	ADJ
iajs-3571	24	20	fatty	fatty	NOUN
iajs-3571	24	21	acids	acid	NOUN
iajs-3571	24	22	into	into	ADP
iajs-3571	24	23	the	the	DET
iajs-3571	24	24	bloodstream	bloodstream	NOUN
iajs-3571	24	25	through	through	ADP
iajs-3571	24	26	lipolysis	lipolysis	NOUN
iajs-3571	24	27	.	.	PUNCT
iajs-3571	25	1	this	this	PRON
iajs-3571	25	2	can	can	AUX
iajs-3571	25	3	result	result	VERB
iajs-3571	25	4	in	in	ADP
iajs-3571	25	5	insulin	insulin	NOUN
iajs-3571	25	6	resistance	resistance	NOUN
iajs-3571	25	7	(	(	PUNCT
iajs-3571	25	8	ir	ir	NOUN
iajs-3571	25	9	)	)	PUNCT
iajs-3571	25	10	and	and	CCONJ
iajs-3571	25	11	the	the	DET
iajs-3571	25	12	development	development	NOUN
iajs-3571	25	13	of	of	ADP
iajs-3571	25	14	t2	t2	PROPN
iajs-3571	25	15	dm	dm	PROPN
iajs-3571	25	16	.	.	PUNCT
iajs-3571	26	1	t2	t2	PROPN
iajs-3571	26	2	dm	dm	PROPN
iajs-3571	26	3	patients	patient	NOUN
iajs-3571	26	4	often	often	ADV
iajs-3571	26	5	have	have	VERB
iajs-3571	26	6	excess	excess	ADJ
iajs-3571	26	7	body	body	NOUN
iajs-3571	26	8	fat	fat	ADJ
iajs-3571	26	9	,	,	PUNCT
iajs-3571	26	10	particularly	particularly	ADV
iajs-3571	26	11	in	in	ADP
iajs-3571	26	12	the	the	DET
iajs-3571	26	13	abdominal	abdominal	ADJ
iajs-3571	26	14	area	area	NOUN
iajs-3571	26	15	,	,	PUNCT
iajs-3571	26	16	contributing	contribute	VERB
iajs-3571	26	17	to	to	ADP
iajs-3571	26	18	insulin	insulin	NOUN
iajs-3571	26	19	resistance	resistance	NOUN
iajs-3571	26	20	through	through	ADP
iajs-3571	26	21	inflammatory	inflammatory	ADJ
iajs-3571	26	22	processes	process	NOUN
iajs-3571	26	23	(	(	PUNCT
iajs-3571	26	24	5	5	NUM
iajs-3571	26	25	)	)	PUNCT
iajs-3571	26	26	.	.	PUNCT
iajs-3571	27	1	insulin	insulin	NOUN
iajs-3571	27	2	resistance	resistance	NOUN
iajs-3571	27	3	is	be	AUX
iajs-3571	27	4	one	one	NUM
iajs-3571	27	5	of	of	ADP
iajs-3571	27	6	the	the	DET
iajs-3571	27	7	first	first	ADJ
iajs-3571	27	8	metabolic	metabolic	NOUN
iajs-3571	27	9	problems	problem	NOUN
iajs-3571	27	10	that	that	PRON
iajs-3571	27	11	can	can	AUX
iajs-3571	27	12	lead	lead	VERB
iajs-3571	27	13	to	to	ADP
iajs-3571	27	14	t2	t2	NOUN
iajs-3571	27	15	dm	dm	NOUN
iajs-3571	27	16	.	.	PUNCT
iajs-3571	28	1	because	because	SCONJ
iajs-3571	28	2	of	of	ADP
iajs-3571	28	3	this	this	PRON
iajs-3571	28	4	,	,	PUNCT
iajs-3571	28	5	it	it	PRON
iajs-3571	28	6	is	be	AUX
iajs-3571	28	7	thought	think	VERB
iajs-3571	28	8	to	to	PART
iajs-3571	28	9	be	be	AUX
iajs-3571	28	10	a	a	DET
iajs-3571	28	11	key	key	ADJ
iajs-3571	28	12	factor	factor	NOUN
iajs-3571	28	13	in	in	ADP
iajs-3571	28	14	how	how	SCONJ
iajs-3571	28	15	the	the	DET
iajs-3571	28	16	disease	disease	NOUN
iajs-3571	28	17	develops	develop	VERB
iajs-3571	28	18	(	(	PUNCT
iajs-3571	28	19	6	6	NUM
iajs-3571	28	20	)	)	PUNCT
iajs-3571	28	21	.	.	PUNCT
iajs-3571	29	1	it	it	PRON
iajs-3571	29	2	is	be	AUX
iajs-3571	29	3	a	a	DET
iajs-3571	29	4	significant	significant	ADJ
iajs-3571	29	5	risk	risk	NOUN
iajs-3571	29	6	factor	factor	NOUN
iajs-3571	29	7	for	for	ADP
iajs-3571	29	8	t2	t2	NOUN
iajs-3571	29	9	dm	dm	PROPN
iajs-3571	29	10	and	and	CCONJ
iajs-3571	29	11	metabolic	metabolic	NOUN
iajs-3571	29	12	syndrome	syndrome	NOUN
iajs-3571	29	13	,	,	PUNCT
iajs-3571	29	14	a	a	DET
iajs-3571	29	15	group	group	NOUN
iajs-3571	29	16	of	of	ADP
iajs-3571	29	17	diseases	disease	NOUN
iajs-3571	29	18	that	that	PRON
iajs-3571	29	19	often	often	ADV
iajs-3571	29	20	go	go	VERB
iajs-3571	29	21	together	together	ADV
iajs-3571	29	22	(	(	PUNCT
iajs-3571	29	23	7	7	NUM
iajs-3571	29	24	)	)	PUNCT
iajs-3571	29	25	.	.	PUNCT
iajs-3571	30	1	insulin	insulin	NOUN
iajs-3571	30	2	is	be	AUX
iajs-3571	30	3	a	a	DET
iajs-3571	30	4	hormone	hormone	NOUN
iajs-3571	30	5	secreted	secrete	VERB
iajs-3571	30	6	from	from	ADP
iajs-3571	30	7	cells	cell	NOUN
iajs-3571	30	8	in	in	ADP
iajs-3571	30	9	the	the	DET
iajs-3571	30	10	islets	islet	NOUN
iajs-3571	30	11	of	of	ADP
iajs-3571	30	12	langerhans	langerhan	NOUN
iajs-3571	30	13	.	.	PUNCT
iajs-3571	31	1	it	it	PRON
iajs-3571	31	2	controls	control	VERB
iajs-3571	31	3	how	how	SCONJ
iajs-3571	31	4	carbohydrates	carbohydrate	NOUN
iajs-3571	31	5	,	,	PUNCT
iajs-3571	31	6	proteins	protein	NOUN
iajs-3571	31	7	,	,	PUNCT
iajs-3571	31	8	and	and	CCONJ
iajs-3571	31	9	fats	fat	NOUN
iajs-3571	31	10	are	be	AUX
iajs-3571	31	11	broken	break	VERB
iajs-3571	31	12	down	down	ADP
iajs-3571	31	13	by	by	ADP
iajs-3571	31	14	helping	help	VERB
iajs-3571	31	15	glucose	glucose	NOUN
iajs-3571	31	16	become	become	VERB
iajs-3571	31	17	fat	fat	ADJ
iajs-3571	31	18	,	,	PUNCT
iajs-3571	31	19	muscle	muscle	NOUN
iajs-3571	31	20	,	,	PUNCT
iajs-3571	31	21	and	and	CCONJ
iajs-3571	31	22	liver	liver	NOUN
iajs-3571	31	23	cells	cell	NOUN
iajs-3571	31	24	(	(	PUNCT
iajs-3571	31	25	8)	8)	NUM
iajs-3571	31	26	.	.	PUNCT
iajs-3571	31	27	glucose	glucose	NOUN
iajs-3571	31	28	provides	provide	VERB
iajs-3571	31	29	energy	energy	NOUN
iajs-3571	31	30	to	to	ADP
iajs-3571	31	31	cells	cell	NOUN
iajs-3571	31	32	or	or	CCONJ
iajs-3571	31	33	is	be	AUX
iajs-3571	31	34	stored	store	VERB
iajs-3571	31	35	as	as	ADP
iajs-3571	31	36	fat	fat	ADJ
iajs-3571	31	37	.	.	PUNCT
iajs-3571	32	1	the	the	DET
iajs-3571	32	2	release	release	NOUN
iajs-3571	32	3	of	of	ADP
iajs-3571	32	4	abnormal	abnormal	ADJ
iajs-3571	32	5	insulin	insulin	NOUN
iajs-3571	32	6	caused	cause	VERB
iajs-3571	32	7	by	by	ADP
iajs-3571	32	8	β	β	NOUN
iajs-3571	32	9	-	-	NOUN
iajs-3571	32	10	cell	cell	NOUN
iajs-3571	32	11	loss	loss	NOUN
iajs-3571	32	12	,	,	PUNCT
iajs-3571	32	13	a	a	DET
iajs-3571	32	14	damaged	damaged	ADJ
iajs-3571	32	15	pancreas	pancrea	NOUN
iajs-3571	32	16	,	,	PUNCT
iajs-3571	32	17	or	or	CCONJ
iajs-3571	32	18	ir	ir	PROPN
iajs-3571	32	19	decreases	decrease	VERB
iajs-3571	32	20	the	the	DET
iajs-3571	32	21	amount	amount	NOUN
iajs-3571	32	22	in	in	ADP
iajs-3571	32	23	circulation	circulation	NOUN
iajs-3571	32	24	and	and	CCONJ
iajs-3571	32	25	inhibits	inhibit	VERB
iajs-3571	32	26	glucose	glucose	NOUN
iajs-3571	32	27	uptake	uptake	NOUN
iajs-3571	32	28	by	by	ADP
iajs-3571	32	29	cells	cell	NOUN
iajs-3571	32	30	(	(	PUNCT
iajs-3571	32	31	9	9	NUM
iajs-3571	32	32	)	)	PUNCT
iajs-3571	32	33	.	.	PUNCT
iajs-3571	33	1	glutathione	glutathione	NOUN
iajs-3571	33	2	-	-	PUNCT
iajs-3571	33	3	s	s	NOUN
iajs-3571	33	4	-	-	PUNCT
iajs-3571	33	5	transferase	transferase	NOUN
iajs-3571	33	6	(	(	PUNCT
iajs-3571	33	7	gsts	gst	NOUN
iajs-3571	33	8	)	)	PUNCT
iajs-3571	33	9	are	be	AUX
iajs-3571	33	10	phase	phase	NOUN
iajs-3571	33	11	-	-	PUNCT
iajs-3571	33	12	ii	ii	NOUN
iajs-3571	33	13	cleaning	cleaning	NOUN
iajs-3571	33	14	enzymes	enzyme	NOUN
iajs-3571	33	15	in	in	ADP
iajs-3571	33	16	all	all	DET
iajs-3571	33	17	living	live	VERB
iajs-3571	33	18	things	thing	NOUN
iajs-3571	33	19	and	and	CCONJ
iajs-3571	33	20	are	be	AUX
iajs-3571	33	21	essential	essential	ADJ
iajs-3571	33	22	for	for	ADP
iajs-3571	33	23	keeping	keep	VERB
iajs-3571	33	24	cells	cell	NOUN
iajs-3571	33	25	in	in	ADP
iajs-3571	33	26	balance	balance	NOUN
iajs-3571	33	27	.	.	PUNCT
iajs-3571	34	1	they	they	PRON
iajs-3571	34	2	defend	defend	VERB
iajs-3571	34	3	cells	cell	NOUN
iajs-3571	34	4	by	by	ADP
iajs-3571	34	5	speeding	speed	VERB
iajs-3571	34	6	up	up	ADP
iajs-3571	34	7	the	the	DET
iajs-3571	34	8	process	process	NOUN
iajs-3571	34	9	between	between	ADP
iajs-3571	34	10	harmful	harmful	ADJ
iajs-3571	34	11	electrophiles	electrophile	NOUN
iajs-3571	34	12	made	make	VERB
iajs-3571	34	13	by	by	ADP
iajs-3571	34	14	cytochrome	cytochrome	ADJ
iajs-3571	34	15	p450	p450	PROPN
iajs-3571	34	16	metabolism	metabolism	NOUN
iajs-3571	34	17	and	and	CCONJ
iajs-3571	34	18	reduced	reduced	ADJ
iajs-3571	34	19	glutathione	glutathione	NOUN
iajs-3571	34	20	(	(	PUNCT
iajs-3571	34	21	gsh	gsh	PROPN
iajs-3571	34	22	)	)	PUNCT
iajs-3571	34	23	to	to	PART
iajs-3571	34	24	form	form	VERB
iajs-3571	34	25	gsh	gsh	NOUN
iajs-3571	34	26	conjugates	conjugate	NOUN
iajs-3571	34	27	(	(	PUNCT
iajs-3571	34	28	10	10	NUM
iajs-3571	34	29	)	)	PUNCT
iajs-3571	34	30	.	.	PUNCT
iajs-3571	35	1	gst	gst	PROPN
iajs-3571	35	2	is	be	AUX
iajs-3571	35	3	thought	think	VERB
iajs-3571	35	4	to	to	PART
iajs-3571	35	5	significantly	significantly	ADV
iajs-3571	35	6	contribute	contribute	VERB
iajs-3571	35	7	to	to	ADP
iajs-3571	35	8	determining	determine	VERB
iajs-3571	35	9	the	the	DET
iajs-3571	35	10	sensitivity	sensitivity	NOUN
iajs-3571	35	11	of	of	ADP
iajs-3571	35	12	cells	cell	NOUN
iajs-3571	35	13	that	that	PRON
iajs-3571	35	14	show	show	VERB
iajs-3571	35	15	a	a	DET
iajs-3571	35	16	wide	wide	ADJ
iajs-3571	35	17	range	range	NOUN
iajs-3571	35	18	of	of	ADP
iajs-3571	35	19	spectrum	spectrum	NOUN
iajs-3571	35	20	toxins	toxin	NOUN
iajs-3571	35	21	(	(	PUNCT
iajs-3571	35	22	11	11	NUM
iajs-3571	35	23	)	)	PUNCT
iajs-3571	35	24	.	.	PUNCT
iajs-3571	36	1	glycosylated	glycosylated	ADJ
iajs-3571	36	2	hemoglobin	hemoglobin	NOUN
iajs-3571	36	3	(	(	PUNCT
iajs-3571	36	4	hba1c	hba1c	PROPN
iajs-3571	36	5	)	)	PUNCT
iajs-3571	36	6	provides	provide	VERB
iajs-3571	36	7	essential	essential	ADJ
iajs-3571	36	8	information	information	NOUN
iajs-3571	36	9	about	about	ADP
iajs-3571	36	10	blood	blood	NOUN
iajs-3571	36	11	glucose	glucose	NOUN
iajs-3571	36	12	values	value	NOUN
iajs-3571	36	13	over	over	ADP
iajs-3571	36	14	a	a	DET
iajs-3571	36	15	few	few	ADJ
iajs-3571	36	16	weeks	week	NOUN
iajs-3571	36	17	.	.	PUNCT
iajs-3571	37	1	it	it	PRON
iajs-3571	37	2	is	be	AUX
iajs-3571	37	3	also	also	ADV
iajs-3571	37	4	the	the	DET
iajs-3571	37	5	primary	primary	ADJ
iajs-3571	37	6	way	way	NOUN
iajs-3571	37	7	that	that	PRON
iajs-3571	37	8	people	people	NOUN
iajs-3571	37	9	with	with	ADP
iajs-3571	37	10	dm	dm	PRON
iajs-3571	37	11	keep	keep	VERB
iajs-3571	37	12	track	track	NOUN
iajs-3571	37	13	of	of	ADP
iajs-3571	37	14	glycemia	glycemia	NOUN
iajs-3571	37	15	(	(	PUNCT
iajs-3571	37	16	12	12	NUM
iajs-3571	37	17	)	)	PUNCT
iajs-3571	37	18	.	.	PUNCT
iajs-3571	38	1	some	some	DET
iajs-3571	38	2	studies	study	NOUN
iajs-3571	38	3	have	have	AUX
iajs-3571	38	4	shown	show	VERB
iajs-3571	38	5	that	that	SCONJ
iajs-3571	38	6	hba1c	hba1c	PROPN
iajs-3571	38	7	could	could	AUX
iajs-3571	38	8	be	be	AUX
iajs-3571	38	9	used	use	VERB
iajs-3571	38	10	as	as	ADP
iajs-3571	38	11	a	a	DET
iajs-3571	38	12	possible	possible	ADJ
iajs-3571	38	13	measure	measure	NOUN
iajs-3571	38	14	to	to	PART
iajs-3571	38	15	identify	identify	VERB
iajs-3571	38	16	cholesterol	cholesterol	NOUN
iajs-3571	38	17	and	and	CCONJ
iajs-3571	38	18	cardiovascular	cardiovascular	ADJ
iajs-3571	38	19	disease	disease	NOUN
iajs-3571	38	20	(	(	PUNCT
iajs-3571	38	21	cvd	cvd	PROPN
iajs-3571	38	22	)	)	PUNCT
iajs-3571	38	23	(	(	PUNCT
iajs-3571	38	24	13	13	NUM
iajs-3571	38	25	)	)	PUNCT
iajs-3571	38	26	.	.	PUNCT
iajs-3571	39	1	apelin-36	apelin-36	PROPN
iajs-3571	39	2	was	be	AUX
iajs-3571	39	3	found	find	VERB
iajs-3571	39	4	to	to	PART
iajs-3571	39	5	be	be	AUX
iajs-3571	39	6	the	the	DET
iajs-3571	39	7	natural	natural	ADJ
iajs-3571	39	8	ligand	ligand	NOUN
iajs-3571	39	9	for	for	ADP
iajs-3571	39	10	the	the	DET
iajs-3571	39	11	apj	apj	PROPN
iajs-3571	39	12	receptor	receptor	NOUN
iajs-3571	39	13	,	,	PUNCT
iajs-3571	39	14	which	which	PRON
iajs-3571	39	15	had	have	AUX
iajs-3571	39	16	not	not	PART
iajs-3571	39	17	been	be	AUX
iajs-3571	39	18	known	know	VERB
iajs-3571	39	19	before	before	ADP
iajs-3571	39	20	(	(	PUNCT
iajs-3571	39	21	14	14	NUM
iajs-3571	39	22	)	)	PUNCT
iajs-3571	39	23	.	.	PUNCT
iajs-3571	40	1	this	this	DET
iajs-3571	40	2	study	study	NOUN
iajs-3571	40	3	aims	aim	VERB
iajs-3571	40	4	to	to	PART
iajs-3571	40	5	clarify	clarify	VERB
iajs-3571	40	6	the	the	DET
iajs-3571	40	7	percentage	percentage	NOUN
iajs-3571	40	8	effect	effect	NOUN
iajs-3571	40	9	of	of	ADP
iajs-3571	40	10	obesity	obesity	NOUN
iajs-3571	40	11	incidence	incidence	NOUN
iajs-3571	40	12	and	and	CCONJ
iajs-3571	40	13	cvd	cvd	PROPN
iajs-3571	40	14	and	and	CCONJ
iajs-3571	40	15	the	the	DET
iajs-3571	40	16	levels	level	NOUN
iajs-3571	40	17	of	of	ADP
iajs-3571	40	18	apelin-36	apelin-36	PROPN
iajs-3571	40	19	,	,	PUNCT
iajs-3571	40	20	gst	gst	NOUN
iajs-3571	40	21	,	,	PUNCT
iajs-3571	40	22	and	and	CCONJ
iajs-3571	40	23	ir	ir	X
iajs-3571	40	24	in	in	ADP
iajs-3571	40	25	people	people	NOUN
iajs-3571	40	26	with	with	ADP
iajs-3571	40	27	and	and	CCONJ
iajs-3571	40	28	without	without	ADP
iajs-3571	40	29	dm	dm	PROPN
iajs-3571	40	30	for	for	ADP
iajs-3571	40	31	both	both	DET
iajs-3571	40	32	genders	gender	NOUN
iajs-3571	40	33	.	.	PUNCT
iajs-3571	41	1	2	2	X
iajs-3571	41	2	.	.	X
iajs-3571	41	3	materials	material	NOUN
iajs-3571	41	4	and	and	CCONJ
iajs-3571	41	5	methods	method	NOUN
iajs-3571	41	6	this	this	DET
iajs-3571	41	7	work	work	NOUN
iajs-3571	41	8	was	be	AUX
iajs-3571	41	9	done	do	VERB
iajs-3571	41	10	at	at	ADP
iajs-3571	41	11	the	the	DET
iajs-3571	41	12	department	department	NOUN
iajs-3571	41	13	of	of	ADP
iajs-3571	41	14	chemistry/	chemistry/	NUM
iajs-3571	41	15	college	college	NOUN
iajs-3571	41	16	of	of	ADP
iajs-3571	41	17	sciences	science	NOUN
iajs-3571	41	18	for	for	ADP
iajs-3571	41	19	women/	women/	NUM
iajs-3571	41	20	university	university	NOUN
iajs-3571	41	21	of	of	ADP
iajs-3571	41	22	baghdad	baghdad	PROPN
iajs-3571	41	23	and	and	CCONJ
iajs-3571	41	24	mustansiriyah	mustansiriyah	VERB
iajs-3571	41	25	university/	university/	NUM
iajs-3571	41	26	national	national	ADJ
iajs-3571	41	27	diabetes	diabetes	NOUN
iajs-3571	41	28	centre	centre	NOUN
iajs-3571	41	29	for	for	ADP
iajs-3571	41	30	treatment	treatment	NOUN
iajs-3571	41	31	and	and	CCONJ
iajs-3571	41	32	research	research	NOUN
iajs-3571	41	33	.	.	PUNCT
iajs-3571	42	1	two	two	NUM
iajs-3571	42	2	groups	group	NOUN
iajs-3571	42	3	of	of	ADP
iajs-3571	42	4	120	120	NUM
iajs-3571	42	5	subjects	subject	NOUN
iajs-3571	42	6	participated	participate	VERB
iajs-3571	42	7	in	in	ADP
iajs-3571	42	8	the	the	DET
iajs-3571	42	9	study	study	NOUN
iajs-3571	42	10	;	;	PUNCT
iajs-3571	42	11	group	group	NOUN
iajs-3571	42	12	1	1	NUM
iajs-3571	42	13	included	include	VERB
iajs-3571	42	14	60	60	NUM
iajs-3571	42	15	t2	t2	NOUN
iajs-3571	42	16	dm	dm	NOUN
iajs-3571	42	17	patients	patient	NOUN
iajs-3571	42	18	.	.	PUNCT
iajs-3571	43	1	the	the	DET
iajs-3571	43	2	study	study	NOUN
iajs-3571	43	3	divided	divide	VERB
iajs-3571	43	4	the	the	DET
iajs-3571	43	5	t2	t2	NOUN
iajs-3571	43	6	dm	dm	NOUN
iajs-3571	43	7	patients	patient	NOUN
iajs-3571	43	8	into	into	ADP
iajs-3571	43	9	31	31	NUM
iajs-3571	43	10	males	male	NOUN
iajs-3571	43	11	and	and	CCONJ
iajs-3571	43	12	29	29	NUM
iajs-3571	43	13	females	female	NOUN
iajs-3571	43	14	.	.	PUNCT
iajs-3571	44	1	group	group	NOUN
iajs-3571	44	2	2	2	NUM
iajs-3571	44	3	consisted	consist	VERB
iajs-3571	44	4	of	of	ADP
iajs-3571	44	5	60	60	NUM
iajs-3571	44	6	individuals	individual	NOUN
iajs-3571	44	7	without	without	ADP
iajs-3571	44	8	dm	dm	NOUN
iajs-3571	44	9	,	,	PUNCT
iajs-3571	44	10	comprising	comprise	VERB
iajs-3571	44	11	35	35	NUM
iajs-3571	44	12	males	male	NOUN
iajs-3571	44	13	and	and	CCONJ
iajs-3571	44	14	25	25	NUM
iajs-3571	44	15	females	female	NOUN
iajs-3571	44	16	.	.	PUNCT
iajs-3571	45	1	all	all	DET
iajs-3571	45	2	groups	group	NOUN
iajs-3571	45	3	were	be	AUX
iajs-3571	45	4	randomly	randomly	ADV
iajs-3571	45	5	selected	select	VERB
iajs-3571	45	6	,	,	PUNCT
iajs-3571	45	7	aged	age	VERB
iajs-3571	45	8	30	30	NUM
iajs-3571	45	9	to	to	PART
iajs-3571	45	10	65	65	NUM
iajs-3571	45	11	years	year	NOUN
iajs-3571	45	12	.	.	PUNCT
iajs-3571	46	1	each	each	DET
iajs-3571	46	2	participant	participant	NOUN
iajs-3571	46	3	(	(	PUNCT
iajs-3571	46	4	patient	patient	NOUN
iajs-3571	46	5	and	and	CCONJ
iajs-3571	46	6	control	control	NOUN
iajs-3571	46	7	)	)	PUNCT
iajs-3571	46	8	was	be	AUX
iajs-3571	46	9	given	give	VERB
iajs-3571	46	10	a	a	DET
iajs-3571	46	11	10	10	NUM
iajs-3571	46	12	ml	ml	ADV
iajs-3571	46	13	disposable	disposable	ADJ
iajs-3571	46	14	syringe	syringe	NOUN
iajs-3571	46	15	.	.	PUNCT
iajs-3571	47	1	the	the	DET
iajs-3571	47	2	blood	blood	NOUN
iajs-3571	47	3	was	be	AUX
iajs-3571	47	4	divided	divide	VERB
iajs-3571	47	5	into	into	ADP
iajs-3571	47	6	two	two	NUM
iajs-3571	47	7	parts	part	NOUN
iajs-3571	47	8	,	,	PUNCT
iajs-3571	47	9	and	and	CCONJ
iajs-3571	47	10	the	the	DET
iajs-3571	47	11	first	first	ADJ
iajs-3571	47	12	part	part	NOUN
iajs-3571	47	13	was	be	AUX
iajs-3571	47	14	placed	place	VERB
iajs-3571	47	15	into	into	ADP
iajs-3571	47	16	a	a	DET
iajs-3571	47	17	gel	gel	NOUN
iajs-3571	47	18	tube	tube	NOUN
iajs-3571	47	19	to	to	PART
iajs-3571	47	20	collect	collect	VERB
iajs-3571	47	21	the	the	DET
iajs-3571	47	22	serum	serum	NOUN
iajs-3571	47	23	.	.	PUNCT
iajs-3571	48	1	the	the	DET
iajs-3571	48	2	first	first	ADJ
iajs-3571	48	3	part	part	NOUN
iajs-3571	48	4	was	be	AUX
iajs-3571	48	5	put	put	VERB
iajs-3571	48	6	into	into	ADP
iajs-3571	48	7	a	a	DET
iajs-3571	48	8	gel	gel	NOUN
iajs-3571	48	9	tube	tube	NOUN
iajs-3571	48	10	to	to	PART
iajs-3571	48	11	collect	collect	VERB
iajs-3571	48	12	the	the	DET
iajs-3571	48	13	serum	serum	NOUN
iajs-3571	48	14	.	.	PUNCT
iajs-3571	49	1	the	the	DET
iajs-3571	49	2	blood	blood	NOUN
iajs-3571	49	3	was	be	AUX
iajs-3571	49	4	spun	spin	VERB
iajs-3571	49	5	at	at	ADP
iajs-3571	49	6	3000	3000	NUM
iajs-3571	49	7	rpm	rpm	NOUN
iajs-3571	49	8	for	for	ADP
iajs-3571	49	9	10	10	NUM
iajs-3571	49	10	minutes	minute	NOUN
iajs-3571	49	11	at	at	ADP
iajs-3571	49	12	room	room	NOUN
iajs-3571	49	13	temperature	temperature	NOUN
iajs-3571	49	14	to	to	PART
iajs-3571	49	15	separate	separate	VERB
iajs-3571	49	16	the	the	DET
iajs-3571	49	17	serum	serum	NOUN
iajs-3571	49	18	after	after	SCONJ
iajs-3571	49	19	it	it	PRON
iajs-3571	49	20	had	have	AUX
iajs-3571	49	21	clotted	clot	VERB
iajs-3571	49	22	,	,	PUNCT
iajs-3571	49	23	and	and	CCONJ
iajs-3571	49	24	then	then	ADV
iajs-3571	49	25	the	the	DET
iajs-3571	49	26	serum	serum	NOUN
iajs-3571	49	27	was	be	AUX
iajs-3571	49	28	placed	place	VERB
iajs-3571	49	29	into	into	ADP
iajs-3571	49	30	aliquots	aliquot	NOUN
iajs-3571	49	31	in	in	ADP
iajs-3571	49	32	an	an	DET
iajs-3571	49	33	eppendorf	eppendorf	ADJ
iajs-3571	49	34	tube	tube	NOUN
iajs-3571	49	35	and	and	CCONJ
iajs-3571	49	36	stored	store	VERB
iajs-3571	49	37	at	at	ADP
iajs-3571	49	38	-20	-20	NUM
iajs-3571	49	39	°	°	ADP
iajs-3571	49	40	c	c	NOUN
iajs-3571	49	41	until	until	ADP
iajs-3571	49	42	testing	testing	NOUN
iajs-3571	49	43	.	.	PUNCT
iajs-3571	50	1	the	the	DET
iajs-3571	50	2	second	second	ADJ
iajs-3571	50	3	part	part	NOUN
iajs-3571	50	4	was	be	AUX
iajs-3571	50	5	transferred	transfer	VERB
iajs-3571	50	6	into	into	ADP
iajs-3571	50	7	an	an	DET
iajs-3571	50	8	edta	edta	NOUN
iajs-3571	50	9	tube	tube	NOUN
iajs-3571	50	10	.	.	PUNCT
iajs-3571	51	1	the	the	DET
iajs-3571	51	2	hba1c	hba1c	PROPN
iajs-3571	51	3	test	test	NOUN
iajs-3571	51	4	was	be	AUX
iajs-3571	51	5	done	do	VERB
iajs-3571	51	6	on	on	ADP
iajs-3571	51	7	this	this	DET
iajs-3571	51	8	sample	sample	NOUN
iajs-3571	51	9	.	.	PUNCT
iajs-3571	52	1	medication	medication	NOUN
iajs-3571	52	2	such	such	ADJ
iajs-3571	52	3	as	as	ADP
iajs-3571	52	4	metformin	metformin	NOUN
iajs-3571	52	5	and	and	CCONJ
iajs-3571	52	6	sulfonylurea	sulfonylurea	NOUN
iajs-3571	52	7	were	be	AUX
iajs-3571	52	8	administered	administer	VERB
iajs-3571	52	9	to	to	PART
iajs-3571	52	10	assist	assist	VERB
iajs-3571	52	11	the	the	DET
iajs-3571	52	12	participants	participant	NOUN
iajs-3571	52	13	.	.	PUNCT
iajs-3571	53	1	the	the	DET
iajs-3571	53	2	kit	kit	NOUN
iajs-3571	53	3	from	from	ADP
iajs-3571	53	4	the	the	DET
iajs-3571	53	5	u.s	u.s	PROPN
iajs-3571	53	6	.	.	PROPN
iajs-3571	53	7	company	company	NOUN
iajs-3571	53	8	biosource	biosource	NOUN
iajs-3571	53	9	was	be	AUX
iajs-3571	53	10	used	use	VERB
iajs-3571	53	11	to	to	PART
iajs-3571	53	12	measure	measure	VERB
iajs-3571	53	13	the	the	DET
iajs-3571	53	14	amount	amount	NOUN
iajs-3571	53	15	of	of	ADP
iajs-3571	53	16	insulin	insulin	NOUN
iajs-3571	53	17	in	in	ADP
iajs-3571	53	18	the	the	DET
iajs-3571	53	19	blood	blood	NOUN
iajs-3571	53	20	during	during	ADP
iajs-3571	53	21	the	the	DET
iajs-3571	53	22	fasting	fasting	NOUN
iajs-3571	53	23	period	period	NOUN
iajs-3571	53	24	.	.	PUNCT
iajs-3571	54	1	the	the	DET
iajs-3571	54	2	kit	kit	NOUN
iajs-3571	54	3	(	(	PUNCT
iajs-3571	54	4	biosource	biosource	PROPN
iajs-3571	54	5	usa	usa	PROPN
iajs-3571	54	6	elisa	elisa	PROPN
iajs-3571	54	7	kit	kit	NOUN
iajs-3571	54	8	from	from	ADP
iajs-3571	54	9	my	my	PRON
iajs-3571	54	10	biosource	biosource	NOUN
iajs-3571	54	11	,	,	PUNCT
iajs-3571	54	12	usa	usa	PROPN
iajs-3571	54	13	used	use	VERB
iajs-3571	54	14	to	to	PART
iajs-3571	54	15	measure	measure	VERB
iajs-3571	54	16	the	the	DET
iajs-3571	54	17	amount	amount	NOUN
iajs-3571	54	18	to	to	PART
iajs-3571	54	19	measure	measure	VERB
iajs-3571	54	20	the	the	DET
iajs-3571	54	21	amount	amount	NOUN
iajs-3571	54	22	of	of	ADP
iajs-3571	54	23	human	human	ADJ
iajs-3571	54	24	total	total	ADJ
iajs-3571	54	25	serum	serum	NOUN
iajs-3571	54	26	apelin-36	apelin-36	PROPN
iajs-3571	54	27	.	.	PUNCT
iajs-3571	55	1	the	the	DET
iajs-3571	55	2	cobas	cobas	PROPN
iajs-3571	55	3	c111	c111	PROPN
iajs-3571	55	4	germany	germany	PROPN
iajs-3571	55	5	analyzer	analyzer	NOUN
iajs-3571	55	6	was	be	AUX
iajs-3571	55	7	used	use	VERB
iajs-3571	55	8	to	to	PART
iajs-3571	55	9	measure	measure	VERB
iajs-3571	55	10	the	the	DET
iajs-3571	55	11	amount	amount	NOUN
iajs-3571	55	12	to	to	PART
iajs-3571	55	13	measure	measure	NOUN
iajs-3571	55	14	ihjpas	ihjpa	NOUN
iajs-3571	55	15	.	.	PUNCT
iajs-3571	56	1	2025	2025	NUM
iajs-3571	56	2	,	,	PUNCT
iajs-3571	56	3	38(2	38(2	NUM
iajs-3571	56	4	)	)	PUNCT
iajs-3571	56	5	225	225	NUM
iajs-3571	56	6	fasting	fast	VERB
iajs-3571	56	7	blood	blood	NOUN
iajs-3571	56	8	sugar	sugar	NOUN
iajs-3571	56	9	(	(	PUNCT
iajs-3571	56	10	fbs	fbs	PROPN
iajs-3571	56	11	)	)	PUNCT
iajs-3571	56	12	,	,	PUNCT
iajs-3571	56	13	triglyceride	triglyceride	INTJ
iajs-3571	56	14	(	(	PUNCT
iajs-3571	56	15	t.g	t.g	PROPN
iajs-3571	56	16	.	.	PROPN
iajs-3571	56	17	)	)	PUNCT
iajs-3571	56	18	,	,	PUNCT
iajs-3571	56	19	total	total	ADJ
iajs-3571	56	20	cholesterol	cholesterol	NOUN
iajs-3571	56	21	(	(	PUNCT
iajs-3571	56	22	cho	cho	NOUN
iajs-3571	56	23	)	)	PUNCT
iajs-3571	56	24	,	,	PUNCT
iajs-3571	56	25	and	and	CCONJ
iajs-3571	56	26	high	high	ADJ
iajs-3571	56	27	-	-	PUNCT
iajs-3571	56	28	density	density	NOUN
iajs-3571	56	29	lipoprotein	lipoprotein	ADJ
iajs-3571	56	30	(	(	PUNCT
iajs-3571	56	31	hdl	hdl	NOUN
iajs-3571	56	32	-	-	PUNCT
iajs-3571	56	33	c	c	NOUN
iajs-3571	56	34	)	)	PUNCT
iajs-3571	56	35	.	.	PUNCT
iajs-3571	57	1	the	the	DET
iajs-3571	57	2	cobas	cobas	PROPN
iajs-3571	57	3	c	c	PROPN
iajs-3571	57	4	111	111	NUM
iajs-3571	57	5	origin	origin	NOUN
iajs-3571	57	6	germany	germany	PROPN
iajs-3571	57	7	analyzer	analyzer	NOUN
iajs-3571	57	8	automatically	automatically	ADV
iajs-3571	57	9	calculates	calculate	VERB
iajs-3571	57	10	the	the	DET
iajs-3571	57	11	ratio	ratio	NOUN
iajs-3571	57	12	between	between	ADP
iajs-3571	57	13	a1c	a1c	PROPN
iajs-3571	57	14	and	and	CCONJ
iajs-3571	57	15	hb	hb	NOUN
iajs-3571	57	16	of	of	ADP
iajs-3571	57	17	each	each	DET
iajs-3571	57	18	sample	sample	NOUN
iajs-3571	57	19	.	.	PUNCT
iajs-3571	58	1	gsh	gsh	PROPN
iajs-3571	58	2	(	(	PUNCT
iajs-3571	58	3	sigma	sigma	PROPN
iajs-3571	58	4	chemistry	chemistry	PROPN
iajs-3571	58	5	,	,	PUNCT
iajs-3571	58	6	usa	usa	PROPN
iajs-3571	58	7	)	)	PUNCT
iajs-3571	58	8	was	be	AUX
iajs-3571	58	9	used	use	VERB
iajs-3571	58	10	to	to	PART
iajs-3571	58	11	measure	measure	VERB
iajs-3571	58	12	gst	gst	NOUN
iajs-3571	58	13	activity	activity	NOUN
iajs-3571	58	14	by	by	ADP
iajs-3571	58	15	hand	hand	NOUN
iajs-3571	58	16	.	.	PUNCT
iajs-3571	59	1	the	the	DET
iajs-3571	59	2	homeostasis	homeostasis	NOUN
iajs-3571	59	3	model	model	NOUN
iajs-3571	59	4	assessment	assessment	NOUN
iajs-3571	59	5	(	(	PUNCT
iajs-3571	59	6	homa	homa	NOUN
iajs-3571	59	7	-	-	PUNCT
iajs-3571	59	8	ir	ir	NOUN
iajs-3571	59	9	)	)	PUNCT
iajs-3571	59	10	measures	measure	NOUN
iajs-3571	59	11	ir=	ir=	PROPN
iajs-3571	59	12	fbs	fbs	X
iajs-3571	59	13	(	(	PUNCT
iajs-3571	59	14	mg	mg	PROPN
iajs-3571	59	15	/	/	SYM
iajs-3571	59	16	dl	dl	NOUN
iajs-3571	59	17	)	)	PUNCT
iajs-3571	59	18	x	x	SYM
iajs-3571	59	19	fasting	fast	VERB
iajs-3571	59	20	insulin	insulin	NOUN
iajs-3571	59	21	(	(	PUNCT
iajs-3571	59	22	mu	mu	NOUN
iajs-3571	59	23	/	/	SYM
iajs-3571	59	24	l	l	NOUN
iajs-3571	59	25	)	)	PUNCT
iajs-3571	59	26	/	/	SYM
iajs-3571	59	27	405	405	NUM
iajs-3571	59	28	(	(	PUNCT
iajs-3571	59	29	for	for	ADP
iajs-3571	59	30	si	si	PROPN
iajs-3571	59	31	units	unit	NOUN
iajs-3571	59	32	)	)	PUNCT
iajs-3571	59	33	.	.	PUNCT
iajs-3571	60	1	2.1	2.1	NUM
iajs-3571	60	2	.	.	PUNCT
iajs-3571	61	1	data	datum	NOUN
iajs-3571	61	2	analysis	analysis	NOUN
iajs-3571	61	3	the	the	DET
iajs-3571	61	4	statistical	statistical	ADJ
iajs-3571	61	5	analysis	analysis	NOUN
iajs-3571	61	6	was	be	AUX
iajs-3571	61	7	done	do	VERB
iajs-3571	61	8	with	with	ADP
iajs-3571	61	9	spss	spss	PROPN
iajs-3571	61	10	,	,	PUNCT
iajs-3571	61	11	version	version	NOUN
iajs-3571	61	12	26	26	NUM
iajs-3571	61	13	.	.	PUNCT
iajs-3571	62	1	the	the	DET
iajs-3571	62	2	data	datum	NOUN
iajs-3571	62	3	was	be	AUX
iajs-3571	62	4	shown	show	VERB
iajs-3571	62	5	as	as	ADP
iajs-3571	62	6	a	a	DET
iajs-3571	62	7	median	median	NOUN
iajs-3571	62	8	(	(	PUNCT
iajs-3571	62	9	mean	mean	INTJ
iajs-3571	62	10	se	se	X
iajs-3571	62	11	)	)	PUNCT
iajs-3571	62	12	.	.	PUNCT
iajs-3571	63	1	the	the	DET
iajs-3571	63	2	anova	anova	PROPN
iajs-3571	63	3	test	test	NOUN
iajs-3571	63	4	was	be	AUX
iajs-3571	63	5	used	use	VERB
iajs-3571	63	6	to	to	PART
iajs-3571	63	7	find	find	VERB
iajs-3571	63	8	the	the	DET
iajs-3571	63	9	difference	difference	NOUN
iajs-3571	63	10	between	between	ADP
iajs-3571	63	11	the	the	DET
iajs-3571	63	12	factors	factor	NOUN
iajs-3571	63	13	using	use	VERB
iajs-3571	63	14	the	the	DET
iajs-3571	63	15	ttest	tt	ADJ
iajs-3571	63	16	(	(	PUNCT
iajs-3571	63	17	p	p	NOUN
iajs-3571	63	18	-	-	PUNCT
iajs-3571	63	19	value	value	NOUN
iajs-3571	63	20	)	)	PUNCT
iajs-3571	63	21	,	,	PUNCT
iajs-3571	63	22	lsd	lsd	NOUN
iajs-3571	63	23	,	,	PUNCT
iajs-3571	63	24	and	and	CCONJ
iajs-3571	63	25	correlation	correlation	NOUN
iajs-3571	63	26	coefficient	coefficient	NOUN
iajs-3571	63	27	(	(	PUNCT
iajs-3571	63	28	r	r	NOUN
iajs-3571	63	29	)	)	PUNCT
iajs-3571	63	30	.	.	PUNCT
iajs-3571	64	1	this	this	DET
iajs-3571	64	2	study	study	NOUN
iajs-3571	64	3	used	use	VERB
iajs-3571	64	4	the	the	DET
iajs-3571	64	5	probability	probability	NOUN
iajs-3571	64	6	value	value	NOUN
iajs-3571	64	7	to	to	PART
iajs-3571	64	8	determine	determine	VERB
iajs-3571	64	9	the	the	DET
iajs-3571	64	10	statistical	statistical	ADJ
iajs-3571	64	11	significance	significance	NOUN
iajs-3571	64	12	;	;	PUNCT
iajs-3571	64	13	if	if	SCONJ
iajs-3571	64	14	the	the	DET
iajs-3571	64	15	probability	probability	NOUN
iajs-3571	64	16	value	value	NOUN
iajs-3571	64	17	was	be	AUX
iajs-3571	64	18	less	less	ADJ
iajs-3571	64	19	than	than	ADP
iajs-3571	64	20	0.05	0.05	NUM
iajs-3571	64	21	,	,	PUNCT
iajs-3571	64	22	it	it	PRON
iajs-3571	64	23	was	be	AUX
iajs-3571	64	24	considered	consider	VERB
iajs-3571	64	25	significant	significant	ADJ
iajs-3571	64	26	,	,	PUNCT
iajs-3571	64	27	and	and	CCONJ
iajs-3571	64	28	if	if	SCONJ
iajs-3571	64	29	it	it	PRON
iajs-3571	64	30	exceeded	exceed	VERB
iajs-3571	64	31	0.05	0.05	NUM
iajs-3571	64	32	,	,	PUNCT
iajs-3571	64	33	it	it	PRON
iajs-3571	64	34	was	be	AUX
iajs-3571	64	35	not	not	PART
iajs-3571	64	36	.	.	PUNCT
iajs-3571	65	1	3	3	X
iajs-3571	65	2	.	.	NOUN
iajs-3571	65	3	results	result	NOUN
iajs-3571	65	4	and	and	CCONJ
iajs-3571	65	5	discussion	discussion	NOUN
iajs-3571	65	6	table	table	NOUN
iajs-3571	65	7	1	1	NUM
iajs-3571	65	8	shows	show	VERB
iajs-3571	65	9	a	a	DET
iajs-3571	65	10	statistically	statistically	ADV
iajs-3571	65	11	significant	significant	ADJ
iajs-3571	65	12	difference	difference	NOUN
iajs-3571	65	13	between	between	ADP
iajs-3571	65	14	the	the	DET
iajs-3571	65	15	male	male	ADJ
iajs-3571	65	16	group	group	NOUN
iajs-3571	65	17	with	with	ADP
iajs-3571	65	18	t2	t2	PROPN
iajs-3571	65	19	dm	dm	PROPN
iajs-3571	65	20	and	and	CCONJ
iajs-3571	65	21	the	the	DET
iajs-3571	65	22	male	male	ADJ
iajs-3571	65	23	control	control	NOUN
iajs-3571	65	24	group	group	NOUN
iajs-3571	65	25	without	without	ADP
iajs-3571	65	26	t2	t2	PROPN
iajs-3571	65	27	dm	dm	PROPN
iajs-3571	65	28	.	.	PUNCT
iajs-3571	66	1	the	the	DET
iajs-3571	66	2	study	study	NOUN
iajs-3571	66	3	showed	show	VERB
iajs-3571	66	4	that	that	SCONJ
iajs-3571	66	5	age	age	NOUN
iajs-3571	66	6	,	,	PUNCT
iajs-3571	66	7	bmi	bmi	PROPN
iajs-3571	66	8	,	,	PUNCT
iajs-3571	66	9	fsg	fsg	PROPN
iajs-3571	66	10	,	,	PUNCT
iajs-3571	66	11	and	and	CCONJ
iajs-3571	66	12	hba1c	hba1c	PROPN
iajs-3571	66	13	showed	show	VERB
iajs-3571	66	14	substantial	substantial	ADJ
iajs-3571	66	15	differences	difference	NOUN
iajs-3571	66	16	between	between	ADP
iajs-3571	66	17	the	the	DET
iajs-3571	66	18	groups	group	NOUN
iajs-3571	66	19	with	with	ADP
iajs-3571	66	20	a	a	DET
iajs-3571	66	21	p	p	NOUN
iajs-3571	66	22	-	-	PUNCT
iajs-3571	66	23	value	value	NOUN
iajs-3571	66	24	≤	≤	NUM
iajs-3571	66	25	0.05	0.05	NUM
iajs-3571	66	26	.	.	PUNCT
iajs-3571	67	1	cholesterol	cholesterol	PROPN
iajs-3571	67	2	,	,	PUNCT
iajs-3571	67	3	t.g	t.g	PROPN
iajs-3571	67	4	.	.	PROPN
iajs-3571	67	5	,	,	PUNCT
iajs-3571	67	6	ldl	ldl	NOUN
iajs-3571	67	7	-	-	PUNCT
iajs-3571	67	8	c	c	NOUN
iajs-3571	67	9	,	,	PUNCT
iajs-3571	67	10	and	and	CCONJ
iajs-3571	67	11	vldl	vldl	NOUN
iajs-3571	67	12	showed	show	VERB
iajs-3571	67	13	non	non	ADJ
iajs-3571	67	14	-	-	ADJ
iajs-3571	67	15	significant	significant	ADJ
iajs-3571	67	16	differences	difference	NOUN
iajs-3571	67	17	among	among	ADP
iajs-3571	67	18	groups	group	NOUN
iajs-3571	67	19	1	1	NUM
iajs-3571	67	20	and	and	CCONJ
iajs-3571	67	21	2	2	NUM
iajs-3571	67	22	(	(	PUNCT
iajs-3571	67	23	p	p	NOUN
iajs-3571	67	24	≥	≥	NOUN
iajs-3571	67	25	0.05	0.05	NUM
iajs-3571	67	26	)	)	PUNCT
iajs-3571	67	27	.	.	PUNCT
iajs-3571	68	1	however	however	ADV
iajs-3571	68	2	,	,	PUNCT
iajs-3571	68	3	hdl	hdl	PROPN
iajs-3571	68	4	showed	show	VERB
iajs-3571	68	5	significant	significant	ADJ
iajs-3571	68	6	differences	difference	NOUN
iajs-3571	68	7	.	.	PUNCT
iajs-3571	69	1	the	the	DET
iajs-3571	69	2	earlier	early	ADJ
iajs-3571	69	3	study	study	NOUN
iajs-3571	69	4	of	of	ADP
iajs-3571	69	5	suastika	suastika	PROPN
iajs-3571	69	6	et	et	PROPN
iajs-3571	69	7	al	al	PROPN
iajs-3571	69	8	.	.	PROPN
iajs-3571	69	9	agrees	agree	VERB
iajs-3571	69	10	with	with	ADP
iajs-3571	69	11	the	the	DET
iajs-3571	69	12	present	present	ADJ
iajs-3571	69	13	study	study	NOUN
iajs-3571	69	14	.	.	PUNCT
iajs-3571	70	1	there	there	PRON
iajs-3571	70	2	is	be	VERB
iajs-3571	70	3	a	a	DET
iajs-3571	70	4	strong	strong	ADJ
iajs-3571	70	5	relationship	relationship	NOUN
iajs-3571	70	6	between	between	ADP
iajs-3571	70	7	increased	increase	VERB
iajs-3571	70	8	age	age	NOUN
iajs-3571	70	9	and	and	CCONJ
iajs-3571	70	10	the	the	DET
iajs-3571	70	11	incidence	incidence	NOUN
iajs-3571	70	12	of	of	ADP
iajs-3571	70	13	dm	dm	NOUN
iajs-3571	70	14	;	;	PUNCT
iajs-3571	70	15	when	when	SCONJ
iajs-3571	70	16	the	the	DET
iajs-3571	70	17	age	age	NOUN
iajs-3571	70	18	of	of	ADP
iajs-3571	70	19	the	the	DET
iajs-3571	70	20	infected	infected	ADJ
iajs-3571	70	21	person	person	NOUN
iajs-3571	70	22	increases	increase	VERB
iajs-3571	70	23	,	,	PUNCT
iajs-3571	70	24	it	it	PRON
iajs-3571	70	25	may	may	AUX
iajs-3571	70	26	be	be	AUX
iajs-3571	70	27	more	more	ADV
iajs-3571	70	28	likely	likely	ADJ
iajs-3571	70	29	to	to	PART
iajs-3571	70	30	be	be	AUX
iajs-3571	70	31	associated	associate	VERB
iajs-3571	70	32	with	with	ADP
iajs-3571	70	33	cvd	cvd	PROPN
iajs-3571	70	34	(	(	PUNCT
iajs-3571	70	35	15	15	NUM
iajs-3571	70	36	)	)	PUNCT
iajs-3571	70	37	.	.	PUNCT
iajs-3571	71	1	taylor	taylor	PROPN
iajs-3571	71	2	et	et	PROPN
iajs-3571	71	3	al	al	PROPN
iajs-3571	71	4	.	.	PROPN
iajs-3571	71	5	results	result	NOUN
iajs-3571	71	6	agreed	agree	VERB
iajs-3571	71	7	very	very	ADV
iajs-3571	71	8	well	well	ADV
iajs-3571	71	9	with	with	ADP
iajs-3571	71	10	our	our	PRON
iajs-3571	71	11	findings	finding	NOUN
iajs-3571	71	12	.	.	PUNCT
iajs-3571	72	1	metabolic	metabolic	NOUN
iajs-3571	72	2	diseases	disease	NOUN
iajs-3571	72	3	,	,	PUNCT
iajs-3571	72	4	like	like	ADP
iajs-3571	72	5	t2	t2	NOUN
iajs-3571	72	6	dm	dm	PROPN
iajs-3571	72	7	and	and	CCONJ
iajs-3571	72	8	cvd	cvd	PROPN
iajs-3571	72	9	,	,	PUNCT
iajs-3571	72	10	are	be	AUX
iajs-3571	72	11	more	more	ADV
iajs-3571	72	12	common	common	ADJ
iajs-3571	72	13	in	in	ADP
iajs-3571	72	14	older	old	ADJ
iajs-3571	72	15	people	people	NOUN
iajs-3571	72	16	.	.	PUNCT
iajs-3571	73	1	this	this	PRON
iajs-3571	73	2	could	could	AUX
iajs-3571	73	3	be	be	AUX
iajs-3571	73	4	because	because	SCONJ
iajs-3571	73	5	of	of	ADP
iajs-3571	73	6	age	age	NOUN
iajs-3571	73	7	or	or	CCONJ
iajs-3571	73	8	the	the	DET
iajs-3571	73	9	aging	age	VERB
iajs-3571	73	10	process	process	NOUN
iajs-3571	73	11	itself	itself	PRON
iajs-3571	73	12	or	or	CCONJ
iajs-3571	73	13	other	other	ADJ
iajs-3571	73	14	age	age	NOUN
iajs-3571	73	15	-	-	PUNCT
iajs-3571	73	16	related	relate	VERB
iajs-3571	73	17	risk	risk	NOUN
iajs-3571	73	18	factors	factor	NOUN
iajs-3571	73	19	for	for	ADP
iajs-3571	73	20	t2	t2	NOUN
iajs-3571	73	21	dm	dm	PROPN
iajs-3571	73	22	and	and	CCONJ
iajs-3571	73	23	cvd	cvd	PROPN
iajs-3571	73	24	,	,	PUNCT
iajs-3571	73	25	like	like	ADP
iajs-3571	73	26	central	central	ADJ
iajs-3571	73	27	obesity	obesity	NOUN
iajs-3571	73	28	,	,	PUNCT
iajs-3571	73	29	mitochondrial	mitochondrial	ADJ
iajs-3571	73	30	dysfunction	dysfunction	NOUN
iajs-3571	73	31	,	,	PUNCT
iajs-3571	73	32	ffa	ffa	NOUN
iajs-3571	73	33	and	and	CCONJ
iajs-3571	73	34	lipid	lipid	NOUN
iajs-3571	73	35	metabolism	metabolism	NOUN
iajs-3571	73	36	disorders	disorder	NOUN
iajs-3571	73	37	,	,	PUNCT
iajs-3571	73	38	inflammation	inflammation	NOUN
iajs-3571	73	39	,	,	PUNCT
iajs-3571	73	40	cell	cell	NOUN
iajs-3571	73	41	dysfunction	dysfunction	NOUN
iajs-3571	73	42	,	,	PUNCT
iajs-3571	73	43	ir	ir	PROPN
iajs-3571	73	44	,	,	PUNCT
iajs-3571	73	45	metabolic	metabolic	NOUN
iajs-3571	73	46	syndrome	syndrome	NOUN
iajs-3571	73	47	,	,	PUNCT
iajs-3571	73	48	and	and	CCONJ
iajs-3571	73	49	so	so	ADV
iajs-3571	73	50	on	on	ADV
iajs-3571	73	51	.	.	PUNCT
iajs-3571	74	1	for	for	ADP
iajs-3571	74	2	males	male	NOUN
iajs-3571	74	3	,	,	PUNCT
iajs-3571	74	4	the	the	DET
iajs-3571	74	5	bmi	bmi	NOUN
iajs-3571	74	6	showed	show	VERB
iajs-3571	74	7	a	a	DET
iajs-3571	74	8	significant	significant	ADJ
iajs-3571	74	9	difference	difference	NOUN
iajs-3571	74	10	in	in	ADP
iajs-3571	74	11	high	high	ADJ
iajs-3571	74	12	muscle	muscle	NOUN
iajs-3571	74	13	mass	mass	NOUN
iajs-3571	74	14	(	(	PUNCT
iajs-3571	74	15	16	16	NUM
iajs-3571	74	16	)	)	PUNCT
iajs-3571	74	17	.	.	PUNCT
iajs-3571	75	1	table	table	NOUN
iajs-3571	75	2	1	1	NUM
iajs-3571	75	3	.	.	PUNCT
iajs-3571	76	1	mean	mean	NOUN
iajs-3571	76	2	±	±	NUM
iajs-3571	76	3	se	se	X
iajs-3571	76	4	among	among	ADP
iajs-3571	76	5	male	male	NOUN
iajs-3571	76	6	with	with	ADP
iajs-3571	76	7	t2	t2	NOUN
iajs-3571	76	8	dm	dm	NOUN
iajs-3571	76	9	patient	patient	NOUN
iajs-3571	76	10	and	and	CCONJ
iajs-3571	76	11	male	male	ADJ
iajs-3571	76	12	without	without	ADP
iajs-3571	76	13	t2	t2	NOUN
iajs-3571	76	14	dm	dm	PROPN
iajs-3571	76	15	as	as	ADP
iajs-3571	76	16	control	control	NOUN
iajs-3571	76	17	.	.	PUNCT
iajs-3571	77	1	parameters	parameter	NOUN
iajs-3571	77	2	male	male	VERB
iajs-3571	77	3	with	with	ADP
iajs-3571	77	4	t2	t2	PROPN
iajs-3571	77	5	dm	dm	PROPN
iajs-3571	77	6	group	group	NOUN
iajs-3571	77	7	(	(	PUNCT
iajs-3571	77	8	1	1	NUM
iajs-3571	77	9	)	)	PUNCT
iajs-3571	77	10	(	(	PUNCT
iajs-3571	77	11	n=31	n=31	NOUN
iajs-3571	77	12	)	)	PUNCT
iajs-3571	77	13	male	male	ADJ
iajs-3571	77	14	control	control	NOUN
iajs-3571	77	15	group	group	NOUN
iajs-3571	77	16	(	(	PUNCT
iajs-3571	77	17	2	2	NUM
iajs-3571	77	18	)	)	PUNCT
iajs-3571	77	19	(	(	PUNCT
iajs-3571	77	20	n=35	n=35	PROPN
iajs-3571	77	21	)	)	PUNCT
iajs-3571	77	22	p	p	ADJ
iajs-3571	77	23	-	-	PUNCT
iajs-3571	77	24	value	value	NOUN
iajs-3571	77	25	age	age	NOUN
iajs-3571	77	26	(	(	PUNCT
iajs-3571	77	27	year	year	NOUN
iajs-3571	77	28	)	)	PUNCT
iajs-3571	77	29	57.16	57.16	NUM
iajs-3571	77	30	±	±	NUM
iajs-3571	77	31	1.17	1.17	NUM
iajs-3571	77	32	(	(	PUNCT
iajs-3571	77	33	58	58	NUM
iajs-3571	77	34	)	)	PUNCT
iajs-3571	77	35	42.74±1.40	42.74±1.40	PROPN
iajs-3571	77	36	(	(	PUNCT
iajs-3571	77	37	42	42	NUM
iajs-3571	77	38	)	)	PUNCT
iajs-3571	77	39	*	*	PUNCT
iajs-3571	78	1	*	*	PUNCT
iajs-3571	78	2	0.0001	0.0001	NUM
iajs-3571	78	3	bmi	bmi	NOUN
iajs-3571	78	4	(	(	PUNCT
iajs-3571	78	5	kg	kg	NOUN
iajs-3571	78	6	/	/	SYM
iajs-3571	78	7	m2	m2	PROPN
iajs-3571	78	8	)	)	PUNCT
iajs-3571	78	9	body	body	NOUN
iajs-3571	78	10	mass	mass	NOUN
iajs-3571	78	11	index	index	NOUN
iajs-3571	78	12	28.84±	28.84±	NUM
iajs-3571	78	13	0.75	0.75	NUM
iajs-3571	78	14	(	(	PUNCT
iajs-3571	78	15	28.30	28.30	NUM
iajs-3571	78	16	)	)	PUNCT
iajs-3571	78	17	31.88±0.46	31.88±0.46	NUM
iajs-3571	78	18	(	(	PUNCT
iajs-3571	78	19	30.30	30.30	NUM
iajs-3571	78	20	)	)	PUNCT
iajs-3571	78	21	*	*	PUNCT
iajs-3571	79	1	*	*	SYM
iajs-3571	79	2	0.001	0.001	NUM
iajs-3571	79	3	fbs	fbs	X
iajs-3571	79	4	(	(	PUNCT
iajs-3571	79	5	mg	mg	PROPN
iajs-3571	79	6	/	/	SYM
iajs-3571	79	7	dl	dl	NOUN
iajs-3571	79	8	)	)	PUNCT
iajs-3571	79	9	fasting	fast	VERB
iajs-3571	79	10	blood	blood	NOUN
iajs-3571	79	11	sugar	sugar	NOUN
iajs-3571	79	12	212.2±15.07	212.2±15.07	NUM
iajs-3571	79	13	(	(	PUNCT
iajs-3571	79	14	195	195	NUM
iajs-3571	79	15	)	)	PUNCT
iajs-3571	79	16	96.24±2.12	96.24±2.12	NUM
iajs-3571	79	17	(	(	PUNCT
iajs-3571	79	18	101	101	NUM
iajs-3571	79	19	)	)	PUNCT
iajs-3571	79	20	*	*	PUNCT
iajs-3571	80	1	*	*	PUNCT
iajs-3571	80	2	0.0001	0.0001	NUM
iajs-3571	80	3	hba1c	hba1c	PROPN
iajs-3571	80	4	(	(	PUNCT
iajs-3571	80	5	%	%	INTJ
iajs-3571	80	6	)	)	PUNCT
iajs-3571	80	7	glycated	glycate	VERB
iajs-3571	80	8	hemoglobin	hemoglobin	NOUN
iajs-3571	80	9	8.19±	8.19±	NOUN
iajs-3571	80	10	0.37	0.37	NUM
iajs-3571	80	11	(	(	PUNCT
iajs-3571	80	12	7.70	7.70	NUM
iajs-3571	80	13	)	)	PUNCT
iajs-3571	80	14	5.09±0.072	5.09±0.072	PROPN
iajs-3571	80	15	(	(	PUNCT
iajs-3571	80	16	5	5	NUM
iajs-3571	80	17	)	)	PUNCT
iajs-3571	80	18	*	*	PUNCT
iajs-3571	80	19	*	*	PUNCT
iajs-3571	80	20	0.0001	0.0001	NUM
iajs-3571	80	21	cho	cho	NOUN
iajs-3571	80	22	(	(	PUNCT
iajs-3571	80	23	mg	mg	PROPN
iajs-3571	80	24	/	/	SYM
iajs-3571	80	25	dl	dl	NOUN
iajs-3571	80	26	)	)	PUNCT
iajs-3571	80	27	cholesterol	cholesterol	NOUN
iajs-3571	80	28	172.53±9.29	172.53±9.29	NUM
iajs-3571	80	29	(	(	PUNCT
iajs-3571	80	30	163	163	NUM
iajs-3571	80	31	)	)	PUNCT
iajs-3571	80	32	180.180±6.24	180.180±6.24	NUM
iajs-3571	80	33	(	(	PUNCT
iajs-3571	80	34	196	196	NUM
iajs-3571	80	35	)	)	PUNCT
iajs-3571	80	36	0.489	0.489	NUM
iajs-3571	80	37	tg	tg	INTJ
iajs-3571	80	38	(	(	PUNCT
iajs-3571	80	39	mg	mg	PROPN
iajs-3571	80	40	/	/	SYM
iajs-3571	80	41	dl	dl	NOUN
iajs-3571	80	42	)	)	PUNCT
iajs-3571	80	43	triglycerides	triglyceride	NOUN
iajs-3571	80	44	173.03±13.96	173.03±13.96	NUM
iajs-3571	80	45	(	(	PUNCT
iajs-3571	80	46	167	167	NUM
iajs-3571	80	47	)	)	PUNCT
iajs-3571	80	48	198.16±17.66	198.16±17.66	NUM
iajs-3571	80	49	(	(	PUNCT
iajs-3571	80	50	129	129	NUM
iajs-3571	80	51	)	)	PUNCT
iajs-3571	80	52	0.277	0.277	NUM
iajs-3571	80	53	hdl	hdl	PROPN
iajs-3571	80	54	-	-	PUNCT
iajs-3571	80	55	c	c	PROPN
iajs-3571	80	56	(	(	PUNCT
iajs-3571	80	57	mg	mg	PROPN
iajs-3571	80	58	/	/	SYM
iajs-3571	80	59	dl	dl	NOUN
iajs-3571	80	60	)	)	PUNCT
iajs-3571	80	61	high	high	ADJ
iajs-3571	80	62	-	-	PUNCT
iajs-3571	80	63	density	density	NOUN
iajs-3571	80	64	lipoprotein	lipoprotein	ADJ
iajs-3571	80	65	40.07±1.59	40.07±1.59	NUM
iajs-3571	80	66	(	(	PUNCT
iajs-3571	80	67	39	39	NUM
iajs-3571	80	68	)	)	PUNCT
iajs-3571	80	69	35.27±1.084	35.27±1.084	NUM
iajs-3571	80	70	(	(	PUNCT
iajs-3571	80	71	34	34	NUM
iajs-3571	80	72	)	)	PUNCT
iajs-3571	80	73	*	*	PUNCT
iajs-3571	80	74	0.014	0.014	NUM
iajs-3571	80	75	ldl	ldl	PROPN
iajs-3571	80	76	-	-	PUNCT
iajs-3571	80	77	c	c	PROPN
iajs-3571	80	78	(	(	PUNCT
iajs-3571	80	79	mg	mg	PROPN
iajs-3571	80	80	/	/	SYM
iajs-3571	80	81	dl	dl	NOUN
iajs-3571	80	82	)	)	PUNCT
iajs-3571	80	83	low	low	ADJ
iajs-3571	80	84	-	-	PUNCT
iajs-3571	80	85	density	density	NOUN
iajs-3571	80	86	lipoprotein	lipoprotein	ADJ
iajs-3571	80	87	96.16±6.93	96.16±6.93	X
iajs-3571	80	88	(	(	PUNCT
iajs-3571	80	89	98	98	NUM
iajs-3571	80	90	)	)	PUNCT
iajs-3571	80	91	106.35±4.89	106.35±4.89	NUM
iajs-3571	80	92	(	(	PUNCT
iajs-3571	80	93	116	116	NUM
iajs-3571	80	94	)	)	PUNCT
iajs-3571	81	1	0.226	0.226	NUM
iajs-3571	81	2	ihjpas	ihjpa	VERB
iajs-3571	81	3	.	.	PUNCT
iajs-3571	82	1	2025	2025	NUM
iajs-3571	82	2	,	,	PUNCT
iajs-3571	82	3	38(2	38(2	NUM
iajs-3571	82	4	)	)	PUNCT
iajs-3571	82	5	226	226	NUM
iajs-3571	82	6	parameters	parameter	NOUN
iajs-3571	82	7	male	male	ADJ
iajs-3571	82	8	with	with	ADP
iajs-3571	82	9	t2	t2	PROPN
iajs-3571	82	10	dm	dm	PROPN
iajs-3571	82	11	group	group	NOUN
iajs-3571	82	12	(	(	PUNCT
iajs-3571	82	13	1	1	NUM
iajs-3571	82	14	)	)	PUNCT
iajs-3571	82	15	(	(	PUNCT
iajs-3571	82	16	n=31	n=31	NOUN
iajs-3571	82	17	)	)	PUNCT
iajs-3571	82	18	male	male	ADJ
iajs-3571	82	19	control	control	NOUN
iajs-3571	82	20	group	group	NOUN
iajs-3571	82	21	(	(	PUNCT
iajs-3571	82	22	2	2	NUM
iajs-3571	82	23	)	)	PUNCT
iajs-3571	82	24	(	(	PUNCT
iajs-3571	82	25	n=35	n=35	PROPN
iajs-3571	82	26	)	)	PUNCT
iajs-3571	82	27	p	p	ADJ
iajs-3571	82	28	-	-	PUNCT
iajs-3571	82	29	value	value	NOUN
iajs-3571	82	30	vldl	vldl	NOUN
iajs-3571	82	31	-	-	PUNCT
iajs-3571	82	32	c	c	NOUN
iajs-3571	82	33	(	(	PUNCT
iajs-3571	82	34	mg	mg	PROPN
iajs-3571	82	35	/	/	SYM
iajs-3571	82	36	dl	dl	NOUN
iajs-3571	82	37	)	)	PUNCT
iajs-3571	82	38	very	very	ADV
iajs-3571	82	39	low	low	ADJ
iajs-3571	82	40	-	-	PUNCT
iajs-3571	82	41	density	density	NOUN
iajs-3571	82	42	lipoprotein	lipoprotein	ADJ
iajs-3571	82	43	38.16±4.51	38.16±4.51	PROPN
iajs-3571	82	44	(	(	PUNCT
iajs-3571	82	45	36	36	NUM
iajs-3571	82	46	)	)	PUNCT
iajs-3571	82	47	39.47±3.53	39.47±3.53	PROPN
iajs-3571	82	48	(	(	PUNCT
iajs-3571	82	49	38.40	38.40	NUM
iajs-3571	82	50	)	)	PUNCT
iajs-3571	82	51	0.817	0.817	NUM
iajs-3571	82	52	data	datum	NOUN
iajs-3571	82	53	were	be	AUX
iajs-3571	82	54	presented	present	VERB
iajs-3571	82	55	as	as	ADP
iajs-3571	82	56	mean	mean	NOUN
iajs-3571	82	57	±	±	NUM
iajs-3571	82	58	se	se	X
iajs-3571	82	59	(	(	PUNCT
iajs-3571	82	60	median	median	PROPN
iajs-3571	82	61	)	)	PUNCT
iajs-3571	82	62	,	,	PUNCT
iajs-3571	82	63	*	*	PUNCT
iajs-3571	82	64	*	*	PUNCT
iajs-3571	82	65	is	be	AUX
iajs-3571	82	66	significant	significant	ADJ
iajs-3571	82	67	at	at	ADP
iajs-3571	82	68	the	the	DET
iajs-3571	82	69	p	p	NOUN
iajs-3571	82	70	value	value	NOUN
iajs-3571	82	71	≤	≤	NUM
iajs-3571	82	72	0.001	0.001	NUM
iajs-3571	82	73	level	level	NOUN
iajs-3571	82	74	.	.	PUNCT
iajs-3571	83	1	there	there	PRON
iajs-3571	83	2	was	be	VERB
iajs-3571	83	3	a	a	DET
iajs-3571	83	4	significant	significant	ADJ
iajs-3571	83	5	difference	difference	NOUN
iajs-3571	83	6	in	in	ADP
iajs-3571	83	7	homa	homa	NOUN
iajs-3571	83	8	-	-	PUNCT
iajs-3571	83	9	ir	ir	PROPN
iajs-3571	83	10	between	between	ADP
iajs-3571	83	11	the	the	DET
iajs-3571	83	12	male	male	ADJ
iajs-3571	83	13	patients	patient	NOUN
iajs-3571	83	14	(	(	PUNCT
iajs-3571	83	15	0.91±150.7	0.91±150.7	NOUN
iajs-3571	83	16	)	)	PUNCT
iajs-3571	83	17	group	group	NOUN
iajs-3571	83	18	and	and	CCONJ
iajs-3571	83	19	the	the	DET
iajs-3571	83	20	control	control	NOUN
iajs-3571	83	21	group	group	NOUN
iajs-3571	83	22	(	(	PUNCT
iajs-3571	83	23	0.11±0.008	0.11±0.008	NOUN
iajs-3571	83	24	)	)	PUNCT
iajs-3571	83	25	at	at	ADP
iajs-3571	83	26	p	p	NOUN
iajs-3571	83	27	-	-	PUNCT
iajs-3571	83	28	value	value	NOUN
iajs-3571	83	29	(	(	PUNCT
iajs-3571	83	30	≤	≤	NOUN
iajs-3571	83	31	0.05	0.05	NUM
iajs-3571	83	32	)	)	PUNCT
iajs-3571	83	33	.	.	PUNCT
iajs-3571	84	1	the	the	DET
iajs-3571	84	2	homa	homa	PROPN
iajs-3571	84	3	-	-	PUNCT
iajs-3571	84	4	ir	ir	PROPN
iajs-3571	84	5	had	have	VERB
iajs-3571	84	6	a	a	DET
iajs-3571	84	7	moderately	moderately	ADV
iajs-3571	84	8	significant	significant	ADJ
iajs-3571	84	9	correlation	correlation	NOUN
iajs-3571	84	10	with	with	ADP
iajs-3571	84	11	the	the	DET
iajs-3571	84	12	increase	increase	NOUN
iajs-3571	84	13	of	of	ADP
iajs-3571	84	14	the	the	DET
iajs-3571	84	15	bmi	bmi	NOUN
iajs-3571	84	16	percentile	percentile	NOUN
iajs-3571	84	17	in	in	ADP
iajs-3571	84	18	the	the	DET
iajs-3571	84	19	study	study	NOUN
iajs-3571	84	20	population	population	NOUN
iajs-3571	84	21	,	,	PUNCT
iajs-3571	84	22	which	which	PRON
iajs-3571	84	23	is	be	AUX
iajs-3571	84	24	why	why	SCONJ
iajs-3571	84	25	the	the	DET
iajs-3571	84	26	current	current	ADJ
iajs-3571	84	27	study	study	NOUN
iajs-3571	84	28	can	can	AUX
iajs-3571	84	29	serve	serve	VERB
iajs-3571	84	30	as	as	ADP
iajs-3571	84	31	evidence	evidence	NOUN
iajs-3571	84	32	to	to	PART
iajs-3571	84	33	propose	propose	VERB
iajs-3571	84	34	an	an	DET
iajs-3571	84	35	early	early	ADJ
iajs-3571	84	36	diagnosis	diagnosis	NOUN
iajs-3571	84	37	of	of	ADP
iajs-3571	84	38	ir	ir	PROPN
iajs-3571	84	39	as	as	ADP
iajs-3571	84	40	a	a	DET
iajs-3571	84	41	preventive	preventive	ADJ
iajs-3571	84	42	measure	measure	NOUN
iajs-3571	84	43	for	for	ADP
iajs-3571	84	44	the	the	DET
iajs-3571	84	45	development	development	NOUN
iajs-3571	84	46	of	of	ADP
iajs-3571	84	47	t2	t2	PROPN
iajs-3571	84	48	dm	dm	PROPN
iajs-3571	84	49	and	and	CCONJ
iajs-3571	84	50	cvd	cvd	PROPN
iajs-3571	84	51	in	in	ADP
iajs-3571	84	52	the	the	DET
iajs-3571	84	53	chiapas	chiapas	PROPN
iajs-3571	84	54	adolescent	adolescent	ADJ
iajs-3571	84	55	population	population	NOUN
iajs-3571	84	56	(	(	PUNCT
iajs-3571	84	57	17	17	NUM
iajs-3571	84	58	)	)	PUNCT
iajs-3571	84	59	,	,	PUNCT
iajs-3571	84	60	and	and	CCONJ
iajs-3571	84	61	this	this	PRON
iajs-3571	84	62	agrees	agree	VERB
iajs-3571	84	63	with	with	ADP
iajs-3571	84	64	the	the	DET
iajs-3571	84	65	current	current	ADJ
iajs-3571	84	66	study	study	NOUN
iajs-3571	84	67	.	.	PUNCT
iajs-3571	85	1	insulin	insulin	NOUN
iajs-3571	85	2	showed	show	VERB
iajs-3571	85	3	a	a	DET
iajs-3571	85	4	significant	significant	ADJ
iajs-3571	85	5	difference	difference	NOUN
iajs-3571	85	6	(	(	PUNCT
iajs-3571	85	7	1.84	1.84	NUM
iajs-3571	85	8	±0.290	±0.290	NOUN
iajs-3571	85	9	)	)	PUNCT
iajs-3571	85	10	for	for	ADP
iajs-3571	85	11	patients	patient	NOUN
iajs-3571	85	12	and	and	CCONJ
iajs-3571	85	13	(	(	PUNCT
iajs-3571	85	14	0.483±0.038	0.483±0.038	PROPN
iajs-3571	85	15	)	)	PUNCT
iajs-3571	85	16	for	for	ADP
iajs-3571	85	17	the	the	DET
iajs-3571	85	18	control	control	NOUN
iajs-3571	85	19	group	group	NOUN
iajs-3571	85	20	at	at	ADP
iajs-3571	85	21	p	p	NOUN
iajs-3571	85	22	-	-	PUNCT
iajs-3571	85	23	value	value	NOUN
iajs-3571	85	24	≤	≤	NOUN
iajs-3571	85	25	0.05	0.05	NUM
iajs-3571	85	26	)	)	PUNCT
iajs-3571	85	27	.	.	PUNCT
iajs-3571	86	1	the	the	DET
iajs-3571	86	2	apelin-36	apelin-36	PROPN
iajs-3571	86	3	showed	show	VERB
iajs-3571	86	4	a	a	DET
iajs-3571	86	5	significant	significant	ADJ
iajs-3571	86	6	difference	difference	NOUN
iajs-3571	86	7	between	between	ADP
iajs-3571	86	8	male	male	ADJ
iajs-3571	86	9	patients	patient	NOUN
iajs-3571	86	10	(	(	PUNCT
iajs-3571	86	11	22.01±1.20	22.01±1.20	NUM
iajs-3571	86	12	)	)	PUNCT
iajs-3571	86	13	and	and	CCONJ
iajs-3571	86	14	the	the	DET
iajs-3571	86	15	male	male	PROPN
iajs-3571	86	16	control	control	NOUN
iajs-3571	86	17	group	group	NOUN
iajs-3571	86	18	(	(	PUNCT
iajs-3571	86	19	10.41±	10.41±	NUM
iajs-3571	86	20	0.32	0.32	NUM
iajs-3571	86	21	)	)	PUNCT
iajs-3571	86	22	.	.	PUNCT
iajs-3571	87	1	previous	previous	ADJ
iajs-3571	87	2	study	study	NOUN
iajs-3571	87	3	indicated	indicate	VERB
iajs-3571	87	4	a	a	DET
iajs-3571	87	5	significant	significant	ADJ
iajs-3571	87	6	relationship	relationship	NOUN
iajs-3571	87	7	between	between	ADP
iajs-3571	87	8	apelin-36	apelin-36	PROPN
iajs-3571	87	9	and	and	CCONJ
iajs-3571	87	10	t2	t2	PROPN
iajs-3571	87	11	dm	dm	PROPN
iajs-3571	87	12	,	,	PUNCT
iajs-3571	87	13	which	which	PRON
iajs-3571	87	14	have	have	AUX
iajs-3571	87	15	reduced	reduce	VERB
iajs-3571	87	16	body	body	NOUN
iajs-3571	87	17	weight	weight	NOUN
iajs-3571	87	18	and	and	CCONJ
iajs-3571	87	19	blood	blood	NOUN
iajs-3571	87	20	glucose	glucose	NOUN
iajs-3571	87	21	while	while	SCONJ
iajs-3571	87	22	improving	improve	VERB
iajs-3571	87	23	glucose	glucose	NOUN
iajs-3571	87	24	tolerance	tolerance	NOUN
iajs-3571	87	25	and	and	CCONJ
iajs-3571	87	26	lipid	lipid	NOUN
iajs-3571	87	27	profile	profile	NOUN
iajs-3571	87	28	(	(	PUNCT
iajs-3571	87	29	18	18	NUM
iajs-3571	87	30	)	)	PUNCT
iajs-3571	87	31	.	.	PUNCT
iajs-3571	88	1	for	for	ADP
iajs-3571	88	2	the	the	DET
iajs-3571	88	3	gst	gst	NOUN
iajs-3571	88	4	activity	activity	NOUN
iajs-3571	88	5	,	,	PUNCT
iajs-3571	88	6	there	there	PRON
iajs-3571	88	7	was	be	VERB
iajs-3571	88	8	a	a	DET
iajs-3571	88	9	non	non	ADJ
iajs-3571	88	10	-	-	ADJ
iajs-3571	88	11	significant	significant	ADJ
iajs-3571	88	12	difference	difference	NOUN
iajs-3571	88	13	between	between	ADP
iajs-3571	88	14	male	male	ADJ
iajs-3571	88	15	patients	patient	NOUN
iajs-3571	88	16	(	(	PUNCT
iajs-3571	88	17	6.66±0.73	6.66±0.73	PROPN
iajs-3571	88	18	)	)	PUNCT
iajs-3571	88	19	and	and	CCONJ
iajs-3571	88	20	the	the	DET
iajs-3571	88	21	male	male	PROPN
iajs-3571	88	22	control	control	NOUN
iajs-3571	88	23	group	group	NOUN
iajs-3571	88	24	(	(	PUNCT
iajs-3571	88	25	6.68	6.68	NUM
iajs-3571	88	26	±	±	NUM
iajs-3571	88	27	0.944	0.944	NUM
iajs-3571	88	28	)	)	PUNCT
iajs-3571	88	29	.	.	PUNCT
iajs-3571	89	1	it	it	PRON
iajs-3571	89	2	has	have	AUX
iajs-3571	89	3	been	be	AUX
iajs-3571	89	4	showed	show	VERB
iajs-3571	89	5	that	that	SCONJ
iajs-3571	89	6	diabetic	diabetic	ADJ
iajs-3571	89	7	patients	patient	NOUN
iajs-3571	89	8	have	have	VERB
iajs-3571	89	9	lower	low	ADJ
iajs-3571	89	10	levels	level	NOUN
iajs-3571	89	11	of	of	ADP
iajs-3571	89	12	antioxidant	antioxidant	ADJ
iajs-3571	89	13	power	power	NOUN
iajs-3571	89	14	,	,	PUNCT
iajs-3571	89	15	which	which	PRON
iajs-3571	89	16	is	be	AUX
iajs-3571	89	17	related	relate	VERB
iajs-3571	89	18	to	to	ADP
iajs-3571	89	19	an	an	DET
iajs-3571	89	20	increased	increase	VERB
iajs-3571	89	21	chance	chance	NOUN
iajs-3571	89	22	of	of	ADP
iajs-3571	89	23	developing	develop	VERB
iajs-3571	89	24	dm	dm	NOUN
iajs-3571	89	25	.	.	PUNCT
iajs-3571	90	1	the	the	DET
iajs-3571	90	2	gst	gst	PROPN
iajs-3571	90	3	play	play	VERB
iajs-3571	90	4	an	an	DET
iajs-3571	90	5	essential	essential	ADJ
iajs-3571	90	6	role	role	NOUN
iajs-3571	90	7	in	in	ADP
iajs-3571	90	8	the	the	DET
iajs-3571	90	9	defense	defense	NOUN
iajs-3571	90	10	of	of	ADP
iajs-3571	90	11	cells	cell	NOUN
iajs-3571	90	12	against	against	ADP
iajs-3571	90	13	ros	ros	PROPN
iajs-3571	90	14	because	because	SCONJ
iajs-3571	90	15	of	of	ADP
iajs-3571	90	16	their	their	PRON
iajs-3571	90	17	ability	ability	NOUN
iajs-3571	90	18	to	to	PART
iajs-3571	90	19	employ	employ	VERB
iajs-3571	90	20	a	a	DET
iajs-3571	90	21	diverse	diverse	ADJ
iajs-3571	90	22	array	array	NOUN
iajs-3571	90	23	of	of	ADP
iajs-3571	90	24	oxidative	oxidative	ADJ
iajs-3571	90	25	stress	stress	NOUN
iajs-3571	90	26	products	product	NOUN
iajs-3571	90	27	as	as	ADP
iajs-3571	90	28	substrates	substrate	NOUN
iajs-3571	90	29	(	(	PUNCT
iajs-3571	90	30	19	19	NUM
iajs-3571	90	31	)	)	PUNCT
iajs-3571	90	32	,	,	PUNCT
iajs-3571	90	33	as	as	SCONJ
iajs-3571	90	34	revealed	reveal	VERB
iajs-3571	90	35	in	in	ADP
iajs-3571	90	36	table	table	NOUN
iajs-3571	90	37	2	2	NUM
iajs-3571	90	38	.	.	PUNCT
iajs-3571	90	39	table	table	NOUN
iajs-3571	90	40	2	2	NUM
iajs-3571	90	41	.	.	PUNCT
iajs-3571	91	1	mean	mean	NOUN
iajs-3571	91	2	±	±	PROPN
iajs-3571	91	3	se	se	PROPN
iajs-3571	91	4	values	value	NOUN
iajs-3571	91	5	between	between	ADP
iajs-3571	91	6	apelin-36	apelin-36	PROPN
iajs-3571	91	7	,	,	PUNCT
iajs-3571	91	8	insulin	insulin	NOUN
iajs-3571	91	9	and	and	CCONJ
iajs-3571	91	10	homa	homa	PROPN
iajs-3571	91	11	ir	ir	PROPN
iajs-3571	91	12	for	for	ADP
iajs-3571	91	13	male	male	ADJ
iajs-3571	91	14	patient	patient	NOUN
iajs-3571	91	15	and	and	CCONJ
iajs-3571	91	16	control	control	NOUN
iajs-3571	91	17	.	.	PUNCT
iajs-3571	92	1	parameters	parameter	NOUN
iajs-3571	92	2	male	male	VERB
iajs-3571	92	3	with	with	ADP
iajs-3571	92	4	t2	t2	PROPN
iajs-3571	92	5	dm	dm	PROPN
iajs-3571	92	6	group	group	NOUN
iajs-3571	92	7	(	(	PUNCT
iajs-3571	92	8	1	1	NUM
iajs-3571	92	9	)	)	PUNCT
iajs-3571	92	10	(	(	PUNCT
iajs-3571	92	11	n=31	n=31	NOUN
iajs-3571	92	12	)	)	PUNCT
iajs-3571	92	13	male	male	ADJ
iajs-3571	92	14	control	control	NOUN
iajs-3571	92	15	group	group	NOUN
iajs-3571	92	16	(	(	PUNCT
iajs-3571	92	17	2	2	NUM
iajs-3571	92	18	)	)	PUNCT
iajs-3571	92	19	(	(	PUNCT
iajs-3571	92	20	n=35	n=35	PROPN
iajs-3571	92	21	)	)	PUNCT
iajs-3571	92	22	p	p	ADJ
iajs-3571	92	23	-	-	PUNCT
iajs-3571	92	24	value	value	NOUN
iajs-3571	92	25	apelin-36	apelin-36	PROPN
iajs-3571	92	26	(	(	PUNCT
iajs-3571	92	27	nmol	nmol	NOUN
iajs-3571	92	28	/	/	SYM
iajs-3571	92	29	ml	ml	NOUN
iajs-3571	92	30	)	)	PUNCT
iajs-3571	92	31	22.01±1.20	22.01±1.20	NUM
iajs-3571	92	32	(	(	PUNCT
iajs-3571	92	33	21.25	21.25	NUM
iajs-3571	92	34	)	)	PUNCT
iajs-3571	92	35	10.41±0.32	10.41±0.32	PROPN
iajs-3571	92	36	(	(	PUNCT
iajs-3571	92	37	10.12	10.12	NUM
iajs-3571	92	38	)	)	PUNCT
iajs-3571	92	39	*	*	PUNCT
iajs-3571	93	1	*	*	PUNCT
iajs-3571	93	2	0.0001	0.0001	NUM
iajs-3571	93	3	insulin	insulin	NOUN
iajs-3571	93	4	(	(	PUNCT
iajs-3571	93	5	ng	ng	PROPN
iajs-3571	93	6	/	/	SYM
iajs-3571	93	7	ml	ml	PROPN
iajs-3571	93	8	)	)	PUNCT
iajs-3571	93	9	1.84±0.290	1.84±0.290	PROPN
iajs-3571	93	10	(	(	PUNCT
iajs-3571	93	11	0.844	0.844	NUM
iajs-3571	93	12	)	)	PUNCT
iajs-3571	93	13	0.483±0.038	0.483±0.038	NOUN
iajs-3571	93	14	(	(	PUNCT
iajs-3571	93	15	0.55	0.55	NUM
iajs-3571	93	16	)	)	PUNCT
iajs-3571	94	1	*	*	PUNCT
iajs-3571	94	2	*	*	PUNCT
iajs-3571	94	3	0.001	0.001	NUM
iajs-3571	94	4	homa	homa	NOUN
iajs-3571	94	5	-	-	PUNCT
iajs-3571	94	6	ir	ir	NOUN
iajs-3571	94	7	insulin	insulin	NOUN
iajs-3571	94	8	resistance	resistance	NOUN
iajs-3571	94	9	0.91±150.7	0.91±150.7	NOUN
iajs-3571	94	10	(	(	PUNCT
iajs-3571	94	11	0.58	0.58	NUM
iajs-3571	94	12	)	)	PUNCT
iajs-3571	94	13	0.11±0.008	0.11±0.008	NOUN
iajs-3571	94	14	(	(	PUNCT
iajs-3571	94	15	0.126	0.126	NUM
iajs-3571	94	16	)	)	PUNCT
iajs-3571	95	1	*	*	PUNCT
iajs-3571	95	2	*	*	PUNCT
iajs-3571	95	3	0.0001	0.0001	NUM
iajs-3571	95	4	gst	gst	NOUN
iajs-3571	95	5	activity	activity	NOUN
iajs-3571	95	6	(	(	PUNCT
iajs-3571	95	7	iu	iu	PROPN
iajs-3571	95	8	/	/	SYM
iajs-3571	95	9	l	l	NOUN
iajs-3571	95	10	)	)	PUNCT
iajs-3571	95	11	glutathione	glutathione	NOUN
iajs-3571	95	12	-	-	PUNCT
iajs-3571	95	13	s	s	NOUN
iajs-3571	95	14	-	-	PUNCT
iajs-3571	95	15	transferase	transferase	NOUN
iajs-3571	95	16	6.66±0.73	6.66±0.73	NOUN
iajs-3571	95	17	(	(	PUNCT
iajs-3571	95	18	5.20	5.20	NUM
iajs-3571	95	19	)	)	PUNCT
iajs-3571	95	20	6.68±0.944	6.68±0.944	PROPN
iajs-3571	95	21	(	(	PUNCT
iajs-3571	95	22	5.20	5.20	NUM
iajs-3571	95	23	)	)	PUNCT
iajs-3571	95	24	0.984	0.984	NUM
iajs-3571	95	25	data	datum	NOUN
iajs-3571	95	26	were	be	AUX
iajs-3571	95	27	presented	present	VERB
iajs-3571	95	28	as	as	ADP
iajs-3571	95	29	mean	mean	NOUN
iajs-3571	95	30	±	±	NUM
iajs-3571	95	31	se	se	X
iajs-3571	95	32	(	(	PUNCT
iajs-3571	95	33	median	median	PROPN
iajs-3571	95	34	)	)	PUNCT
iajs-3571	95	35	,	,	PUNCT
iajs-3571	95	36	*	*	PUNCT
iajs-3571	95	37	*	*	PUNCT
iajs-3571	95	38	is	be	AUX
iajs-3571	95	39	significant	significant	ADJ
iajs-3571	95	40	at	at	ADP
iajs-3571	95	41	the	the	DET
iajs-3571	95	42	p	p	NOUN
iajs-3571	95	43	value	value	NOUN
iajs-3571	95	44	≤	≤	NUM
iajs-3571	95	45	0.001	0.001	NUM
iajs-3571	95	46	level	level	NOUN
iajs-3571	95	47	.	.	PUNCT
iajs-3571	96	1	table	table	NOUN
iajs-3571	96	2	3	3	NUM
iajs-3571	96	3	displays	display	VERB
iajs-3571	96	4	the	the	DET
iajs-3571	96	5	mean	mean	ADJ
iajs-3571	96	6	standard	standard	ADJ
iajs-3571	96	7	error	error	NOUN
iajs-3571	96	8	(	(	PUNCT
iajs-3571	96	9	se	se	X
iajs-3571	96	10	)	)	PUNCT
iajs-3571	96	11	values	value	NOUN
iajs-3571	96	12	for	for	ADP
iajs-3571	96	13	bmi	bmi	NOUN
iajs-3571	96	14	,	,	PUNCT
iajs-3571	96	15	age	age	NOUN
iajs-3571	96	16	,	,	PUNCT
iajs-3571	96	17	cholesterol	cholesterol	NOUN
iajs-3571	96	18	,	,	PUNCT
iajs-3571	96	19	tg	tg	PROPN
iajs-3571	96	20	,	,	PUNCT
iajs-3571	96	21	hdl	hdl	PROPN
iajs-3571	96	22	-	-	PUNCT
iajs-3571	96	23	c	c	PROPN
iajs-3571	96	24	,	,	PUNCT
iajs-3571	96	25	and	and	CCONJ
iajs-3571	96	26	vldl	vldl	PROPN
iajs-3571	96	27	-	-	PUNCT
iajs-3571	96	28	c.	c.	PROPN
iajs-3571	97	1	the	the	DET
iajs-3571	97	2	results	result	NOUN
iajs-3571	97	3	indicate	indicate	VERB
iajs-3571	97	4	a	a	DET
iajs-3571	97	5	non	non	ADJ
iajs-3571	97	6	-	-	ADJ
iajs-3571	97	7	significant	significant	ADJ
iajs-3571	97	8	difference	difference	NOUN
iajs-3571	97	9	between	between	ADP
iajs-3571	97	10	the	the	DET
iajs-3571	97	11	female	female	ADJ
iajs-3571	97	12	patients	patient	NOUN
iajs-3571	97	13	and	and	CCONJ
iajs-3571	97	14	the	the	DET
iajs-3571	97	15	control	control	NOUN
iajs-3571	97	16	group	group	NOUN
iajs-3571	97	17	,	,	PUNCT
iajs-3571	97	18	with	with	ADP
iajs-3571	97	19	a	a	DET
iajs-3571	97	20	p	p	NOUN
iajs-3571	97	21	-	-	PUNCT
iajs-3571	97	22	value	value	NOUN
iajs-3571	97	23	of	of	ADP
iajs-3571	97	24	less	less	ADJ
iajs-3571	97	25	than	than	ADP
iajs-3571	97	26	0.05	0.05	NUM
iajs-3571	97	27	.	.	PUNCT
iajs-3571	98	1	however	however	ADV
iajs-3571	98	2	,	,	PUNCT
iajs-3571	98	3	the	the	DET
iajs-3571	98	4	mean	mean	NOUN
iajs-3571	98	5	se	se	X
iajs-3571	98	6	value	value	NOUN
iajs-3571	98	7	for	for	ADP
iajs-3571	98	8	ldl	ldl	NOUN
iajs-3571	98	9	was	be	AUX
iajs-3571	98	10	significantly	significantly	ADV
iajs-3571	98	11	different	different	ADJ
iajs-3571	98	12	,	,	PUNCT
iajs-3571	98	13	ranging	range	VERB
iajs-3571	98	14	from	from	ADP
iajs-3571	98	15	96.37	96.37	NUM
iajs-3571	98	16	to	to	ADP
iajs-3571	98	17	6.94	6.94	NUM
iajs-3571	98	18	for	for	ADP
iajs-3571	98	19	diabetic	diabetic	ADJ
iajs-3571	98	20	females	female	NOUN
iajs-3571	98	21	to	to	ADP
iajs-3571	98	22	121.73	121.73	NUM
iajs-3571	98	23	to	to	ADP
iajs-3571	98	24	7.34	7.34	NUM
iajs-3571	98	25	for	for	ADP
iajs-3571	98	26	the	the	DET
iajs-3571	98	27	control	control	NOUN
iajs-3571	98	28	group	group	NOUN
iajs-3571	98	29	,	,	PUNCT
iajs-3571	98	30	with	with	ADP
iajs-3571	98	31	a	a	DET
iajs-3571	98	32	p	p	NOUN
iajs-3571	98	33	-	-	PUNCT
iajs-3571	98	34	value	value	NOUN
iajs-3571	98	35	of	of	ADP
iajs-3571	98	36	less	less	ADJ
iajs-3571	98	37	than	than	ADP
iajs-3571	98	38	0.05	0.05	NUM
iajs-3571	98	39	.	.	PUNCT
iajs-3571	98	40	ihjpas	ihjpas	PROPN
iajs-3571	98	41	.	.	PUNCT
iajs-3571	99	1	2025	2025	NUM
iajs-3571	99	2	,	,	PUNCT
iajs-3571	99	3	38(2	38(2	NUM
iajs-3571	99	4	)	)	PUNCT
iajs-3571	99	5	227	227	NUM
iajs-3571	99	6	table	table	NOUN
iajs-3571	99	7	3	3	NUM
iajs-3571	99	8	.	.	PUNCT
iajs-3571	100	1	mean	mean	NOUN
iajs-3571	100	2	±	±	PROPN
iajs-3571	100	3	se	se	X
iajs-3571	100	4	between	between	ADP
iajs-3571	100	5	female	female	ADJ
iajs-3571	100	6	diabetics	diabetic	NOUN
iajs-3571	100	7	and	and	CCONJ
iajs-3571	100	8	female	female	NOUN
iajs-3571	100	9	as	as	ADP
iajs-3571	100	10	controls	control	NOUN
iajs-3571	100	11	.	.	PUNCT
iajs-3571	101	1	parameters	parameter	NOUN
iajs-3571	101	2	female	female	ADJ
iajs-3571	101	3	with	with	ADP
iajs-3571	101	4	t2	t2	PROPN
iajs-3571	101	5	dm	dm	PROPN
iajs-3571	101	6	group	group	NOUN
iajs-3571	101	7	(	(	PUNCT
iajs-3571	101	8	1	1	NUM
iajs-3571	101	9	)	)	PUNCT
iajs-3571	101	10	(	(	PUNCT
iajs-3571	101	11	n=29	n=29	ADJ
iajs-3571	101	12	)	)	PUNCT
iajs-3571	101	13	female	female	ADJ
iajs-3571	101	14	control	control	NOUN
iajs-3571	101	15	group	group	NOUN
iajs-3571	101	16	(	(	PUNCT
iajs-3571	101	17	2	2	NUM
iajs-3571	101	18	)	)	PUNCT
iajs-3571	101	19	(	(	PUNCT
iajs-3571	101	20	n=25	n=25	X
iajs-3571	101	21	)	)	PUNCT
iajs-3571	101	22	p	p	ADJ
iajs-3571	101	23	-	-	PUNCT
iajs-3571	101	24	value	value	NOUN
iajs-3571	101	25	age	age	NOUN
iajs-3571	101	26	(	(	PUNCT
iajs-3571	101	27	year	year	NOUN
iajs-3571	101	28	)	)	PUNCT
iajs-3571	101	29	52.68±1.47	52.68±1.47	PROPN
iajs-3571	101	30	(	(	PUNCT
iajs-3571	101	31	53	53	NUM
iajs-3571	101	32	)	)	PUNCT
iajs-3571	101	33	51.04±2.17	51.04±2.17	PROPN
iajs-3571	101	34	(	(	PUNCT
iajs-3571	101	35	53	53	NUM
iajs-3571	101	36	)	)	PUNCT
iajs-3571	101	37	0.524	0.524	NUM
iajs-3571	101	38	bmi	bmi	X
iajs-3571	101	39	(	(	PUNCT
iajs-3571	101	40	kg	kg	NOUN
iajs-3571	101	41	/	/	SYM
iajs-3571	101	42	m2	m2	PROPN
iajs-3571	101	43	)	)	PUNCT
iajs-3571	101	44	body	body	NOUN
iajs-3571	101	45	mass	mass	NOUN
iajs-3571	101	46	index	index	NOUN
iajs-3571	101	47	33.01±1.19	33.01±1.19	NUM
iajs-3571	101	48	(	(	PUNCT
iajs-3571	101	49	34	34	NUM
iajs-3571	101	50	)	)	PUNCT
iajs-3571	101	51	32.30±0.55	32.30±0.55	PROPN
iajs-3571	101	52	(	(	PUNCT
iajs-3571	101	53	31.1	31.1	NUM
iajs-3571	101	54	)	)	PUNCT
iajs-3571	101	55	0.609	0.609	NUM
iajs-3571	101	56	fbs	fbs	NOUN
iajs-3571	101	57	(	(	PUNCT
iajs-3571	101	58	mg	mg	PROPN
iajs-3571	101	59	/	/	SYM
iajs-3571	101	60	dl	dl	NOUN
iajs-3571	101	61	)	)	PUNCT
iajs-3571	101	62	fasting	fast	VERB
iajs-3571	101	63	blood	blood	NOUN
iajs-3571	101	64	sugar	sugar	NOUN
iajs-3571	101	65	218.68±15.89	218.68±15.89	NUM
iajs-3571	101	66	(	(	PUNCT
iajs-3571	101	67	200	200	NUM
iajs-3571	101	68	)	)	PUNCT
iajs-3571	101	69	95.11±1.87	95.11±1.87	NUM
iajs-3571	101	70	(	(	PUNCT
iajs-3571	101	71	96	96	NUM
iajs-3571	101	72	)	)	PUNCT
iajs-3571	101	73	*	*	PUNCT
iajs-3571	102	1	*	*	PUNCT
iajs-3571	102	2	0.0001	0.0001	NUM
iajs-3571	102	3	hba1c	hba1c	NOUN
iajs-3571	102	4	(	(	PUNCT
iajs-3571	102	5	mg	mg	PROPN
iajs-3571	102	6	/	/	SYM
iajs-3571	102	7	dl	dl	NOUN
iajs-3571	102	8	)	)	PUNCT
iajs-3571	102	9	glycated	glycate	VERB
iajs-3571	102	10	hemoglobin	hemoglobin	NOUN
iajs-3571	102	11	8.381±0.264	8.381±0.264	PROPN
iajs-3571	102	12	(	(	PUNCT
iajs-3571	102	13	8.20	8.20	NUM
iajs-3571	102	14	)	)	PUNCT
iajs-3571	103	1	5.39±0.078	5.39±0.078	NUM
iajs-3571	103	2	(	(	PUNCT
iajs-3571	103	3	5.50	5.50	NUM
iajs-3571	103	4	)	)	PUNCT
iajs-3571	103	5	*	*	PUNCT
iajs-3571	103	6	*	*	PUNCT
iajs-3571	103	7	0.0001	0.0001	NUM
iajs-3571	103	8	cho	cho	NOUN
iajs-3571	103	9	(	(	PUNCT
iajs-3571	103	10	mg	mg	PROPN
iajs-3571	103	11	/	/	SYM
iajs-3571	103	12	dl	dl	NOUN
iajs-3571	103	13	)	)	PUNCT
iajs-3571	103	14	cholesterol	cholesterol	NOUN
iajs-3571	103	15	191.20±14.18	191.20±14.18	NUM
iajs-3571	103	16	(	(	PUNCT
iajs-3571	103	17	173	173	NUM
iajs-3571	103	18	)	)	PUNCT
iajs-3571	103	19	191.92±9.53	191.92±9.53	NUM
iajs-3571	103	20	(	(	PUNCT
iajs-3571	103	21	201	201	NUM
iajs-3571	103	22	)	)	PUNCT
iajs-3571	103	23	0.968	0.968	NUM
iajs-3571	103	24	tg	tg	PROPN
iajs-3571	103	25	(	(	PUNCT
iajs-3571	103	26	mg	mg	PROPN
iajs-3571	103	27	/	/	SYM
iajs-3571	103	28	dl	dl	NOUN
iajs-3571	103	29	)	)	PUNCT
iajs-3571	103	30	triglycerides	triglyceride	NOUN
iajs-3571	103	31	160.96±16.69	160.96±16.69	NOUN
iajs-3571	103	32	(	(	PUNCT
iajs-3571	103	33	133	133	NUM
iajs-3571	103	34	)	)	PUNCT
iajs-3571	103	35	165.18±9.43	165.18±9.43	NUM
iajs-3571	103	36	(	(	PUNCT
iajs-3571	103	37	181	181	NUM
iajs-3571	103	38	)	)	PUNCT
iajs-3571	103	39	0.834	0.834	NUM
iajs-3571	103	40	hdl	hdl	PROPN
iajs-3571	103	41	-	-	PUNCT
iajs-3571	103	42	c	c	PROPN
iajs-3571	103	43	(	(	PUNCT
iajs-3571	103	44	mg	mg	PROPN
iajs-3571	103	45	/	/	SYM
iajs-3571	103	46	dl	dl	NOUN
iajs-3571	103	47	)	)	PUNCT
iajs-3571	103	48	high	high	ADJ
iajs-3571	103	49	-	-	PUNCT
iajs-3571	103	50	density	density	NOUN
iajs-3571	103	51	lipoprotein	lipoprotein	ADJ
iajs-3571	103	52	44.06±2.59	44.06±2.59	NUM
iajs-3571	103	53	(	(	PUNCT
iajs-3571	103	54	44	44	NUM
iajs-3571	103	55	)	)	PUNCT
iajs-3571	103	56	41.80±2.63	41.80±2.63	NOUN
iajs-3571	103	57	(	(	PUNCT
iajs-3571	103	58	37	37	NUM
iajs-3571	103	59	)	)	PUNCT
iajs-3571	103	60	0.544	0.544	NUM
iajs-3571	103	61	ldl	ldl	NOUN
iajs-3571	103	62	-	-	PUNCT
iajs-3571	103	63	c	c	NOUN
iajs-3571	103	64	(	(	PUNCT
iajs-3571	103	65	mg	mg	PROPN
iajs-3571	103	66	/	/	SYM
iajs-3571	103	67	dl	dl	NOUN
iajs-3571	103	68	)	)	PUNCT
iajs-3571	103	69	low	low	ADJ
iajs-3571	103	70	-	-	PUNCT
iajs-3571	103	71	density	density	NOUN
iajs-3571	103	72	lipoprotein	lipoprotein	ADJ
iajs-3571	103	73	96.37±6.94	96.37±6.94	NOUN
iajs-3571	103	74	(	(	PUNCT
iajs-3571	103	75	97	97	NUM
iajs-3571	103	76	)	)	PUNCT
iajs-3571	103	77	121.73±7.34	121.73±7.34	NUM
iajs-3571	103	78	(	(	PUNCT
iajs-3571	103	79	124	124	NUM
iajs-3571	103	80	)	)	PUNCT
iajs-3571	103	81	*	*	PUNCT
iajs-3571	103	82	0.015	0.015	NUM
iajs-3571	103	83	vldl	vldl	NOUN
iajs-3571	103	84	-	-	PUNCT
iajs-3571	103	85	c	c	NOUN
iajs-3571	103	86	(	(	PUNCT
iajs-3571	103	87	mg	mg	PROPN
iajs-3571	103	88	/	/	SYM
iajs-3571	103	89	dl	dl	NOUN
iajs-3571	103	90	)	)	PUNCT
iajs-3571	103	91	very	very	ADV
iajs-3571	103	92	low	low	ADJ
iajs-3571	103	93	-	-	PUNCT
iajs-3571	103	94	density	density	NOUN
iajs-3571	103	95	lipoprotein	lipoprotein	ADJ
iajs-3571	103	96	33.24±3.39	33.24±3.39	NUM
iajs-3571	103	97	(	(	PUNCT
iajs-3571	103	98	27	27	NUM
iajs-3571	103	99	)	)	SYM
iajs-3571	103	100	35.164±3.37	35.164±3.37	NUM
iajs-3571	103	101	(	(	PUNCT
iajs-3571	103	102	36.2	36.2	NUM
iajs-3571	103	103	)	)	PUNCT
iajs-3571	103	104	0.691	0.691	NUM
iajs-3571	103	105	data	datum	NOUN
iajs-3571	103	106	were	be	AUX
iajs-3571	103	107	presented	present	VERB
iajs-3571	103	108	as	as	ADP
iajs-3571	103	109	mean	mean	NOUN
iajs-3571	103	110	±	±	NUM
iajs-3571	103	111	se	se	X
iajs-3571	103	112	(	(	PUNCT
iajs-3571	103	113	median	median	PROPN
iajs-3571	103	114	)	)	PUNCT
iajs-3571	103	115	,	,	PUNCT
iajs-3571	103	116	*	*	PUNCT
iajs-3571	103	117	*	*	PUNCT
iajs-3571	103	118	is	be	AUX
iajs-3571	103	119	significant	significant	ADJ
iajs-3571	103	120	at	at	ADP
iajs-3571	103	121	the	the	DET
iajs-3571	103	122	p	p	NOUN
iajs-3571	103	123	value	value	NOUN
iajs-3571	103	124	≤	≤	NUM
iajs-3571	103	125	0.001	0.001	NUM
iajs-3571	103	126	level	level	NOUN
iajs-3571	103	127	.	.	PUNCT
iajs-3571	104	1	the	the	DET
iajs-3571	104	2	fbs	fbs	PROPN
iajs-3571	104	3	and	and	CCONJ
iajs-3571	104	4	hba1c	hba1c	PROPN
iajs-3571	104	5	gave	give	VERB
iajs-3571	104	6	a	a	DET
iajs-3571	104	7	significant	significant	ADJ
iajs-3571	104	8	difference	difference	NOUN
iajs-3571	104	9	between	between	ADP
iajs-3571	104	10	the	the	DET
iajs-3571	104	11	groups	group	NOUN
iajs-3571	104	12	(	(	PUNCT
iajs-3571	104	13	p	p	NOUN
iajs-3571	104	14	≤	≤	NUM
iajs-3571	104	15	0.05	0.05	NUM
iajs-3571	104	16	)	)	PUNCT
iajs-3571	104	17	.	.	PUNCT
iajs-3571	105	1	fbs	fbs	PROPN
iajs-3571	105	2	's	's	PART
iajs-3571	105	3	mean	mean	ADJ
iajs-3571	105	4	±	±	PROPN
iajs-3571	105	5	se	se	PROPN
iajs-3571	105	6	values	value	NOUN
iajs-3571	105	7	were	be	AUX
iajs-3571	105	8	(	(	PUNCT
iajs-3571	105	9	218.68±15.89	218.68±15.89	NOUN
iajs-3571	105	10	)	)	PUNCT
iajs-3571	105	11	for	for	ADP
iajs-3571	105	12	t2	t2	NOUN
iajs-3571	105	13	dm	dm	PROPN
iajs-3571	105	14	patients	patient	NOUN
iajs-3571	105	15	and	and	CCONJ
iajs-3571	105	16	(	(	PUNCT
iajs-3571	105	17	95.11±1.87	95.11±1.87	NUM
iajs-3571	105	18	)	)	PUNCT
iajs-3571	105	19	for	for	ADP
iajs-3571	105	20	control	control	NOUN
iajs-3571	105	21	and	and	CCONJ
iajs-3571	105	22	for	for	ADP
iajs-3571	105	23	the	the	DET
iajs-3571	105	24	hba1c	hba1c	PROPN
iajs-3571	105	25	was	be	AUX
iajs-3571	105	26	(	(	PUNCT
iajs-3571	105	27	8.381±0.264	8.381±0.264	NOUN
iajs-3571	105	28	)	)	PUNCT
iajs-3571	105	29	for	for	ADP
iajs-3571	105	30	patients	patient	NOUN
iajs-3571	105	31	with	with	ADP
iajs-3571	105	32	dm	dm	PROPN
iajs-3571	105	33	and	and	CCONJ
iajs-3571	105	34	5.39±0.078	5.39±0.078	PROPN
iajs-3571	105	35	for	for	ADP
iajs-3571	105	36	controls	control	NOUN
iajs-3571	105	37	,	,	PUNCT
iajs-3571	105	38	as	as	SCONJ
iajs-3571	105	39	shown	show	VERB
iajs-3571	105	40	in	in	ADP
iajs-3571	105	41	table	table	NOUN
iajs-3571	105	42	3	3	NUM
iajs-3571	105	43	.	.	PUNCT
iajs-3571	106	1	the	the	DET
iajs-3571	106	2	current	current	ADJ
iajs-3571	106	3	results	result	NOUN
iajs-3571	106	4	are	be	AUX
iajs-3571	106	5	consistent	consistent	ADJ
iajs-3571	106	6	with	with	ADP
iajs-3571	106	7	the	the	DET
iajs-3571	106	8	results	result	NOUN
iajs-3571	106	9	of	of	ADP
iajs-3571	106	10	salmeron	salmeron	NOUN
iajs-3571	106	11	et	et	PROPN
iajs-3571	106	12	al	al	PROPN
iajs-3571	106	13	.	.	PROPN
iajs-3571	106	14	,	,	PUNCT
iajs-3571	106	15	who	who	PRON
iajs-3571	106	16	found	find	VERB
iajs-3571	106	17	no	no	DET
iajs-3571	106	18	connection	connection	NOUN
iajs-3571	106	19	between	between	ADP
iajs-3571	106	20	total	total	ADJ
iajs-3571	106	21	fat	fat	ADJ
iajs-3571	106	22	consumption	consumption	NOUN
iajs-3571	106	23	and	and	CCONJ
iajs-3571	106	24	the	the	DET
iajs-3571	106	25	risk	risk	NOUN
iajs-3571	106	26	of	of	ADP
iajs-3571	106	27	t2	t2	NOUN
iajs-3571	106	28	dm	dm	NOUN
iajs-3571	106	29	in	in	ADP
iajs-3571	106	30	their	their	PRON
iajs-3571	106	31	sizeable	sizeable	ADJ
iajs-3571	106	32	prospective	prospective	ADJ
iajs-3571	106	33	study	study	NOUN
iajs-3571	106	34	of	of	ADP
iajs-3571	106	35	women	woman	NOUN
iajs-3571	106	36	(	(	PUNCT
iajs-3571	106	37	20	20	NUM
iajs-3571	106	38	)	)	PUNCT
iajs-3571	106	39	.	.	PUNCT
iajs-3571	107	1	another	another	DET
iajs-3571	107	2	study	study	NOUN
iajs-3571	107	3	found	find	VERB
iajs-3571	107	4	that	that	SCONJ
iajs-3571	107	5	dm	dm	PROPN
iajs-3571	107	6	raises	raise	VERB
iajs-3571	107	7	the	the	DET
iajs-3571	107	8	risk	risk	NOUN
iajs-3571	107	9	of	of	ADP
iajs-3571	107	10	heart	heart	NOUN
iajs-3571	107	11	failure	failure	NOUN
iajs-3571	107	12	,	,	PUNCT
iajs-3571	107	13	and	and	CCONJ
iajs-3571	107	14	women	woman	NOUN
iajs-3571	107	15	with	with	ADP
iajs-3571	107	16	t2	t2	NOUN
iajs-3571	107	17	dm	dm	NUM
iajs-3571	107	18	are	be	AUX
iajs-3571	107	19	much	much	ADV
iajs-3571	107	20	more	more	ADV
iajs-3571	107	21	likely	likely	ADJ
iajs-3571	107	22	to	to	PART
iajs-3571	107	23	have	have	VERB
iajs-3571	107	24	heart	heart	NOUN
iajs-3571	107	25	failure	failure	NOUN
iajs-3571	107	26	than	than	ADP
iajs-3571	107	27	men	man	NOUN
iajs-3571	107	28	with	with	ADP
iajs-3571	107	29	t2	t2	NOUN
iajs-3571	107	30	dm	dm	X
iajs-3571	107	31	(	(	PUNCT
iajs-3571	107	32	21	21	NUM
iajs-3571	107	33	)	)	PUNCT
iajs-3571	107	34	.	.	PUNCT
iajs-3571	108	1	this	this	PRON
iajs-3571	108	2	is	be	AUX
iajs-3571	108	3	due	due	ADJ
iajs-3571	108	4	to	to	ADP
iajs-3571	108	5	the	the	DET
iajs-3571	108	6	increased	increase	VERB
iajs-3571	108	7	ldl	ldl	NOUN
iajs-3571	108	8	and	and	CCONJ
iajs-3571	108	9	its	its	PRON
iajs-3571	108	10	relationship	relationship	NOUN
iajs-3571	108	11	to	to	ADP
iajs-3571	108	12	cvd	cvd	PROPN
iajs-3571	108	13	.	.	PUNCT
iajs-3571	109	1	ldl	ldl	NOUN
iajs-3571	109	2	rises	rise	NOUN
iajs-3571	109	3	,	,	PUNCT
iajs-3571	109	4	indicating	indicate	VERB
iajs-3571	109	5	diabetic	diabetic	ADJ
iajs-3571	109	6	dyslipidemia	dyslipidemia	NOUN
iajs-3571	109	7	and	and	CCONJ
iajs-3571	109	8	a	a	DET
iajs-3571	109	9	higher	high	ADJ
iajs-3571	109	10	risk	risk	NOUN
iajs-3571	109	11	of	of	ADP
iajs-3571	109	12	cvd	cvd	PROPN
iajs-3571	109	13	.	.	PUNCT
iajs-3571	110	1	likewise	likewise	ADV
iajs-3571	110	2	,	,	PUNCT
iajs-3571	110	3	the	the	DET
iajs-3571	110	4	current	current	ADJ
iajs-3571	110	5	study	study	NOUN
iajs-3571	110	6	agrees	agree	VERB
iajs-3571	110	7	with	with	ADP
iajs-3571	110	8	previous	previous	ADJ
iajs-3571	110	9	study	study	NOUN
iajs-3571	110	10	(	(	PUNCT
iajs-3571	110	11	22	22	NUM
iajs-3571	110	12	)	)	PUNCT
iajs-3571	110	13	.	.	PUNCT
iajs-3571	111	1	table	table	NOUN
iajs-3571	111	2	4	4	NUM
iajs-3571	111	3	displays	display	VERB
iajs-3571	111	4	all	all	DET
iajs-3571	111	5	the	the	DET
iajs-3571	111	6	parameters	parameter	NOUN
iajs-3571	111	7	that	that	PRON
iajs-3571	111	8	significantly	significantly	ADV
iajs-3571	111	9	differed	differ	VERB
iajs-3571	111	10	in	in	ADP
iajs-3571	111	11	mean	mean	PROPN
iajs-3571	111	12	se	se	PROPN
iajs-3571	111	13	values	value	NOUN
iajs-3571	111	14	between	between	ADP
iajs-3571	111	15	the	the	DET
iajs-3571	111	16	female	female	ADJ
iajs-3571	111	17	patient	patient	NOUN
iajs-3571	111	18	and	and	CCONJ
iajs-3571	111	19	control	control	NOUN
iajs-3571	111	20	groups	group	NOUN
iajs-3571	111	21	at	at	ADP
iajs-3571	111	22	a	a	DET
iajs-3571	111	23	p	p	NOUN
iajs-3571	111	24	-	-	PUNCT
iajs-3571	111	25	value	value	NOUN
iajs-3571	111	26	of	of	ADP
iajs-3571	111	27	less	less	ADJ
iajs-3571	111	28	than	than	ADP
iajs-3571	111	29	0.05	0.05	NUM
iajs-3571	111	30	.	.	PUNCT
iajs-3571	112	1	the	the	DET
iajs-3571	112	2	mean	mean	ADJ
iajs-3571	112	3	±	±	PROPN
iajs-3571	112	4	se	se	PROPN
iajs-3571	112	5	value	value	NOUN
iajs-3571	112	6	for	for	ADP
iajs-3571	112	7	apelin-36	apelin-36	PROPN
iajs-3571	112	8	was	be	AUX
iajs-3571	112	9	(	(	PUNCT
iajs-3571	112	10	23.80±1.20	23.80±1.20	NUM
iajs-3571	112	11	)	)	PUNCT
iajs-3571	112	12	for	for	ADP
iajs-3571	112	13	patients	patient	NOUN
iajs-3571	112	14	and	and	CCONJ
iajs-3571	112	15	(	(	PUNCT
iajs-3571	112	16	9.99±0.53	9.99±0.53	NOUN
iajs-3571	112	17	)	)	PUNCT
iajs-3571	112	18	for	for	ADP
iajs-3571	112	19	control	control	NOUN
iajs-3571	112	20	,	,	PUNCT
iajs-3571	112	21	and	and	CCONJ
iajs-3571	112	22	the	the	DET
iajs-3571	112	23	mean	mean	ADJ
iajs-3571	112	24	±	±	PROPN
iajs-3571	112	25	se	se	PROPN
iajs-3571	112	26	value	value	NOUN
iajs-3571	112	27	for	for	ADP
iajs-3571	112	28	insulin	insulin	NOUN
iajs-3571	112	29	was	be	AUX
iajs-3571	112	30	(	(	PUNCT
iajs-3571	112	31	2.31±0.25	2.31±0.25	NOUN
iajs-3571	112	32	)	)	PUNCT
iajs-3571	112	33	for	for	ADP
iajs-3571	112	34	patients	patient	NOUN
iajs-3571	112	35	and	and	CCONJ
iajs-3571	112	36	(	(	PUNCT
iajs-3571	112	37	0.70±0.038	0.70±0.038	PROPN
iajs-3571	112	38	)	)	PUNCT
iajs-3571	112	39	for	for	ADP
iajs-3571	112	40	control	control	NOUN
iajs-3571	112	41	.	.	PUNCT
iajs-3571	113	1	the	the	DET
iajs-3571	113	2	mean	mean	ADJ
iajs-3571	113	3	±	±	PROPN
iajs-3571	113	4	se	se	PROPN
iajs-3571	113	5	value	value	NOUN
iajs-3571	113	6	for	for	ADP
iajs-3571	113	7	homa	homa	NOUN
iajs-3571	113	8	-	-	PUNCT
iajs-3571	113	9	ir	ir	PROPN
iajs-3571	113	10	was	be	AUX
iajs-3571	113	11	(	(	PUNCT
iajs-3571	113	12	1.21±0.15	1.21±0.15	NOUN
iajs-3571	113	13	)	)	PUNCT
iajs-3571	113	14	for	for	ADP
iajs-3571	113	15	patients	patient	NOUN
iajs-3571	113	16	and	and	CCONJ
iajs-3571	113	17	(	(	PUNCT
iajs-3571	113	18	0.16±0.009	0.16±0.009	NOUN
iajs-3571	113	19	)	)	PUNCT
iajs-3571	113	20	for	for	ADP
iajs-3571	113	21	controls	control	NOUN
iajs-3571	113	22	.	.	PUNCT
iajs-3571	114	1	at	at	ADP
iajs-3571	114	2	last	last	ADJ
iajs-3571	114	3	,	,	PUNCT
iajs-3571	114	4	the	the	DET
iajs-3571	114	5	significant	significant	ADJ
iajs-3571	114	6	difference	difference	NOUN
iajs-3571	114	7	(	(	PUNCT
iajs-3571	114	8	mean	mean	NOUN
iajs-3571	114	9	±	±	NUM
iajs-3571	114	10	se	se	PROPN
iajs-3571	114	11	value	value	NOUN
iajs-3571	114	12	)	)	PUNCT
iajs-3571	114	13	for	for	ADP
iajs-3571	114	14	gst	gst	PROPN
iajs-3571	114	15	was	be	AUX
iajs-3571	114	16	(	(	PUNCT
iajs-3571	114	17	5.31±0.78	5.31±0.78	NOUN
iajs-3571	114	18	)	)	PUNCT
iajs-3571	114	19	for	for	ADP
iajs-3571	114	20	patients	patient	NOUN
iajs-3571	114	21	and	and	CCONJ
iajs-3571	114	22	(	(	PUNCT
iajs-3571	114	23	7.97±1.37	7.97±1.37	PROPN
iajs-3571	114	24	)	)	PUNCT
iajs-3571	114	25	for	for	ADP
iajs-3571	114	26	controls	control	NOUN
iajs-3571	114	27	,	,	PUNCT
iajs-3571	114	28	as	as	SCONJ
iajs-3571	114	29	shown	show	VERB
iajs-3571	114	30	in	in	ADP
iajs-3571	114	31	table	table	NOUN
iajs-3571	114	32	4	4	NUM
iajs-3571	114	33	.	.	PUNCT
iajs-3571	114	34	ihjpas	ihjpas	PROPN
iajs-3571	114	35	.	.	PUNCT
iajs-3571	115	1	2025	2025	NUM
iajs-3571	115	2	,	,	PUNCT
iajs-3571	115	3	38(2	38(2	NUM
iajs-3571	115	4	)	)	PUNCT
iajs-3571	115	5	228	228	NUM
iajs-3571	115	6	table	table	NOUN
iajs-3571	115	7	4	4	NUM
iajs-3571	115	8	.	.	PUNCT
iajs-3571	116	1	mean	mean	NOUN
iajs-3571	116	2	±	±	PROPN
iajs-3571	116	3	se	se	PROPN
iajs-3571	116	4	values	value	NOUN
iajs-3571	116	5	between	between	ADP
iajs-3571	116	6	apelin-36	apelin-36	PROPN
iajs-3571	116	7	,	,	PUNCT
iajs-3571	116	8	insulin	insulin	NOUN
iajs-3571	116	9	and	and	CCONJ
iajs-3571	116	10	homa	homa	NOUN
iajs-3571	116	11	-	-	PUNCT
iajs-3571	116	12	ir	ir	PROPN
iajs-3571	116	13	for	for	ADP
iajs-3571	116	14	female	female	ADJ
iajs-3571	116	15	patient	patient	NOUN
iajs-3571	116	16	and	and	CCONJ
iajs-3571	116	17	control	control	NOUN
iajs-3571	116	18	.	.	PUNCT
iajs-3571	117	1	parameters	parameter	NOUN
iajs-3571	117	2	female	female	ADJ
iajs-3571	117	3	with	with	ADP
iajs-3571	117	4	t2	t2	PROPN
iajs-3571	117	5	dm	dm	PROPN
iajs-3571	117	6	group	group	NOUN
iajs-3571	117	7	(	(	PUNCT
iajs-3571	117	8	1	1	NUM
iajs-3571	117	9	)	)	PUNCT
iajs-3571	117	10	(	(	PUNCT
iajs-3571	117	11	n=29	n=29	ADJ
iajs-3571	117	12	)	)	PUNCT
iajs-3571	117	13	female	female	ADJ
iajs-3571	117	14	control	control	NOUN
iajs-3571	117	15	group	group	NOUN
iajs-3571	117	16	(	(	PUNCT
iajs-3571	117	17	2	2	NUM
iajs-3571	117	18	)	)	PUNCT
iajs-3571	117	19	(	(	PUNCT
iajs-3571	117	20	n=25	n=25	X
iajs-3571	117	21	)	)	PUNCT
iajs-3571	117	22	p	p	ADJ
iajs-3571	117	23	-	-	PUNCT
iajs-3571	117	24	value	value	NOUN
iajs-3571	117	25	apelin-36	apelin-36	PROPN
iajs-3571	117	26	(	(	PUNCT
iajs-3571	117	27	nmol	nmol	NOUN
iajs-3571	117	28	/	/	SYM
iajs-3571	117	29	ml	ml	NOUN
iajs-3571	117	30	)	)	PUNCT
iajs-3571	117	31	23.80±1.20	23.80±1.20	NUM
iajs-3571	117	32	(	(	PUNCT
iajs-3571	117	33	24.21	24.21	NUM
iajs-3571	117	34	)	)	PUNCT
iajs-3571	117	35	9.99±0.53	9.99±0.53	NOUN
iajs-3571	117	36	(	(	PUNCT
iajs-3571	117	37	9.14	9.14	NUM
iajs-3571	117	38	)	)	PUNCT
iajs-3571	117	39	*	*	PUNCT
iajs-3571	118	1	*	*	PUNCT
iajs-3571	118	2	0.0001	0.0001	NUM
iajs-3571	118	3	insulin	insulin	NOUN
iajs-3571	118	4	(	(	PUNCT
iajs-3571	118	5	ng	ng	PROPN
iajs-3571	118	6	/	/	SYM
iajs-3571	118	7	ml	ml	NOUN
iajs-3571	118	8	)	)	PUNCT
iajs-3571	118	9	2.31±0.25	2.31±0.25	NOUN
iajs-3571	118	10	(	(	PUNCT
iajs-3571	118	11	2.81	2.81	NUM
iajs-3571	118	12	)	)	PUNCT
iajs-3571	119	1	0.70±0.038	0.70±0.038	PROPN
iajs-3571	119	2	(	(	PUNCT
iajs-3571	119	3	0.77	0.77	NUM
iajs-3571	119	4	)	)	PUNCT
iajs-3571	120	1	*	*	PUNCT
iajs-3571	120	2	*	*	PUNCT
iajs-3571	120	3	0.001	0.001	NUM
iajs-3571	120	4	homa	homa	PROPN
iajs-3571	120	5	ir	ir	PROPN
iajs-3571	120	6	insulin	insulin	NOUN
iajs-3571	120	7	resistance	resistance	NOUN
iajs-3571	120	8	1.21±0.15	1.21±0.15	PROPN
iajs-3571	120	9	(	(	PUNCT
iajs-3571	120	10	1.29	1.29	NUM
iajs-3571	120	11	)	)	PUNCT
iajs-3571	120	12	0.16±0.009	0.16±0.009	PROPN
iajs-3571	120	13	(	(	PUNCT
iajs-3571	120	14	0.17	0.17	NUM
iajs-3571	120	15	)	)	PUNCT
iajs-3571	120	16	*	*	PUNCT
iajs-3571	121	1	*	*	PUNCT
iajs-3571	121	2	0.0001	0.0001	NUM
iajs-3571	121	3	gst	gst	NOUN
iajs-3571	121	4	activity	activity	NOUN
iajs-3571	121	5	(	(	PUNCT
iajs-3571	121	6	iu	iu	PROPN
iajs-3571	121	7	/	/	SYM
iajs-3571	121	8	l	l	NOUN
iajs-3571	121	9	)	)	PUNCT
iajs-3571	121	10	glutathione	glutathione	NOUN
iajs-3571	121	11	-	-	PUNCT
iajs-3571	121	12	s	s	NOUN
iajs-3571	121	13	-	-	PUNCT
iajs-3571	121	14	transferase	transferase	NOUN
iajs-3571	121	15	5.31±0.78	5.31±0.78	NOUN
iajs-3571	121	16	(	(	PUNCT
iajs-3571	121	17	3.64	3.64	NUM
iajs-3571	121	18	)	)	PUNCT
iajs-3571	121	19	7.97±1.37	7.97±1.37	PROPN
iajs-3571	121	20	(	(	PUNCT
iajs-3571	121	21	4.60	4.60	NUM
iajs-3571	121	22	)	)	PUNCT
iajs-3571	121	23	*	*	PUNCT
iajs-3571	122	1	0.088	0.088	NUM
iajs-3571	122	2	data	datum	NOUN
iajs-3571	122	3	were	be	AUX
iajs-3571	122	4	presented	present	VERB
iajs-3571	122	5	as	as	ADP
iajs-3571	122	6	mean	mean	NOUN
iajs-3571	122	7	±	±	NUM
iajs-3571	122	8	se	se	X
iajs-3571	122	9	(	(	PUNCT
iajs-3571	122	10	median	median	PROPN
iajs-3571	122	11	)	)	PUNCT
iajs-3571	122	12	,	,	PUNCT
iajs-3571	122	13	*	*	PUNCT
iajs-3571	122	14	*	*	PUNCT
iajs-3571	122	15	is	be	AUX
iajs-3571	122	16	significant	significant	ADJ
iajs-3571	122	17	at	at	ADP
iajs-3571	122	18	the	the	DET
iajs-3571	122	19	p	p	NOUN
iajs-3571	122	20	value	value	NOUN
iajs-3571	122	21	≤	≤	NUM
iajs-3571	122	22	0.001	0.001	NUM
iajs-3571	122	23	level	level	NOUN
iajs-3571	122	24	there	there	PRON
iajs-3571	122	25	was	be	VERB
iajs-3571	122	26	a	a	DET
iajs-3571	122	27	significant	significant	ADJ
iajs-3571	122	28	difference	difference	NOUN
iajs-3571	122	29	in	in	ADP
iajs-3571	122	30	homa	homa	PROPN
iajs-3571	122	31	ir	ir	PROPN
iajs-3571	122	32	between	between	ADP
iajs-3571	122	33	females	female	NOUN
iajs-3571	122	34	and	and	CCONJ
iajs-3571	122	35	control	control	NOUN
iajs-3571	122	36	females	female	NOUN
iajs-3571	122	37	;	;	PUNCT
iajs-3571	122	38	this	this	DET
iajs-3571	122	39	value	value	NOUN
iajs-3571	122	40	was	be	AUX
iajs-3571	122	41	higher	high	ADJ
iajs-3571	122	42	than	than	ADP
iajs-3571	122	43	that	that	PRON
iajs-3571	122	44	of	of	ADP
iajs-3571	122	45	males	male	NOUN
iajs-3571	122	46	,	,	PUNCT
iajs-3571	122	47	and	and	CCONJ
iajs-3571	122	48	the	the	DET
iajs-3571	122	49	homa	homa	NOUN
iajs-3571	122	50	-	-	PUNCT
iajs-3571	122	51	ir	ir	NOUN
iajs-3571	122	52	index	index	NOUN
iajs-3571	122	53	of	of	ADP
iajs-3571	122	54	female	female	ADJ
iajs-3571	122	55	patients	patient	NOUN
iajs-3571	122	56	was	be	AUX
iajs-3571	122	57	significantly	significantly	ADV
iajs-3571	122	58	higher	high	ADJ
iajs-3571	122	59	than	than	ADP
iajs-3571	122	60	that	that	PRON
iajs-3571	122	61	of	of	ADP
iajs-3571	122	62	males	male	NOUN
iajs-3571	122	63	.	.	PUNCT
iajs-3571	123	1	these	these	DET
iajs-3571	123	2	results	result	NOUN
iajs-3571	123	3	agree	agree	VERB
iajs-3571	123	4	with	with	ADP
iajs-3571	123	5	previous	previous	ADJ
iajs-3571	123	6	study	study	NOUN
iajs-3571	123	7	(	(	PUNCT
iajs-3571	123	8	23	23	NUM
iajs-3571	123	9	)	)	PUNCT
iajs-3571	123	10	.	.	PUNCT
iajs-3571	124	1	table	table	NOUN
iajs-3571	124	2	5	5	NUM
iajs-3571	124	3	displays	display	VERB
iajs-3571	124	4	the	the	DET
iajs-3571	124	5	correlation	correlation	NOUN
iajs-3571	124	6	results	result	NOUN
iajs-3571	124	7	for	for	ADP
iajs-3571	124	8	apelin-36	apelin-36	PROPN
iajs-3571	124	9	in	in	ADP
iajs-3571	124	10	both	both	CCONJ
iajs-3571	124	11	the	the	DET
iajs-3571	124	12	male	male	ADJ
iajs-3571	124	13	and	and	CCONJ
iajs-3571	124	14	female	female	ADJ
iajs-3571	124	15	groups	group	NOUN
iajs-3571	124	16	.	.	PUNCT
iajs-3571	125	1	table	table	NOUN
iajs-3571	125	2	5	5	NUM
iajs-3571	125	3	.	.	PUNCT
iajs-3571	126	1	the	the	DET
iajs-3571	126	2	correlation	correlation	NOUN
iajs-3571	126	3	of	of	ADP
iajs-3571	126	4	apelin-36	apelin-36	PROPN
iajs-3571	126	5	for	for	ADP
iajs-3571	126	6	male	male	ADJ
iajs-3571	126	7	and	and	CCONJ
iajs-3571	126	8	female	female	ADJ
iajs-3571	126	9	groups	group	NOUN
iajs-3571	126	10	.	.	PUNCT
iajs-3571	127	1	apelin-36	apelin-36	PROPN
iajs-3571	127	2	(	(	PUNCT
iajs-3571	127	3	nmol	nmol	PROPN
iajs-3571	127	4	/	/	SYM
iajs-3571	127	5	ml	ml	NOUN
iajs-3571	127	6	)	)	PUNCT
iajs-3571	127	7	for	for	ADP
iajs-3571	127	8	male	male	ADJ
iajs-3571	127	9	(	(	PUNCT
iajs-3571	127	10	n=31	n=31	NOUN
iajs-3571	127	11	)	)	PUNCT
iajs-3571	127	12	apelin-36	apelin-36	PROPN
iajs-3571	127	13	(	(	PUNCT
iajs-3571	127	14	nmol	nmol	PROPN
iajs-3571	127	15	/	/	SYM
iajs-3571	127	16	ml	ml	NOUN
iajs-3571	127	17	)	)	PUNCT
iajs-3571	127	18	for	for	ADP
iajs-3571	127	19	female	female	ADJ
iajs-3571	127	20	(	(	PUNCT
iajs-3571	127	21	n=29	n=29	ADJ
iajs-3571	127	22	)	)	PUNCT
iajs-3571	127	23	parameters	parameter	NOUN
iajs-3571	127	24	person	person	NOUN
iajs-3571	127	25	correlation	correlation	NOUN
iajs-3571	127	26	sig.(2.tailed	sig.(2.taile	VERB
iajs-3571	127	27	)	)	PUNCT
iajs-3571	127	28	person	person	NOUN
iajs-3571	127	29	correlation	correlation	NOUN
iajs-3571	127	30	sig.(2.tailed	sig.(2.taile	VERB
iajs-3571	127	31	)	)	PUNCT
iajs-3571	127	32	age	age	NOUN
iajs-3571	127	33	(	(	PUNCT
iajs-3571	127	34	year	year	NOUN
iajs-3571	127	35	)	)	PUNCT
iajs-3571	127	36	0.034	0.034	NUM
iajs-3571	127	37	0.856	0.856	NUM
iajs-3571	127	38	0.010	0.010	NUM
iajs-3571	127	39	0.957	0.957	NUM
iajs-3571	127	40	bmi	bmi	NOUN
iajs-3571	127	41	(	(	PUNCT
iajs-3571	127	42	kg	kg	NOUN
iajs-3571	127	43	/	/	SYM
iajs-3571	127	44	m2	m2	PROPN
iajs-3571	127	45	)	)	PUNCT
iajs-3571	127	46	0.582	0.582	NUM
iajs-3571	127	47	*	*	PUNCT
iajs-3571	127	48	*	*	NOUN
iajs-3571	128	1	0.001	0.001	NUM
iajs-3571	128	2	0.543	0.543	NUM
iajs-3571	128	3	*	*	NOUN
iajs-3571	128	4	*	*	PUNCT
iajs-3571	128	5	0.002	0.002	NUM
iajs-3571	128	6	tg	tg	PROPN
iajs-3571	128	7	(	(	PUNCT
iajs-3571	128	8	mg	mg	PROPN
iajs-3571	128	9	/	/	SYM
iajs-3571	128	10	dl	dl	NOUN
iajs-3571	128	11	)	)	PUNCT
iajs-3571	128	12	0.150	0.150	NUM
iajs-3571	128	13	0.420	0.420	NUM
iajs-3571	128	14	-0.084	-0.084	NUM
iajs-3571	128	15	0.665	0.665	NUM
iajs-3571	128	16	chol	chol	NOUN
iajs-3571	128	17	(	(	PUNCT
iajs-3571	128	18	mg	mg	PROPN
iajs-3571	128	19	/	/	SYM
iajs-3571	128	20	dl	dl	PROPN
iajs-3571	128	21	)	)	PUNCT
iajs-3571	128	22	-0.165	-0.165	NOUN
iajs-3571	128	23	0.375	0.375	NUM
iajs-3571	128	24	-0.054	-0.054	PUNCT
iajs-3571	128	25	0.779	0.779	NUM
iajs-3571	128	26	hdl	hdl	X
iajs-3571	128	27	(	(	PUNCT
iajs-3571	128	28	mg	mg	PROPN
iajs-3571	128	29	/	/	SYM
iajs-3571	128	30	dl	dl	NOUN
iajs-3571	128	31	)	)	PUNCT
iajs-3571	128	32	-0.32	-0.32	VERB
iajs-3571	128	33	0.865	0.865	NUM
iajs-3571	128	34	-0.092	-0.092	PUNCT
iajs-3571	128	35	0.634	0.634	NUM
iajs-3571	128	36	ldl	ldl	NOUN
iajs-3571	128	37	(	(	PUNCT
iajs-3571	128	38	mg	mg	PROPN
iajs-3571	128	39	/	/	SYM
iajs-3571	128	40	dl	dl	NOUN
iajs-3571	128	41	)	)	PUNCT
iajs-3571	128	42	-0.274	-0.274	NOUN
iajs-3571	128	43	0.137	0.137	NUM
iajs-3571	128	44	-0.287	-0.287	NUM
iajs-3571	128	45	0.131	0.131	NUM
iajs-3571	128	46	vldl	vldl	NOUN
iajs-3571	128	47	(	(	PUNCT
iajs-3571	128	48	mg	mg	PROPN
iajs-3571	128	49	/	/	SYM
iajs-3571	128	50	dl	dl	PROPN
iajs-3571	128	51	)	)	PUNCT
iajs-3571	128	52	-0.080	-0.080	NOUN
iajs-3571	128	53	0.670	0.670	NUM
iajs-3571	128	54	-0.067	-0.067	NUM
iajs-3571	128	55	0.729	0.729	NUM
iajs-3571	128	56	fbs	fbs	X
iajs-3571	128	57	(	(	PUNCT
iajs-3571	128	58	mg	mg	PROPN
iajs-3571	128	59	/	/	SYM
iajs-3571	128	60	dl	dl	PROPN
iajs-3571	128	61	)	)	PUNCT
iajs-3571	128	62	-0.276	-0.276	NOUN
iajs-3571	128	63	0.133	0.133	NUM
iajs-3571	128	64	-0.151	-0.151	SYM
iajs-3571	128	65	0.433	0.433	NUM
iajs-3571	128	66	insulin	insulin	NOUN
iajs-3571	128	67	(	(	PUNCT
iajs-3571	128	68	ng	ng	PROPN
iajs-3571	128	69	/	/	SYM
iajs-3571	128	70	ml	ml	NOUN
iajs-3571	128	71	)	)	PUNCT
iajs-3571	128	72	0.533	0.533	NUM
iajs-3571	128	73	*	*	PUNCT
iajs-3571	128	74	*	*	PUNCT
iajs-3571	128	75	0.002	0.002	NUM
iajs-3571	128	76	0.719	0.719	NUM
iajs-3571	128	77	*	*	PUNCT
iajs-3571	128	78	*	*	PUNCT
iajs-3571	128	79	0.000	0.000	NUM
iajs-3571	128	80	ir	ir	NOUN
iajs-3571	128	81	0.433	0.433	NUM
iajs-3571	128	82	*	*	PUNCT
iajs-3571	128	83	*	*	PUNCT
iajs-3571	128	84	0.015	0.015	NUM
iajs-3571	128	85	0.537	0.537	NUM
iajs-3571	128	86	*	*	SYM
iajs-3571	128	87	*	*	PROPN
iajs-3571	128	88	0.003	0.003	NUM
iajs-3571	128	89	gst	gst	NOUN
iajs-3571	128	90	(	(	PUNCT
iajs-3571	128	91	iu	iu	PROPN
iajs-3571	128	92	/	/	SYM
iajs-3571	128	93	l	l	NOUN
iajs-3571	128	94	)	)	PUNCT
iajs-3571	128	95	-0.012	-0.012	PROPN
iajs-3571	128	96	0.950	0.950	NUM
iajs-3571	128	97	-0.129	-0.129	NUM
iajs-3571	128	98	0.506	0.506	NUM
iajs-3571	128	99	hba1c	hba1c	PROPN
iajs-3571	128	100	(	(	PUNCT
iajs-3571	128	101	%	%	INTJ
iajs-3571	128	102	)	)	PUNCT
iajs-3571	128	103	-0.316	-0.316	PROPN
iajs-3571	128	104	0.083	0.083	NUM
iajs-3571	128	105	0.136	0.136	NUM
iajs-3571	128	106	0.483	0.483	NUM
iajs-3571	128	107	*	*	PUNCT
iajs-3571	128	108	*	*	PUNCT
iajs-3571	128	109	correlation	correlation	NOUN
iajs-3571	128	110	is	be	AUX
iajs-3571	128	111	significant	significant	ADJ
iajs-3571	128	112	at	at	ADP
iajs-3571	128	113	the	the	DET
iajs-3571	128	114	0.001	0.001	NUM
iajs-3571	128	115	level	level	NOUN
iajs-3571	128	116	(	(	PUNCT
iajs-3571	128	117	2	2	NUM
iajs-3571	128	118	-	-	PUNCT
iajs-3571	128	119	tailed	tailed	ADJ
iajs-3571	128	120	)	)	PUNCT
iajs-3571	128	121	.	.	PUNCT
iajs-3571	129	1	when	when	SCONJ
iajs-3571	129	2	comparing	compare	VERB
iajs-3571	129	3	the	the	DET
iajs-3571	129	4	correlation	correlation	NOUN
iajs-3571	129	5	result	result	NOUN
iajs-3571	129	6	values	value	NOUN
iajs-3571	129	7	for	for	ADP
iajs-3571	129	8	all	all	DET
iajs-3571	129	9	parameters	parameter	NOUN
iajs-3571	129	10	for	for	ADP
iajs-3571	129	11	the	the	DET
iajs-3571	129	12	two	two	NUM
iajs-3571	129	13	groups	group	NOUN
iajs-3571	129	14	,	,	PUNCT
iajs-3571	129	15	there	there	PRON
iajs-3571	129	16	was	be	VERB
iajs-3571	129	17	no	no	DET
iajs-3571	129	18	correlation	correlation	NOUN
iajs-3571	129	19	found	find	VERB
iajs-3571	129	20	between	between	ADP
iajs-3571	129	21	apelin-36	apelin-36	PROPN
iajs-3571	129	22	and	and	CCONJ
iajs-3571	129	23	age	age	NOUN
iajs-3571	129	24	,	,	PUNCT
iajs-3571	129	25	lipid	lipid	NOUN
iajs-3571	129	26	profile	profile	NOUN
iajs-3571	129	27	,	,	PUNCT
iajs-3571	129	28	fbs	fbs	PROPN
iajs-3571	129	29	,	,	PUNCT
iajs-3571	129	30	gst	gst	PROPN
iajs-3571	129	31	,	,	PUNCT
iajs-3571	129	32	and	and	CCONJ
iajs-3571	129	33	hba1c	hba1c	PROPN
iajs-3571	129	34	,	,	PUNCT
iajs-3571	129	35	but	but	CCONJ
iajs-3571	129	36	a	a	DET
iajs-3571	129	37	positive	positive	ADJ
iajs-3571	129	38	correlation	correlation	NOUN
iajs-3571	129	39	between	between	ADP
iajs-3571	129	40	apelin-36	apelin-36	PROPN
iajs-3571	129	41	and	and	CCONJ
iajs-3571	129	42	bmi	bmi	NOUN
iajs-3571	129	43	,	,	PUNCT
iajs-3571	129	44	insulin	insulin	NOUN
iajs-3571	129	45	,	,	PUNCT
iajs-3571	129	46	and	and	CCONJ
iajs-3571	129	47	ir	ir	INTJ
iajs-3571	129	48	.	.	PUNCT
iajs-3571	130	1	in	in	ADP
iajs-3571	130	2	this	this	DET
iajs-3571	130	3	aspect	aspect	NOUN
iajs-3571	130	4	,	,	PUNCT
iajs-3571	130	5	current	current	ADJ
iajs-3571	130	6	results	result	NOUN
iajs-3571	130	7	confirm	confirm	VERB
iajs-3571	130	8	that	that	SCONJ
iajs-3571	130	9	apelin-36	apelin-36	PROPN
iajs-3571	130	10	has	have	VERB
iajs-3571	130	11	a	a	DET
iajs-3571	130	12	significant	significant	ADJ
iajs-3571	130	13	relationship	relationship	NOUN
iajs-3571	130	14	with	with	ADP
iajs-3571	130	15	obesity	obesity	NOUN
iajs-3571	130	16	and	and	CCONJ
iajs-3571	130	17	dm	dm	PROPN
iajs-3571	130	18	for	for	ADP
iajs-3571	130	19	both	both	DET
iajs-3571	130	20	sexes	sex	NOUN
iajs-3571	130	21	.	.	PUNCT
iajs-3571	131	1	also	also	ADV
iajs-3571	131	2	,	,	PUNCT
iajs-3571	131	3	obesity	obesity	NOUN
iajs-3571	131	4	has	have	VERB
iajs-3571	131	5	a	a	DET
iajs-3571	131	6	substantial	substantial	ADJ
iajs-3571	131	7	relationship	relationship	NOUN
iajs-3571	131	8	with	with	ADP
iajs-3571	131	9	dm	dm	NOUN
iajs-3571	131	10	,	,	PUNCT
iajs-3571	131	11	and	and	CCONJ
iajs-3571	131	12	the	the	DET
iajs-3571	131	13	homa	homa	NOUN
iajs-3571	131	14	-	-	PUNCT
iajs-3571	131	15	ir	ir	NOUN
iajs-3571	131	16	index	index	NOUN
iajs-3571	131	17	of	of	ADP
iajs-3571	131	18	female	female	ADJ
iajs-3571	131	19	patients	patient	NOUN
iajs-3571	131	20	was	be	AUX
iajs-3571	131	21	significantly	significantly	ADV
iajs-3571	131	22	higher	high	ADJ
iajs-3571	131	23	than	than	ADP
iajs-3571	131	24	that	that	PRON
iajs-3571	131	25	of	of	ADP
iajs-3571	131	26	males	male	NOUN
iajs-3571	131	27	.	.	PUNCT
iajs-3571	132	1	therefore	therefore	ADV
iajs-3571	132	2	,	,	PUNCT
iajs-3571	132	3	apelin-36	apelin-36	PROPN
iajs-3571	132	4	is	be	AUX
iajs-3571	132	5	a	a	DET
iajs-3571	132	6	good	good	ADJ
iajs-3571	132	7	indicator	indicator	NOUN
iajs-3571	132	8	of	of	ADP
iajs-3571	132	9	dm	dm	PROPN
iajs-3571	132	10	in	in	ADP
iajs-3571	132	11	males	male	NOUN
iajs-3571	132	12	and	and	CCONJ
iajs-3571	132	13	females	female	NOUN
iajs-3571	132	14	.	.	PUNCT
iajs-3571	133	1	table	table	NOUN
iajs-3571	133	2	6	6	NUM
iajs-3571	133	3	displays	display	VERB
iajs-3571	133	4	the	the	DET
iajs-3571	133	5	correlation	correlation	NOUN
iajs-3571	133	6	results	result	NOUN
iajs-3571	133	7	for	for	ADP
iajs-3571	133	8	insulin	insulin	NOUN
iajs-3571	133	9	resistance	resistance	NOUN
iajs-3571	133	10	(	(	PUNCT
iajs-3571	133	11	homa	homa	NOUN
iajs-3571	133	12	-	-	PUNCT
iajs-3571	133	13	ir	ir	NOUN
iajs-3571	133	14	)	)	PUNCT
iajs-3571	133	15	for	for	ADP
iajs-3571	133	16	both	both	CCONJ
iajs-3571	133	17	male	male	ADJ
iajs-3571	133	18	and	and	CCONJ
iajs-3571	133	19	female	female	ADJ
iajs-3571	133	20	groups	group	NOUN
iajs-3571	133	21	.	.	PUNCT
iajs-3571	134	1	upon	upon	SCONJ
iajs-3571	134	2	comparing	compare	VERB
iajs-3571	134	3	the	the	DET
iajs-3571	134	4	correlation	correlation	NOUN
iajs-3571	134	5	values	value	NOUN
iajs-3571	134	6	for	for	ADP
iajs-3571	134	7	all	all	DET
iajs-3571	134	8	parameters	parameter	NOUN
iajs-3571	134	9	,	,	PUNCT
iajs-3571	134	10	no	no	DET
iajs-3571	134	11	correlation	correlation	NOUN
iajs-3571	134	12	was	be	AUX
iajs-3571	134	13	found	find	VERB
iajs-3571	134	14	between	between	ADP
iajs-3571	134	15	the	the	DET
iajs-3571	134	16	homa	homa	NOUN
iajs-3571	134	17	-	-	PUNCT
iajs-3571	134	18	ir	ir	PROPN
iajs-3571	134	19	and	and	CCONJ
iajs-3571	134	20	age	age	NOUN
iajs-3571	134	21	,	,	PUNCT
iajs-3571	134	22	lipid	lipid	NOUN
iajs-3571	134	23	profile	profile	NOUN
iajs-3571	134	24	,	,	PUNCT
iajs-3571	134	25	fbs	fbs	PROPN
iajs-3571	134	26	,	,	PUNCT
iajs-3571	134	27	gst	gst	NOUN
iajs-3571	134	28	,	,	PUNCT
iajs-3571	134	29	and	and	CCONJ
iajs-3571	134	30	hba1c	hba1c	PROPN
iajs-3571	134	31	for	for	ADP
iajs-3571	134	32	either	either	DET
iajs-3571	134	33	group	group	NOUN
iajs-3571	134	34	.	.	PUNCT
iajs-3571	135	1	however	however	ADV
iajs-3571	135	2	,	,	PUNCT
iajs-3571	135	3	there	there	PRON
iajs-3571	135	4	was	be	VERB
iajs-3571	135	5	a	a	DET
iajs-3571	135	6	positive	positive	ADJ
iajs-3571	135	7	correlation	correlation	NOUN
iajs-3571	135	8	between	between	ADP
iajs-3571	135	9	the	the	DET
iajs-3571	135	10	homa	homa	NOUN
iajs-3571	135	11	-	-	PUNCT
iajs-3571	135	12	ir	ir	PROPN
iajs-3571	135	13	and	and	CCONJ
iajs-3571	135	14	bmi	bmi	PROPN
iajs-3571	135	15	,	,	PUNCT
iajs-3571	135	16	ihjpas	ihjpas	PROPN
iajs-3571	135	17	.	.	PUNCT
iajs-3571	136	1	2025	2025	NUM
iajs-3571	136	2	,	,	PUNCT
iajs-3571	136	3	38(2	38(2	NUM
iajs-3571	136	4	)	)	PUNCT
iajs-3571	136	5	229	229	NUM
iajs-3571	136	6	insulin	insulin	NOUN
iajs-3571	136	7	,	,	PUNCT
iajs-3571	136	8	and	and	CCONJ
iajs-3571	136	9	apelin-36	apelin-36	PROPN
iajs-3571	136	10	for	for	ADP
iajs-3571	136	11	both	both	DET
iajs-3571	136	12	groups	group	NOUN
iajs-3571	136	13	.	.	PUNCT
iajs-3571	137	1	in	in	ADP
iajs-3571	137	2	this	this	DET
iajs-3571	137	3	aspect	aspect	NOUN
iajs-3571	137	4	,	,	PUNCT
iajs-3571	137	5	current	current	ADJ
iajs-3571	137	6	data	datum	NOUN
iajs-3571	137	7	also	also	ADV
iajs-3571	137	8	confirmed	confirm	VERB
iajs-3571	137	9	that	that	SCONJ
iajs-3571	137	10	ir	ir	PROPN
iajs-3571	137	11	is	be	AUX
iajs-3571	137	12	present	present	ADJ
iajs-3571	137	13	in	in	ADP
iajs-3571	137	14	subjects	subject	NOUN
iajs-3571	137	15	with	with	ADP
iajs-3571	137	16	dm	dm	NUM
iajs-3571	137	17	and	and	CCONJ
iajs-3571	137	18	high	high	ADJ
iajs-3571	137	19	obesity	obesity	NOUN
iajs-3571	137	20	and	and	CCONJ
iajs-3571	137	21	that	that	SCONJ
iajs-3571	137	22	apelin-36	apelin-36	PROPN
iajs-3571	137	23	is	be	AUX
iajs-3571	137	24	a	a	DET
iajs-3571	137	25	significant	significant	ADJ
iajs-3571	137	26	indicator	indicator	NOUN
iajs-3571	137	27	for	for	ADP
iajs-3571	137	28	dm	dm	PROPN
iajs-3571	137	29	in	in	ADP
iajs-3571	137	30	both	both	DET
iajs-3571	137	31	females	female	NOUN
iajs-3571	137	32	and	and	CCONJ
iajs-3571	137	33	males	male	NOUN
iajs-3571	137	34	.	.	PUNCT
iajs-3571	138	1	bmi	bmi	PROPN
iajs-3571	138	2	exhibits	exhibit	VERB
iajs-3571	138	3	a	a	DET
iajs-3571	138	4	positive	positive	ADJ
iajs-3571	138	5	correlation	correlation	NOUN
iajs-3571	138	6	with	with	ADP
iajs-3571	138	7	insulin	insulin	NOUN
iajs-3571	138	8	and	and	CCONJ
iajs-3571	138	9	homair	homair	NOUN
iajs-3571	138	10	,	,	PUNCT
iajs-3571	138	11	as	as	SCONJ
iajs-3571	138	12	the	the	DET
iajs-3571	138	13	ir	ir	PROPN
iajs-3571	138	14	increases	increase	VERB
iajs-3571	138	15	in	in	ADP
iajs-3571	138	16	obese	obese	NOUN
iajs-3571	138	17	with	with	ADP
iajs-3571	138	18	dm	dm	NOUN
iajs-3571	138	19	.	.	PUNCT
iajs-3571	139	1	in	in	ADP
iajs-3571	139	2	another	another	DET
iajs-3571	139	3	study	study	NOUN
iajs-3571	139	4	,	,	PUNCT
iajs-3571	139	5	increased	increase	VERB
iajs-3571	139	6	homa	homa	NOUN
iajs-3571	139	7	-	-	PUNCT
iajs-3571	139	8	ir	ir	PROPN
iajs-3571	139	9	gives	give	VERB
iajs-3571	139	10	rise	rise	NOUN
iajs-3571	139	11	to	to	ADP
iajs-3571	139	12	a	a	DET
iajs-3571	139	13	hyperglycemic	hyperglycemic	ADJ
iajs-3571	139	14	state	state	NOUN
iajs-3571	139	15	and	and	CCONJ
iajs-3571	139	16	is	be	AUX
iajs-3571	139	17	a	a	DET
iajs-3571	139	18	significant	significant	ADJ
iajs-3571	139	19	risk	risk	NOUN
iajs-3571	139	20	factor	factor	NOUN
iajs-3571	139	21	for	for	ADP
iajs-3571	139	22	the	the	DET
iajs-3571	139	23	development	development	NOUN
iajs-3571	139	24	of	of	ADP
iajs-3571	139	25	t2	t2	PROPN
iajs-3571	139	26	dm	dm	PROPN
iajs-3571	139	27	.	.	PROPN
iajs-3571	140	1	based	base	VERB
iajs-3571	140	2	on	on	ADP
iajs-3571	140	3	current	current	ADJ
iajs-3571	140	4	results	result	NOUN
iajs-3571	140	5	,	,	PUNCT
iajs-3571	140	6	it	it	PRON
iajs-3571	140	7	can	can	AUX
iajs-3571	140	8	be	be	AUX
iajs-3571	140	9	concluded	conclude	VERB
iajs-3571	140	10	that	that	SCONJ
iajs-3571	140	11	obesity	obesity	NOUN
iajs-3571	140	12	is	be	AUX
iajs-3571	140	13	a	a	DET
iajs-3571	140	14	risk	risk	NOUN
iajs-3571	140	15	factor	factor	NOUN
iajs-3571	140	16	for	for	ADP
iajs-3571	140	17	the	the	DET
iajs-3571	140	18	development	development	NOUN
iajs-3571	140	19	of	of	ADP
iajs-3571	140	20	t2	t2	PROPN
iajs-3571	140	21	dm	dm	PROPN
iajs-3571	140	22	(	(	PUNCT
iajs-3571	140	23	24	24	NUM
iajs-3571	140	24	)	)	PUNCT
iajs-3571	140	25	.	.	PUNCT
iajs-3571	141	1	table	table	NOUN
iajs-3571	141	2	6	6	NUM
iajs-3571	141	3	.	.	PUNCT
iajs-3571	142	1	the	the	DET
iajs-3571	142	2	correlation	correlation	NOUN
iajs-3571	142	3	of	of	ADP
iajs-3571	142	4	homa	homa	NOUN
iajs-3571	142	5	-	-	PUNCT
iajs-3571	142	6	ir	ir	PROPN
iajs-3571	142	7	for	for	ADP
iajs-3571	142	8	male	male	ADJ
iajs-3571	142	9	and	and	CCONJ
iajs-3571	142	10	female	female	ADJ
iajs-3571	142	11	groups	group	NOUN
iajs-3571	142	12	.	.	PUNCT
iajs-3571	143	1	homa	homa	PROPN
iajs-3571	143	2	ir	ir	PROPN
iajs-3571	143	3	for	for	ADP
iajs-3571	143	4	male	male	ADJ
iajs-3571	143	5	(	(	PUNCT
iajs-3571	143	6	n=31	n=31	NOUN
iajs-3571	143	7	)	)	PUNCT
iajs-3571	143	8	homa	homa	PROPN
iajs-3571	143	9	ir	ir	PROPN
iajs-3571	143	10	for	for	ADP
iajs-3571	143	11	female	female	ADJ
iajs-3571	143	12	(	(	PUNCT
iajs-3571	143	13	n=29	n=29	ADJ
iajs-3571	143	14	)	)	PUNCT
iajs-3571	143	15	parameters	parameter	NOUN
iajs-3571	143	16	person	person	NOUN
iajs-3571	143	17	correlation	correlation	NOUN
iajs-3571	143	18	sig.(2.tailed	sig.(2.taile	VERB
iajs-3571	143	19	)	)	PUNCT
iajs-3571	143	20	person	person	NOUN
iajs-3571	143	21	correlation	correlation	NOUN
iajs-3571	143	22	sig.(2.tailed	sig.(2.taile	VERB
iajs-3571	143	23	)	)	PUNCT
iajs-3571	143	24	age	age	NOUN
iajs-3571	143	25	(	(	PUNCT
iajs-3571	143	26	year	year	NOUN
iajs-3571	143	27	)	)	PUNCT
iajs-3571	143	28	-0.172	-0.172	NUM
iajs-3571	144	1	0.354	0.354	NUM
iajs-3571	144	2	-0.167	-0.167	NUM
iajs-3571	144	3	0.388	0.388	NUM
iajs-3571	144	4	bmi	bmi	NOUN
iajs-3571	144	5	(	(	PUNCT
iajs-3571	144	6	kg	kg	NOUN
iajs-3571	144	7	/	/	SYM
iajs-3571	144	8	m2	m2	PROPN
iajs-3571	144	9	)	)	PUNCT
iajs-3571	144	10	0.591	0.591	NUM
iajs-3571	144	11	*	*	PUNCT
iajs-3571	144	12	*	*	PUNCT
iajs-3571	145	1	0.000	0.000	NUM
iajs-3571	145	2	0.605	0.605	NUM
iajs-3571	145	3	*	*	PUNCT
iajs-3571	145	4	*	*	PUNCT
iajs-3571	145	5	0.001	0.001	NUM
iajs-3571	145	6	tg	tg	INTJ
iajs-3571	145	7	(	(	PUNCT
iajs-3571	145	8	mg	mg	PROPN
iajs-3571	145	9	/	/	SYM
iajs-3571	145	10	dl	dl	NOUN
iajs-3571	145	11	)	)	PUNCT
iajs-3571	145	12	0.280	0.280	NUM
iajs-3571	145	13	0.127	0.127	NUM
iajs-3571	145	14	0.118	0.118	NUM
iajs-3571	145	15	0.542	0.542	NUM
iajs-3571	145	16	chol	chol	NOUN
iajs-3571	145	17	(	(	PUNCT
iajs-3571	145	18	mg	mg	PROPN
iajs-3571	145	19	/	/	SYM
iajs-3571	145	20	dl	dl	PROPN
iajs-3571	145	21	)	)	PUNCT
iajs-3571	145	22	-0.006	-0.006	PROPN
iajs-3571	145	23	0.973	0.973	NUM
iajs-3571	145	24	-0.040	-0.040	NUM
iajs-3571	145	25	0.836	0.836	NUM
iajs-3571	145	26	hdl	hdl	X
iajs-3571	145	27	(	(	PUNCT
iajs-3571	145	28	mg	mg	PROPN
iajs-3571	145	29	/	/	SYM
iajs-3571	145	30	dl	dl	PROPN
iajs-3571	145	31	)	)	PUNCT
iajs-3571	145	32	-0.050	-0.050	PROPN
iajs-3571	145	33	0.790	0.790	NUM
iajs-3571	145	34	0.090	0.090	NUM
iajs-3571	145	35	0.641	0.641	NUM
iajs-3571	145	36	ldl	ldl	NOUN
iajs-3571	145	37	(	(	PUNCT
iajs-3571	145	38	mg	mg	PROPN
iajs-3571	145	39	/	/	SYM
iajs-3571	145	40	dl	dl	PROPN
iajs-3571	145	41	)	)	PUNCT
iajs-3571	145	42	-0.094	-0.094	VERB
iajs-3571	146	1	0.615	0.615	NUM
iajs-3571	146	2	-0.138	-0.138	NUM
iajs-3571	146	3	0.475	0.475	NUM
iajs-3571	146	4	vldl	vldl	NOUN
iajs-3571	146	5	(	(	PUNCT
iajs-3571	146	6	mg	mg	PROPN
iajs-3571	146	7	/	/	SYM
iajs-3571	146	8	dl	dl	PROPN
iajs-3571	146	9	)	)	PUNCT
iajs-3571	146	10	0.036	0.036	NUM
iajs-3571	146	11	0.850	0.850	NUM
iajs-3571	146	12	0.101	0.101	NUM
iajs-3571	146	13	0.604	0.604	NUM
iajs-3571	146	14	fbs	fbs	PROPN
iajs-3571	146	15	(	(	PUNCT
iajs-3571	146	16	mg	mg	PROPN
iajs-3571	146	17	/	/	SYM
iajs-3571	146	18	dl	dl	NOUN
iajs-3571	146	19	)	)	PUNCT
iajs-3571	146	20	0.132	0.132	NUM
iajs-3571	146	21	0.478	0.478	NUM
iajs-3571	146	22	0.336	0.336	NUM
iajs-3571	146	23	0.075	0.075	NUM
iajs-3571	146	24	insulin	insulin	NOUN
iajs-3571	146	25	(	(	PUNCT
iajs-3571	146	26	ng	ng	PROPN
iajs-3571	146	27	/	/	SYM
iajs-3571	146	28	ml	ml	PROPN
iajs-3571	146	29	)	)	PUNCT
iajs-3571	146	30	0.931	0.931	NUM
iajs-3571	146	31	*	*	PUNCT
iajs-3571	146	32	0.000	0.000	NUM
iajs-3571	146	33	0.844	0.844	NUM
iajs-3571	146	34	*	*	PUNCT
iajs-3571	146	35	*	*	PUNCT
iajs-3571	146	36	0.000	0.000	NUM
iajs-3571	146	37	apelin-36	apelin-36	PROPN
iajs-3571	146	38	(	(	PUNCT
iajs-3571	146	39	nmol	nmol	NOUN
iajs-3571	146	40	/	/	SYM
iajs-3571	146	41	ml	ml	NOUN
iajs-3571	146	42	)	)	PUNCT
iajs-3571	146	43	0.433	0.433	NUM
iajs-3571	146	44	*	*	NOUN
iajs-3571	146	45	0.015	0.015	NUM
iajs-3571	146	46	0.537	0.537	NUM
iajs-3571	146	47	*	*	SYM
iajs-3571	146	48	*	*	PROPN
iajs-3571	146	49	0.003	0.003	NUM
iajs-3571	146	50	gst	gst	NOUN
iajs-3571	146	51	(	(	PUNCT
iajs-3571	146	52	iu	iu	PROPN
iajs-3571	146	53	/	/	SYM
iajs-3571	146	54	l	l	NOUN
iajs-3571	146	55	)	)	PUNCT
iajs-3571	146	56	0.240	0.240	NUM
iajs-3571	146	57	0.193	0.193	NUM
iajs-3571	146	58	-0.296	-0.296	NUM
iajs-3571	146	59	0.119	0.119	NUM
iajs-3571	146	60	hba1c	hba1c	PROPN
iajs-3571	146	61	(	(	PUNCT
iajs-3571	146	62	%	%	INTJ
iajs-3571	146	63	)	)	PUNCT
iajs-3571	146	64	-0.008	-0.008	NOUN
iajs-3571	146	65	0.967	0.967	NUM
iajs-3571	146	66	0.074	0.074	NUM
iajs-3571	146	67	0.701	0.701	NUM
iajs-3571	146	68	*	*	PUNCT
iajs-3571	146	69	*	*	PUNCT
iajs-3571	146	70	correlation	correlation	NOUN
iajs-3571	146	71	is	be	AUX
iajs-3571	146	72	significant	significant	ADJ
iajs-3571	146	73	at	at	ADP
iajs-3571	146	74	the	the	DET
iajs-3571	146	75	0.001	0.001	NUM
iajs-3571	146	76	level	level	NOUN
iajs-3571	146	77	(	(	PUNCT
iajs-3571	146	78	2	2	NUM
iajs-3571	146	79	-	-	PUNCT
iajs-3571	146	80	tailed	tailed	ADJ
iajs-3571	146	81	)	)	PUNCT
iajs-3571	146	82	.	.	PUNCT
iajs-3571	147	1	for	for	ADP
iajs-3571	147	2	the	the	DET
iajs-3571	147	3	male	male	ADJ
iajs-3571	147	4	group	group	NOUN
iajs-3571	147	5	,	,	PUNCT
iajs-3571	147	6	the	the	DET
iajs-3571	147	7	roc	roc	PROPN
iajs-3571	147	8	(	(	PUNCT
iajs-3571	147	9	auc	auc	NOUN
iajs-3571	147	10	)	)	PUNCT
iajs-3571	147	11	gave	give	VERB
iajs-3571	147	12	a	a	DET
iajs-3571	147	13	positive	positive	ADJ
iajs-3571	147	14	value	value	NOUN
iajs-3571	147	15	for	for	ADP
iajs-3571	147	16	apelin-36	apelin-36	PROPN
iajs-3571	147	17	;	;	PUNCT
iajs-3571	147	18	the	the	DET
iajs-3571	147	19	result	result	NOUN
iajs-3571	147	20	is	be	AUX
iajs-3571	147	21	an	an	DET
iajs-3571	147	22	excellent	excellent	ADJ
iajs-3571	147	23	value	value	NOUN
iajs-3571	147	24	(	(	PUNCT
iajs-3571	147	25	0.993	0.993	NUM
iajs-3571	147	26	)	)	PUNCT
iajs-3571	147	27	for	for	ADP
iajs-3571	147	28	the	the	DET
iajs-3571	147	29	roc	roc	PROPN
iajs-3571	147	30	.	.	PROPN
iajs-3571	147	31	table	table	PROPN
iajs-3571	147	32	7	7	NUM
iajs-3571	147	33	and	and	CCONJ
iajs-3571	147	34	figure	figure	VERB
iajs-3571	147	35	1	1	NUM
iajs-3571	147	36	demonstrate	demonstrate	VERB
iajs-3571	147	37	that	that	SCONJ
iajs-3571	147	38	apelin-36	apelin-36	PROPN
iajs-3571	147	39	significantly	significantly	ADV
iajs-3571	147	40	impacted	impact	VERB
iajs-3571	147	41	with	with	ADP
iajs-3571	147	42	t2	t2	PROPN
iajs-3571	147	43	dm	dm	PROPN
iajs-3571	147	44	.	.	PUNCT
iajs-3571	148	1	for	for	ADP
iajs-3571	148	2	the	the	DET
iajs-3571	148	3	female	female	ADJ
iajs-3571	148	4	group	group	NOUN
iajs-3571	148	5	,	,	PUNCT
iajs-3571	148	6	the	the	DET
iajs-3571	148	7	roc	roc	PROPN
iajs-3571	148	8	(	(	PUNCT
iajs-3571	148	9	auc	auc	NOUN
iajs-3571	148	10	)	)	PUNCT
iajs-3571	148	11	gave	give	VERB
iajs-3571	148	12	a	a	DET
iajs-3571	148	13	positive	positive	ADJ
iajs-3571	148	14	value	value	NOUN
iajs-3571	148	15	for	for	ADP
iajs-3571	148	16	apelin-36	apelin-36	PROPN
iajs-3571	148	17	;	;	PUNCT
iajs-3571	148	18	the	the	DET
iajs-3571	148	19	result	result	NOUN
iajs-3571	148	20	is	be	AUX
iajs-3571	148	21	an	an	DET
iajs-3571	148	22	excellent	excellent	ADJ
iajs-3571	148	23	value	value	NOUN
iajs-3571	148	24	(	(	PUNCT
iajs-3571	148	25	0.993	0.993	NUM
iajs-3571	148	26	)	)	PUNCT
iajs-3571	148	27	for	for	ADP
iajs-3571	148	28	the	the	DET
iajs-3571	148	29	roc	roc	PROPN
iajs-3571	148	30	.	.	PROPN
iajs-3571	148	31	table	table	NOUN
iajs-3571	148	32	8	8	NUM
iajs-3571	148	33	and	and	CCONJ
iajs-3571	148	34	figure	figure	VERB
iajs-3571	148	35	2	2	NUM
iajs-3571	148	36	demonstrate	demonstrate	VERB
iajs-3571	148	37	that	that	SCONJ
iajs-3571	148	38	apelin-36	apelin-36	PROPN
iajs-3571	148	39	significantly	significantly	ADV
iajs-3571	148	40	impacted	impact	VERB
iajs-3571	148	41	with	with	ADP
iajs-3571	148	42	t2	t2	PROPN
iajs-3571	148	43	dm	dm	PROPN
iajs-3571	148	44	.	.	PUNCT
iajs-3571	149	1	the	the	DET
iajs-3571	149	2	two	two	NUM
iajs-3571	149	3	groups	group	NOUN
iajs-3571	149	4	had	have	VERB
iajs-3571	149	5	excellent	excellent	ADJ
iajs-3571	149	6	results	result	NOUN
iajs-3571	149	7	for	for	ADP
iajs-3571	149	8	linking	link	VERB
iajs-3571	149	9	apelin-36	apelin-36	PROPN
iajs-3571	149	10	with	with	ADP
iajs-3571	149	11	dm	dm	PROPN
iajs-3571	149	12	upon	upon	SCONJ
iajs-3571	149	13	rock	rock	NOUN
iajs-3571	149	14	analysis	analysis	NOUN
iajs-3571	149	15	,	,	PUNCT
iajs-3571	149	16	as	as	SCONJ
iajs-3571	149	17	shown	show	VERB
iajs-3571	149	18	in	in	ADP
iajs-3571	149	19	figures	figure	NOUN
iajs-3571	149	20	1	1	NUM
iajs-3571	149	21	and	and	CCONJ
iajs-3571	149	22	2	2	NUM
iajs-3571	149	23	for	for	ADP
iajs-3571	149	24	the	the	DET
iajs-3571	149	25	male	male	ADJ
iajs-3571	149	26	and	and	CCONJ
iajs-3571	149	27	female	female	ADJ
iajs-3571	149	28	groups	group	NOUN
iajs-3571	149	29	.	.	PUNCT
iajs-3571	150	1	table	table	NOUN
iajs-3571	150	2	7	7	NUM
iajs-3571	150	3	.	.	PUNCT
iajs-3571	151	1	the	the	DET
iajs-3571	151	2	result	result	NOUN
iajs-3571	151	3	of	of	ADP
iajs-3571	151	4	apelin-36	apelin-36	PROPN
iajs-3571	151	5	at	at	ADP
iajs-3571	151	6	the	the	DET
iajs-3571	151	7	roc	roc	PROPN
iajs-3571	151	8	(	(	PUNCT
iajs-3571	151	9	auc	auc	NOUN
iajs-3571	151	10	)	)	PUNCT
iajs-3571	151	11	analysis	analysis	NOUN
iajs-3571	151	12	for	for	ADP
iajs-3571	151	13	male	male	ADJ
iajs-3571	151	14	group	group	NOUN
iajs-3571	151	15	.	.	PUNCT
iajs-3571	152	1	cut	cut	VERB
iajs-3571	152	2	-	-	PUNCT
iajs-3571	152	3	off	off	ADP
iajs-3571	152	4	point	point	NOUN
iajs-3571	152	5	sensitivity	sensitivity	NOUN
iajs-3571	152	6	specificity	specificity	NOUN
iajs-3571	152	7	std	std	NOUN
iajs-3571	152	8	.	.	PUNCT
iajs-3571	152	9	errora	errora	VERB
iajs-3571	152	10	asymptotic	asymptotic	ADJ
iajs-3571	152	11	sig.b	sig.b	PROPN
iajs-3571	152	12	asymptotic	asymptotic	ADJ
iajs-3571	152	13	95	95	NUM
iajs-3571	152	14	%	%	NOUN
iajs-3571	152	15	ci	ci	NOUN
iajs-3571	152	16	0.993	0.993	NUM
iajs-3571	152	17	-	-	SYM
iajs-3571	152	18	12.7310	12.7310	NUM
iajs-3571	152	19	1.000	1.000	NUM
iajs-3571	152	20	0.086	0.086	NUM
iajs-3571	152	21	0.006	0.006	NUM
iajs-3571	152	22	0.0001	0.0001	NUM
iajs-3571	152	23	lower	lower	ADV
iajs-3571	152	24	bound	bind	VERB
iajs-3571	152	25	upper	upper	ADJ
iajs-3571	152	26	bound	bind	VERB
iajs-3571	152	27	0.980	0.980	NUM
iajs-3571	152	28	1.000	1.000	NUM
iajs-3571	152	29	a.	a.	NOUN
iajs-3571	152	30	under	under	ADP
iajs-3571	152	31	the	the	DET
iajs-3571	152	32	nonparametric	nonparametric	NOUN
iajs-3571	152	33	assumption	assumption	NOUN
iajs-3571	152	34	,	,	PUNCT
iajs-3571	152	35	null	null	ADJ
iajs-3571	152	36	hypothesis	hypothesis	NOUN
iajs-3571	152	37	:	:	PUNCT
iajs-3571	152	38	true	true	ADJ
iajs-3571	152	39	area	area	NOUN
iajs-3571	152	40	=	=	SYM
iajs-3571	152	41	0.5	0.5	NUM
iajs-3571	152	42	.	.	PUNCT
iajs-3571	152	43	table	table	NOUN
iajs-3571	152	44	8	8	NUM
iajs-3571	152	45	.	.	PUNCT
iajs-3571	153	1	the	the	DET
iajs-3571	153	2	result	result	NOUN
iajs-3571	153	3	of	of	ADP
iajs-3571	153	4	apelin-36	apelin-36	PROPN
iajs-3571	153	5	at	at	ADP
iajs-3571	153	6	the	the	DET
iajs-3571	153	7	roc	roc	PROPN
iajs-3571	153	8	(	(	PUNCT
iajs-3571	153	9	auc	auc	NOUN
iajs-3571	153	10	)	)	PUNCT
iajs-3571	153	11	analysis	analysis	NOUN
iajs-3571	153	12	for	for	ADP
iajs-3571	153	13	female	female	ADJ
iajs-3571	153	14	group	group	NOUN
iajs-3571	153	15	.	.	PUNCT
iajs-3571	154	1	cut	cut	VERB
iajs-3571	154	2	-	-	PUNCT
iajs-3571	154	3	off	off	ADP
iajs-3571	154	4	point	point	NOUN
iajs-3571	154	5	sensitivity	sensitivity	NOUN
iajs-3571	154	6	specificity	specificity	NOUN
iajs-3571	154	7	std	std	NOUN
iajs-3571	154	8	.	.	PUNCT
iajs-3571	154	9	errora	errora	VERB
iajs-3571	154	10	asymptotic	asymptotic	ADJ
iajs-3571	154	11	sig.b	sig.b	PROPN
iajs-3571	154	12	asymptotic	asymptotic	ADJ
iajs-3571	154	13	95	95	NUM
iajs-3571	154	14	%	%	NOUN
iajs-3571	154	15	ci	ci	NOUN
iajs-3571	154	16	0.977	0.977	NUM
iajs-3571	154	17	-	-	SYM
iajs-3571	154	18	9.3430	9.3430	NUM
iajs-3571	154	19	1.000	1.000	NUM
iajs-3571	154	20	0.320	0.320	NUM
iajs-3571	154	21	0.016	0.016	NUM
iajs-3571	154	22	0.0001	0.0001	NUM
iajs-3571	154	23	lower	lower	ADV
iajs-3571	154	24	bound	bind	VERB
iajs-3571	154	25	upper	upper	ADJ
iajs-3571	154	26	bound	bind	VERB
iajs-3571	154	27	0.945	0.945	NUM
iajs-3571	154	28	1.000	1.000	NUM
iajs-3571	154	29	a.	a.	NOUN
iajs-3571	154	30	under	under	ADP
iajs-3571	154	31	the	the	DET
iajs-3571	154	32	nonparametric	nonparametric	NOUN
iajs-3571	154	33	assumption	assumption	NOUN
iajs-3571	154	34	,	,	PUNCT
iajs-3571	154	35	b.	b.	PROPN
iajs-3571	154	36	null	null	PROPN
iajs-3571	154	37	hypothesis	hypothesis	NOUN
iajs-3571	154	38	:	:	PUNCT
iajs-3571	154	39	true	true	ADJ
iajs-3571	154	40	area	area	NOUN
iajs-3571	154	41	=	=	SYM
iajs-3571	154	42	0.5	0.5	NUM
iajs-3571	154	43	.	.	PUNCT
iajs-3571	154	44	ihjpas	ihjpas	PROPN
iajs-3571	154	45	.	.	PUNCT
iajs-3571	155	1	2025	2025	NUM
iajs-3571	155	2	,	,	PUNCT
iajs-3571	155	3	38(2	38(2	NUM
iajs-3571	155	4	)	)	PUNCT
iajs-3571	155	5	230	230	NUM
iajs-3571	155	6	figure	figure	NOUN
iajs-3571	155	7	1	1	NUM
iajs-3571	155	8	.	.	PUNCT
iajs-3571	156	1	the	the	DET
iajs-3571	156	2	roc	roc	PROPN
iajs-3571	156	3	carve	carve	NOUN
iajs-3571	156	4	for	for	ADP
iajs-3571	156	5	apelin-36	apelin-36	PROPN
iajs-3571	156	6	with	with	ADP
iajs-3571	156	7	diabetic	diabetic	ADJ
iajs-3571	156	8	male	male	NOUN
iajs-3571	156	9	.	.	PUNCT
iajs-3571	157	1	figure	figure	NOUN
iajs-3571	157	2	2	2	NUM
iajs-3571	157	3	.	.	PUNCT
iajs-3571	158	1	the	the	DET
iajs-3571	158	2	roc	roc	PROPN
iajs-3571	158	3	carve	carve	NOUN
iajs-3571	158	4	for	for	ADP
iajs-3571	158	5	apelin-36	apelin-36	PROPN
iajs-3571	158	6	with	with	ADP
iajs-3571	158	7	diabetic	diabetic	ADJ
iajs-3571	158	8	female	female	NOUN
iajs-3571	158	9	.	.	PUNCT
iajs-3571	159	1	the	the	DET
iajs-3571	159	2	present	present	ADJ
iajs-3571	159	3	study	study	NOUN
iajs-3571	159	4	shows	show	VERB
iajs-3571	159	5	that	that	SCONJ
iajs-3571	159	6	males	male	NOUN
iajs-3571	159	7	with	with	ADP
iajs-3571	159	8	advanced	advanced	ADJ
iajs-3571	159	9	age	age	NOUN
iajs-3571	159	10	and	and	CCONJ
iajs-3571	159	11	increased	increase	VERB
iajs-3571	159	12	muscle	muscle	NOUN
iajs-3571	159	13	mass	mass	NOUN
iajs-3571	159	14	and	and	CCONJ
iajs-3571	159	15	weight	weight	NOUN
iajs-3571	159	16	are	be	AUX
iajs-3571	159	17	more	more	ADV
iajs-3571	159	18	likely	likely	ADJ
iajs-3571	159	19	to	to	PART
iajs-3571	159	20	develop	develop	VERB
iajs-3571	159	21	t2	t2	NOUN
iajs-3571	159	22	dm	dm	NOUN
iajs-3571	159	23	.	.	PUNCT
iajs-3571	160	1	they	they	PRON
iajs-3571	160	2	may	may	AUX
iajs-3571	160	3	reach	reach	VERB
iajs-3571	160	4	advanced	advanced	ADJ
iajs-3571	160	5	stages	stage	NOUN
iajs-3571	160	6	of	of	ADP
iajs-3571	160	7	the	the	DET
iajs-3571	160	8	disease	disease	NOUN
iajs-3571	160	9	early	early	ADV
iajs-3571	160	10	,	,	PUNCT
iajs-3571	160	11	and	and	CCONJ
iajs-3571	160	12	women	woman	NOUN
iajs-3571	160	13	are	be	AUX
iajs-3571	160	14	less	less	ADV
iajs-3571	160	15	likely	likely	ADJ
iajs-3571	160	16	to	to	PART
iajs-3571	160	17	develop	develop	VERB
iajs-3571	160	18	diabetes	diabetes	NOUN
iajs-3571	160	19	than	than	ADP
iajs-3571	160	20	men	man	NOUN
iajs-3571	160	21	.	.	PUNCT
iajs-3571	161	1	the	the	DET
iajs-3571	161	2	common	common	ADJ
iajs-3571	161	3	element	element	NOUN
iajs-3571	161	4	between	between	ADP
iajs-3571	161	5	the	the	DET
iajs-3571	161	6	two	two	NUM
iajs-3571	161	7	sexes	sex	NOUN
iajs-3571	161	8	is	be	AUX
iajs-3571	161	9	obesity	obesity	NOUN
iajs-3571	161	10	,	,	PUNCT
iajs-3571	161	11	which	which	PRON
iajs-3571	161	12	is	be	AUX
iajs-3571	161	13	the	the	DET
iajs-3571	161	14	incidence	incidence	NOUN
iajs-3571	161	15	of	of	ADP
iajs-3571	161	16	dm	dm	PROPN
iajs-3571	161	17	.	.	PUNCT
iajs-3571	162	1	the	the	DET
iajs-3571	162	2	weights	weight	NOUN
iajs-3571	162	3	of	of	ADP
iajs-3571	162	4	men	man	NOUN
iajs-3571	162	5	are	be	AUX
iajs-3571	162	6	less	less	ADJ
iajs-3571	162	7	than	than	ADP
iajs-3571	162	8	in	in	ADP
iajs-3571	162	9	women	woman	NOUN
iajs-3571	162	10	,	,	PUNCT
iajs-3571	162	11	which	which	PRON
iajs-3571	162	12	may	may	AUX
iajs-3571	162	13	be	be	AUX
iajs-3571	162	14	attributed	attribute	VERB
iajs-3571	162	15	to	to	ADP
iajs-3571	162	16	the	the	DET
iajs-3571	162	17	pattern	pattern	NOUN
iajs-3571	162	18	of	of	ADP
iajs-3571	162	19	fat	fat	ADJ
iajs-3571	162	20	distribution	distribution	NOUN
iajs-3571	162	21	and	and	CCONJ
iajs-3571	162	22	the	the	DET
iajs-3571	162	23	extent	extent	NOUN
iajs-3571	162	24	of	of	ADP
iajs-3571	162	25	its	its	PRON
iajs-3571	162	26	role	role	NOUN
iajs-3571	162	27	in	in	ADP
iajs-3571	162	28	the	the	DET
iajs-3571	162	29	incidence	incidence	NOUN
iajs-3571	162	30	of	of	ADP
iajs-3571	162	31	the	the	DET
iajs-3571	162	32	disease	disease	NOUN
iajs-3571	162	33	,	,	PUNCT
iajs-3571	162	34	and	and	CCONJ
iajs-3571	162	35	apelin-36	apelin-36	PROPN
iajs-3571	162	36	is	be	AUX
iajs-3571	162	37	a	a	DET
iajs-3571	162	38	good	good	ADJ
iajs-3571	162	39	indicator	indicator	NOUN
iajs-3571	162	40	for	for	ADP
iajs-3571	162	41	male	male	ADJ
iajs-3571	162	42	and	and	CCONJ
iajs-3571	162	43	female	female	ADJ
iajs-3571	162	44	patients	patient	NOUN
iajs-3571	162	45	with	with	ADP
iajs-3571	162	46	t2	t2	PROPN
iajs-3571	162	47	dm	dm	PROPN
iajs-3571	162	48	.	.	PUNCT
iajs-3571	163	1	the	the	DET
iajs-3571	163	2	current	current	ADJ
iajs-3571	163	3	results	result	NOUN
iajs-3571	163	4	agree	agree	VERB
iajs-3571	163	5	with	with	ADP
iajs-3571	163	6	delaney	delaney	PROPN
iajs-3571	163	7	et	et	PROPN
iajs-3571	163	8	al	al	PROPN
iajs-3571	163	9	.	.	PROPN
iajs-3571	163	10	,	,	PUNCT
iajs-3571	163	11	who	who	PRON
iajs-3571	163	12	suggested	suggest	VERB
iajs-3571	163	13	that	that	SCONJ
iajs-3571	163	14	t2	t2	NOUN
iajs-3571	163	15	dm	dm	NOUN
iajs-3571	163	16	is	be	AUX
iajs-3571	163	17	more	more	ADV
iajs-3571	163	18	common	common	ADJ
iajs-3571	163	19	in	in	ADP
iajs-3571	163	20	men	man	NOUN
iajs-3571	163	21	than	than	ADP
iajs-3571	163	22	women	woman	NOUN
iajs-3571	163	23	.	.	PUNCT
iajs-3571	164	1	in	in	ADP
iajs-3571	164	2	middle	middle	ADJ
iajs-3571	164	3	age	age	NOUN
iajs-3571	164	4	,	,	PUNCT
iajs-3571	164	5	more	more	ADJ
iajs-3571	164	6	men	man	NOUN
iajs-3571	164	7	than	than	ADP
iajs-3571	164	8	women	woman	NOUN
iajs-3571	164	9	have	have	VERB
iajs-3571	164	10	t2	t2	NOUN
iajs-3571	164	11	dm	dm	NOUN
iajs-3571	164	12	.	.	PUNCT
iajs-3571	165	1	one	one	NUM
iajs-3571	165	2	of	of	ADP
iajs-3571	165	3	the	the	DET
iajs-3571	165	4	reasons	reason	NOUN
iajs-3571	165	5	that	that	PRON
iajs-3571	165	6	t2	t2	NOUN
iajs-3571	165	7	dm	dm	NOUN
iajs-3571	165	8	is	be	AUX
iajs-3571	165	9	more	more	ADV
iajs-3571	165	10	common	common	ADJ
iajs-3571	165	11	in	in	ADP
iajs-3571	165	12	women	woman	NOUN
iajs-3571	165	13	than	than	ADP
iajs-3571	165	14	in	in	ADP
iajs-3571	165	15	men	man	NOUN
iajs-3571	165	16	that	that	SCONJ
iajs-3571	165	17	the	the	DET
iajs-3571	165	18	difference	difference	NOUN
iajs-3571	165	19	in	in	ADP
iajs-3571	165	20	the	the	DET
iajs-3571	165	21	distribution	distribution	NOUN
iajs-3571	165	22	of	of	ADP
iajs-3571	165	23	adipose	adipose	ADJ
iajs-3571	165	24	tissue	tissue	NOUN
iajs-3571	165	25	(	(	PUNCT
iajs-3571	165	26	fat	fat	NOUN
iajs-3571	165	27	)	)	PUNCT
iajs-3571	165	28	in	in	ADP
iajs-3571	165	29	different	different	ADJ
iajs-3571	165	30	body	body	NOUN
iajs-3571	165	31	regions	region	NOUN
iajs-3571	165	32	in	in	ADP
iajs-3571	165	33	women	woman	NOUN
iajs-3571	165	34	than	than	ADP
iajs-3571	165	35	in	in	ADP
iajs-3571	165	36	men	man	NOUN
iajs-3571	165	37	(	(	PUNCT
iajs-3571	165	38	25,26	25,26	NOUN
iajs-3571	165	39	)	)	PUNCT
iajs-3571	165	40	indicated	indicate	VERB
iajs-3571	165	41	that	that	SCONJ
iajs-3571	165	42	the	the	DET
iajs-3571	165	43	greater	great	ADJ
iajs-3571	165	44	prevalence	prevalence	NOUN
iajs-3571	165	45	of	of	ADP
iajs-3571	165	46	t2	t2	NOUN
iajs-3571	165	47	dm	dm	NOUN
iajs-3571	165	48	in	in	ADP
iajs-3571	165	49	older	old	ADJ
iajs-3571	165	50	men	man	NOUN
iajs-3571	165	51	compared	compare	VERB
iajs-3571	165	52	to	to	ADP
iajs-3571	165	53	older	old	ADJ
iajs-3571	165	54	women	woman	NOUN
iajs-3571	165	55	was	be	AUX
iajs-3571	165	56	associated	associate	VERB
iajs-3571	165	57	with	with	ADP
iajs-3571	165	58	a	a	DET
iajs-3571	165	59	higher	high	ADJ
iajs-3571	165	60	visceral	visceral	ADJ
iajs-3571	165	61	fat	fat	ADJ
iajs-3571	165	62	percentage	percentage	NOUN
iajs-3571	165	63	in	in	ADP
iajs-3571	165	64	men	man	NOUN
iajs-3571	165	65	.	.	PUNCT
iajs-3571	166	1	in	in	ADP
iajs-3571	166	2	contrast	contrast	NOUN
iajs-3571	166	3	,	,	PUNCT
iajs-3571	166	4	bmi	bmi	PROPN
iajs-3571	166	5	differences	difference	NOUN
iajs-3571	166	6	were	be	AUX
iajs-3571	166	7	not	not	PART
iajs-3571	166	8	related	relate	VERB
iajs-3571	166	9	to	to	ADP
iajs-3571	166	10	this	this	DET
iajs-3571	166	11	disparity	disparity	NOUN
iajs-3571	166	12	.	.	PUNCT
iajs-3571	167	1	also	also	ADV
iajs-3571	167	2	,	,	PUNCT
iajs-3571	167	3	sex	sex	NOUN
iajs-3571	167	4	differences	difference	NOUN
iajs-3571	167	5	have	have	AUX
iajs-3571	167	6	been	be	AUX
iajs-3571	167	7	found	find	VERB
iajs-3571	167	8	in	in	ADP
iajs-3571	167	9	the	the	DET
iajs-3571	167	10	onset	onset	NOUN
iajs-3571	167	11	and	and	CCONJ
iajs-3571	167	12	development	development	NOUN
iajs-3571	167	13	of	of	ADP
iajs-3571	167	14	diabetic	diabetic	ADJ
iajs-3571	167	15	problems	problem	NOUN
iajs-3571	167	16	,	,	PUNCT
iajs-3571	167	17	which	which	PRON
iajs-3571	167	18	shows	show	VERB
iajs-3571	167	19	how	how	SCONJ
iajs-3571	167	20	important	important	ADJ
iajs-3571	167	21	it	it	PRON
iajs-3571	167	22	is	be	AUX
iajs-3571	167	23	to	to	PART
iajs-3571	167	24	treat	treat	VERB
iajs-3571	167	25	dm	dm	NUM
iajs-3571	167	26	differently	differently	ADV
iajs-3571	167	27	for	for	ADP
iajs-3571	167	28	men	man	NOUN
iajs-3571	167	29	and	and	CCONJ
iajs-3571	167	30	women	woman	NOUN
iajs-3571	167	31	.	.	PUNCT
iajs-3571	168	1	as	as	ADP
iajs-3571	168	2	with	with	ADP
iajs-3571	168	3	almost	almost	ADV
iajs-3571	168	4	all	all	DET
iajs-3571	168	5	diseases	disease	NOUN
iajs-3571	168	6	,	,	PUNCT
iajs-3571	168	7	the	the	DET
iajs-3571	168	8	sex	sex	NOUN
iajs-3571	168	9	of	of	ADP
iajs-3571	168	10	the	the	DET
iajs-3571	168	11	person	person	NOUN
iajs-3571	168	12	with	with	ADP
iajs-3571	168	13	dm	dm	PRON
iajs-3571	168	14	should	should	AUX
iajs-3571	168	15	be	be	AUX
iajs-3571	168	16	taken	take	VERB
iajs-3571	168	17	into	into	ADP
iajs-3571	168	18	account	account	NOUN
iajs-3571	168	19	when	when	SCONJ
iajs-3571	168	20	deciding	decide	VERB
iajs-3571	168	21	how	how	SCONJ
iajs-3571	168	22	to	to	PART
iajs-3571	168	23	treat	treat	VERB
iajs-3571	168	24	them	they	PRON
iajs-3571	168	25	(	(	PUNCT
iajs-3571	168	26	27	27	NUM
iajs-3571	168	27	)	)	PUNCT
iajs-3571	168	28	.	.	PUNCT
iajs-3571	169	1	diabetes	diabetes	NOUN
iajs-3571	169	2	raises	raise	VERB
iajs-3571	169	3	the	the	DET
iajs-3571	169	4	risk	risk	NOUN
iajs-3571	169	5	of	of	ADP
iajs-3571	169	6	cvd	cvd	PROPN
iajs-3571	169	7	,	,	PUNCT
iajs-3571	169	8	and	and	CCONJ
iajs-3571	169	9	women	woman	NOUN
iajs-3571	169	10	with	with	ADP
iajs-3571	169	11	diabetes	diabetes	NOUN
iajs-3571	169	12	are	be	AUX
iajs-3571	169	13	much	much	ADV
iajs-3571	169	14	more	more	ADV
iajs-3571	169	15	likely	likely	ADJ
iajs-3571	169	16	to	to	PART
iajs-3571	169	17	have	have	VERB
iajs-3571	169	18	heart	heart	NOUN
iajs-3571	169	19	failure	failure	NOUN
iajs-3571	169	20	than	than	ADP
iajs-3571	169	21	men	man	NOUN
iajs-3571	169	22	with	with	ADP
iajs-3571	169	23	dm	dm	PROPN
iajs-3571	169	24	(	(	PUNCT
iajs-3571	169	25	28	28	NUM
iajs-3571	169	26	)	)	PUNCT
iajs-3571	169	27	.	.	PUNCT
iajs-3571	170	1	t2	t2	NOUN
iajs-3571	170	2	dm	dm	PROPN
iajs-3571	170	3	causes	cause	VERB
iajs-3571	170	4	several	several	ADJ
iajs-3571	170	5	problems	problem	NOUN
iajs-3571	170	6	with	with	ADP
iajs-3571	170	7	the	the	DET
iajs-3571	170	8	large	large	ADJ
iajs-3571	170	9	blood	blood	NOUN
iajs-3571	170	10	vessels	vessel	NOUN
iajs-3571	170	11	through	through	ADP
iajs-3571	170	12	different	different	ADJ
iajs-3571	170	13	pathogenic	pathogenic	ADJ
iajs-3571	170	14	pathways	pathway	NOUN
iajs-3571	170	15	,	,	PUNCT
iajs-3571	170	16	such	such	ADJ
iajs-3571	170	17	as	as	ADP
iajs-3571	170	18	high	high	ADJ
iajs-3571	170	19	blood	blood	NOUN
iajs-3571	170	20	sugar	sugar	NOUN
iajs-3571	170	21	and	and	CCONJ
iajs-3571	170	22	ir	ir	PROPN
iajs-3571	170	23	.	.	PROPN
iajs-3571	171	1	t2	t2	PROPN
iajs-3571	171	2	dm	dm	PROPN
iajs-3571	171	3	is	be	AUX
iajs-3571	171	4	accompanied	accompany	VERB
iajs-3571	171	5	by	by	ADP
iajs-3571	171	6	arterial	arterial	ADJ
iajs-3571	171	7	disease	disease	NOUN
iajs-3571	171	8	(	(	PUNCT
iajs-3571	171	9	29	29	NUM
iajs-3571	171	10	)	)	PUNCT
iajs-3571	171	11	.	.	PUNCT
iajs-3571	172	1	age	age	NOUN
iajs-3571	172	2	at	at	ADP
iajs-3571	172	3	t2	t2	NOUN
iajs-3571	172	4	dm	dm	PROPN
iajs-3571	172	5	diagnosis	diagnosis	NOUN
iajs-3571	172	6	has	have	VERB
iajs-3571	172	7	predictive	predictive	ADJ
iajs-3571	172	8	importance	importance	NOUN
iajs-3571	172	9	for	for	ADP
iajs-3571	172	10	life	life	NOUN
iajs-3571	172	11	and	and	CCONJ
iajs-3571	172	12	cardiovascular	cardiovascular	ADJ
iajs-3571	172	13	risks	risk	NOUN
iajs-3571	172	14	,	,	PUNCT
iajs-3571	172	15	which	which	PRON
iajs-3571	172	16	has	have	VERB
iajs-3571	172	17	implications	implication	NOUN
iajs-3571	172	18	for	for	ADP
iajs-3571	172	19	determining	determine	VERB
iajs-3571	172	20	appropriate	appropriate	ADJ
iajs-3571	172	21	treatment	treatment	NOUN
iajs-3571	172	22	strategies	strategy	NOUN
iajs-3571	172	23	,	,	PUNCT
iajs-3571	172	24	making	make	VERB
iajs-3571	172	25	clinical	clinical	ADJ
iajs-3571	172	26	decisions	decision	NOUN
iajs-3571	172	27	,	,	PUNCT
iajs-3571	172	28	and	and	CCONJ
iajs-3571	172	29	giving	give	VERB
iajs-3571	172	30	care	care	NOUN
iajs-3571	172	31	based	base	VERB
iajs-3571	172	32	on	on	ADP
iajs-3571	172	33	guidelines	guideline	NOUN
iajs-3571	172	34	.	.	PUNCT
iajs-3571	173	1	based	base	VERB
iajs-3571	173	2	on	on	ADP
iajs-3571	173	3	this	this	DET
iajs-3571	173	4	result	result	NOUN
iajs-3571	173	5	,	,	PUNCT
iajs-3571	173	6	t2	t2	NOUN
iajs-3571	173	7	dm	dm	PROPN
iajs-3571	173	8	is	be	AUX
iajs-3571	173	9	more	more	ADV
iajs-3571	173	10	likely	likely	ADJ
iajs-3571	173	11	to	to	PART
iajs-3571	173	12	be	be	AUX
iajs-3571	173	13	prevented	prevent	VERB
iajs-3571	173	14	or	or	CCONJ
iajs-3571	173	15	delayed	delay	VERB
iajs-3571	173	16	in	in	ADP
iajs-3571	173	17	younger	young	ADJ
iajs-3571	173	18	people	people	NOUN
iajs-3571	173	19	(	(	PUNCT
iajs-3571	173	20	30	30	NUM
iajs-3571	173	21	)	)	PUNCT
iajs-3571	173	22	.	.	PUNCT
iajs-3571	174	1	in	in	ADP
iajs-3571	174	2	patients	patient	NOUN
iajs-3571	174	3	with	with	ADP
iajs-3571	174	4	t2	t2	PROPN
iajs-3571	174	5	dm	dm	PROPN
iajs-3571	174	6	,	,	PUNCT
iajs-3571	174	7	the	the	DET
iajs-3571	174	8	disease	disease	NOUN
iajs-3571	174	9	becomes	become	VERB
iajs-3571	174	10	more	more	ADV
iajs-3571	174	11	complicated	complicated	ADJ
iajs-3571	174	12	after	after	ADP
iajs-3571	174	13	a	a	DET
iajs-3571	174	14	long	long	ADJ
iajs-3571	174	15	time	time	NOUN
iajs-3571	174	16	,	,	PUNCT
iajs-3571	174	17	for	for	ADP
iajs-3571	174	18	example	example	NOUN
iajs-3571	174	19	,	,	PUNCT
iajs-3571	174	20	diseases	disease	NOUN
iajs-3571	174	21	of	of	ADP
iajs-3571	174	22	the	the	DET
iajs-3571	174	23	liver	liver	NOUN
iajs-3571	174	24	,	,	PUNCT
iajs-3571	174	25	kidneys	kidney	NOUN
iajs-3571	174	26	,	,	PUNCT
iajs-3571	174	27	heart	heart	NOUN
iajs-3571	174	28	,	,	PUNCT
iajs-3571	174	29	and	and	CCONJ
iajs-3571	174	30	retinas	retina	NOUN
iajs-3571	174	31	.	.	PUNCT
iajs-3571	175	1	elevated	elevated	ADJ
iajs-3571	175	2	serum	serum	NOUN
iajs-3571	175	3	concentrations	concentration	NOUN
iajs-3571	175	4	of	of	ADP
iajs-3571	175	5	enzymatic	enzymatic	ADJ
iajs-3571	175	6	and	and	CCONJ
iajs-3571	175	7	non	non	ADJ
iajs-3571	175	8	-	-	ADJ
iajs-3571	175	9	enzymatic	enzymatic	ADJ
iajs-3571	175	10	markers	marker	NOUN
iajs-3571	175	11	of	of	ADP
iajs-3571	175	12	liver	liver	NOUN
iajs-3571	175	13	function	function	NOUN
iajs-3571	175	14	in	in	ADP
iajs-3571	175	15	t2	t2	NOUN
iajs-3571	175	16	dm	dm	AUX
iajs-3571	175	17	support	support	VERB
iajs-3571	175	18	the	the	DET
iajs-3571	175	19	hypothesis	hypothesis	NOUN
iajs-3571	175	20	that	that	PRON
iajs-3571	175	21	the	the	DET
iajs-3571	175	22	liver	liver	NOUN
iajs-3571	175	23	plays	play	VERB
iajs-3571	175	24	a	a	DET
iajs-3571	175	25	vital	vital	ADJ
iajs-3571	175	26	role	role	NOUN
iajs-3571	175	27	in	in	ADP
iajs-3571	175	28	the	the	DET
iajs-3571	175	29	pathogenesis	pathogenesis	NOUN
iajs-3571	175	30	of	of	ADP
iajs-3571	175	31	t2	t2	NOUN
iajs-3571	175	32	dm	dm	NOUN
iajs-3571	175	33	and	and	CCONJ
iajs-3571	175	34	that	that	SCONJ
iajs-3571	175	35	hepatic	hepatic	ADJ
iajs-3571	175	36	enzymes	enzyme	NOUN
iajs-3571	175	37	may	may	AUX
iajs-3571	175	38	be	be	AUX
iajs-3571	175	39	helpful	helpful	ADJ
iajs-3571	175	40	to	to	ADP
iajs-3571	175	41	additional	additional	ADJ
iajs-3571	175	42	markers	marker	NOUN
iajs-3571	175	43	of	of	ADP
iajs-3571	175	44	individuals	individual	NOUN
iajs-3571	175	45	at	at	ADP
iajs-3571	175	46	high	high	ADJ
iajs-3571	175	47	risk	risk	NOUN
iajs-3571	175	48	for	for	ADP
iajs-3571	175	49	developing	develop	VERB
iajs-3571	175	50	dm	dm	PROPN
iajs-3571	175	51	.	.	PUNCT
iajs-3571	175	52	elevated	elevate	VERB
iajs-3571	175	53	levels	level	NOUN
iajs-3571	175	54	of	of	ADP
iajs-3571	175	55	renal	renal	ADJ
iajs-3571	175	56	profile	profile	NOUN
iajs-3571	175	57	markers	marker	NOUN
iajs-3571	175	58	in	in	ADP
iajs-3571	175	59	the	the	DET
iajs-3571	175	60	serum	serum	NOUN
iajs-3571	175	61	were	be	AUX
iajs-3571	175	62	associated	associate	VERB
iajs-3571	175	63	with	with	ADP
iajs-3571	175	64	an	an	DET
iajs-3571	175	65	increased	increase	VERB
iajs-3571	175	66	risk	risk	NOUN
iajs-3571	175	67	of	of	ADP
iajs-3571	175	68	t2	t2	NOUN
iajs-3571	175	69	dm	dm	NOUN
iajs-3571	175	70	and	and	CCONJ
iajs-3571	175	71	hyperglycemia	hyperglycemia	NOUN
iajs-3571	175	72	.	.	PUNCT
iajs-3571	176	1	as	as	SCONJ
iajs-3571	176	2	dm	dm	PROPN
iajs-3571	176	3	is	be	AUX
iajs-3571	176	4	the	the	DET
iajs-3571	176	5	primary	primary	ADJ
iajs-3571	176	6	cause	cause	NOUN
iajs-3571	176	7	of	of	ADP
iajs-3571	176	8	renal	renal	ADJ
iajs-3571	176	9	morbidity	morbidity	NOUN
iajs-3571	176	10	and	and	CCONJ
iajs-3571	176	11	mortality	mortality	NOUN
iajs-3571	176	12	,	,	PUNCT
iajs-3571	176	13	sugar	sugar	NOUN
iajs-3571	176	14	management	management	NOUN
iajs-3571	176	15	can	can	AUX
iajs-3571	176	16	reverse	reverse	VERB
iajs-3571	176	17	the	the	DET
iajs-3571	176	18	progression	progression	NOUN
iajs-3571	176	19	of	of	ADP
iajs-3571	176	20	kidney	kidney	NOUN
iajs-3571	176	21	damage	damage	NOUN
iajs-3571	176	22	(	(	PUNCT
iajs-3571	176	23	31	31	NUM
iajs-3571	176	24	)	)	PUNCT
iajs-3571	176	25	.	.	PUNCT
iajs-3571	177	1	previous	previous	ADJ
iajs-3571	177	2	study	study	NOUN
iajs-3571	177	3	showed	show	VERB
iajs-3571	177	4	that	that	SCONJ
iajs-3571	177	5	age	age	NOUN
iajs-3571	177	6	plays	play	VERB
iajs-3571	177	7	a	a	DET
iajs-3571	177	8	significant	significant	ADJ
iajs-3571	177	9	part	part	NOUN
iajs-3571	177	10	in	in	ADP
iajs-3571	177	11	developing	develop	VERB
iajs-3571	177	12	t2	t2	NOUN
iajs-3571	177	13	dm	dm	NOUN
iajs-3571	177	14	risk	risk	NOUN
iajs-3571	177	15	after	after	ADP
iajs-3571	177	16	40	40	NUM
iajs-3571	177	17	years	year	NOUN
iajs-3571	177	18	(	(	PUNCT
iajs-3571	177	19	32	32	NUM
iajs-3571	177	20	)	)	PUNCT
iajs-3571	177	21	.	.	PUNCT
iajs-3571	178	1	adopting	adopt	VERB
iajs-3571	178	2	a	a	DET
iajs-3571	178	3	healthy	healthy	ADJ
iajs-3571	178	4	lifestyle	lifestyle	NOUN
iajs-3571	178	5	is	be	AUX
iajs-3571	178	6	associated	associate	VERB
iajs-3571	178	7	with	with	ADP
iajs-3571	178	8	a	a	DET
iajs-3571	178	9	considerable	considerable	ADJ
iajs-3571	178	10	reduction	reduction	NOUN
iajs-3571	178	11	in	in	ADP
iajs-3571	178	12	the	the	DET
iajs-3571	178	13	risk	risk	NOUN
iajs-3571	178	14	of	of	ADP
iajs-3571	178	15	t2	t2	NOUN
iajs-3571	178	16	dm	dm	NUM
iajs-3571	178	17	and	and	CCONJ
iajs-3571	178	18	adverse	adverse	ADJ
iajs-3571	178	19	long	long	ADJ
iajs-3571	178	20	-	-	PUNCT
iajs-3571	178	21	term	term	NOUN
iajs-3571	178	22	ihjpas	ihjpa	NOUN
iajs-3571	178	23	.	.	PUNCT
iajs-3571	179	1	2025	2025	NUM
iajs-3571	179	2	,	,	PUNCT
iajs-3571	179	3	38(2	38(2	NUM
iajs-3571	179	4	)	)	PUNCT
iajs-3571	179	5	231	231	NUM
iajs-3571	179	6	outcomes	outcome	NOUN
iajs-3571	179	7	among	among	ADP
iajs-3571	179	8	diabetic	diabetic	ADJ
iajs-3571	179	9	patients	patient	NOUN
iajs-3571	179	10	;	;	PUNCT
iajs-3571	179	11	reducing	reduce	VERB
iajs-3571	179	12	the	the	DET
iajs-3571	179	13	global	global	ADJ
iajs-3571	179	14	burden	burden	NOUN
iajs-3571	179	15	of	of	ADP
iajs-3571	179	16	t2	t2	NOUN
iajs-3571	179	17	dm	dm	NUM
iajs-3571	179	18	should	should	AUX
iajs-3571	179	19	be	be	AUX
iajs-3571	179	20	based	base	VERB
iajs-3571	179	21	on	on	ADP
iajs-3571	179	22	addressing	address	VERB
iajs-3571	179	23	multiple	multiple	ADJ
iajs-3571	179	24	risk	risk	NOUN
iajs-3571	179	25	factors	factor	NOUN
iajs-3571	179	26	(	(	PUNCT
iajs-3571	179	27	33	33	NUM
iajs-3571	179	28	)	)	PUNCT
iajs-3571	179	29	.	.	PUNCT
iajs-3571	180	1	4	4	X
iajs-3571	180	2	.	.	X
iajs-3571	180	3	conclusion	conclusion	NOUN
iajs-3571	180	4	in	in	ADP
iajs-3571	180	5	conclusion	conclusion	NOUN
iajs-3571	180	6	,	,	PUNCT
iajs-3571	180	7	apelin-36	apelin-36	PROPN
iajs-3571	180	8	is	be	AUX
iajs-3571	180	9	a	a	DET
iajs-3571	180	10	good	good	ADJ
iajs-3571	180	11	indicator	indicator	NOUN
iajs-3571	180	12	for	for	ADP
iajs-3571	180	13	patients	patient	NOUN
iajs-3571	180	14	with	with	ADP
iajs-3571	180	15	t2	t2	PROPN
iajs-3571	180	16	dm	dm	PROPN
iajs-3571	180	17	,	,	PUNCT
iajs-3571	180	18	both	both	DET
iajs-3571	180	19	males	male	NOUN
iajs-3571	180	20	and	and	CCONJ
iajs-3571	180	21	females	female	NOUN
iajs-3571	180	22	.	.	PUNCT
iajs-3571	181	1	although	although	SCONJ
iajs-3571	181	2	women	woman	NOUN
iajs-3571	181	3	are	be	AUX
iajs-3571	181	4	less	less	ADV
iajs-3571	181	5	likely	likely	ADJ
iajs-3571	181	6	to	to	PART
iajs-3571	181	7	develop	develop	VERB
iajs-3571	181	8	dm	dm	PROPN
iajs-3571	181	9	than	than	ADP
iajs-3571	181	10	men	man	NOUN
iajs-3571	181	11	,	,	PUNCT
iajs-3571	181	12	they	they	PRON
iajs-3571	181	13	are	be	AUX
iajs-3571	181	14	more	more	ADV
iajs-3571	181	15	likely	likely	ADJ
iajs-3571	181	16	to	to	PART
iajs-3571	181	17	experience	experience	VERB
iajs-3571	181	18	common	common	ADJ
iajs-3571	181	19	complications	complication	NOUN
iajs-3571	181	20	,	,	PUNCT
iajs-3571	181	21	such	such	ADJ
iajs-3571	181	22	as	as	ADP
iajs-3571	181	23	cvd	cvd	PROPN
iajs-3571	181	24	.	.	PUNCT
iajs-3571	182	1	on	on	ADP
iajs-3571	182	2	the	the	DET
iajs-3571	182	3	other	other	ADJ
iajs-3571	182	4	hand	hand	NOUN
iajs-3571	182	5	,	,	PUNCT
iajs-3571	182	6	men	man	NOUN
iajs-3571	182	7	are	be	AUX
iajs-3571	182	8	more	more	ADV
iajs-3571	182	9	likely	likely	ADJ
iajs-3571	182	10	to	to	PART
iajs-3571	182	11	develop	develop	VERB
iajs-3571	182	12	t2	t2	NOUN
iajs-3571	182	13	dm	dm	NOUN
iajs-3571	182	14	due	due	ADP
iajs-3571	182	15	to	to	ADP
iajs-3571	182	16	factors	factor	NOUN
iajs-3571	182	17	such	such	ADJ
iajs-3571	182	18	as	as	ADP
iajs-3571	182	19	age	age	NOUN
iajs-3571	182	20	,	,	PUNCT
iajs-3571	182	21	higher	high	ADJ
iajs-3571	182	22	muscle	muscle	NOUN
iajs-3571	182	23	mass	mass	NOUN
iajs-3571	182	24	(	(	PUNCT
iajs-3571	182	25	bmi	bmi	PROPN
iajs-3571	182	26	)	)	PUNCT
iajs-3571	182	27	,	,	PUNCT
iajs-3571	182	28	and	and	CCONJ
iajs-3571	182	29	weight	weight	NOUN
iajs-3571	182	30	.	.	PUNCT
iajs-3571	183	1	acknowledgment	acknowledgment	NOUN
iajs-3571	183	2	the	the	DET
iajs-3571	183	3	authors	author	NOUN
iajs-3571	183	4	thank	thank	VERB
iajs-3571	183	5	the	the	DET
iajs-3571	183	6	department	department	NOUN
iajs-3571	183	7	of	of	ADP
iajs-3571	183	8	chemistry/	chemistry/	NUM
iajs-3571	183	9	college	college	NOUN
iajs-3571	183	10	of	of	ADP
iajs-3571	183	11	sciences	science	NOUN
iajs-3571	183	12	for	for	ADP
iajs-3571	183	13	women/	women/	NUM
iajs-3571	183	14	university	university	NOUN
iajs-3571	183	15	of	of	ADP
iajs-3571	183	16	baghdad	baghdad	PROPN
iajs-3571	183	17	and	and	CCONJ
iajs-3571	183	18	the	the	DET
iajs-3571	183	19	national	national	PROPN
iajs-3571	183	20	diabetic	diabetic	PROPN
iajs-3571	183	21	centre/	centre/	PROPN
iajs-3571	183	22	al	al	PROPN
iajs-3571	183	23	-	-	PUNCT
iajs-3571	183	24	mustansiriyah	mustansiriyah	NOUN
iajs-3571	183	25	university	university	NOUN
iajs-3571	183	26	for	for	ADP
iajs-3571	183	27	their	their	PRON
iajs-3571	183	28	support	support	NOUN
iajs-3571	183	29	.	.	PUNCT
iajs-3571	184	1	conflict	conflict	NOUN
iajs-3571	184	2	of	of	ADP
iajs-3571	184	3	interest	interest	NOUN
iajs-3571	184	4	there	there	PRON
iajs-3571	184	5	was	be	VERB
iajs-3571	184	6	no	no	DET
iajs-3571	184	7	conflict	conflict	NOUN
iajs-3571	184	8	of	of	ADP
iajs-3571	184	9	interest	interest	NOUN
iajs-3571	184	10	.	.	PUNCT
iajs-3571	185	1	funding	fund	VERB
iajs-3571	185	2	the	the	DET
iajs-3571	185	3	research	research	NOUN
iajs-3571	185	4	work	work	NOUN
iajs-3571	185	5	did	do	AUX
iajs-3571	185	6	not	not	PART
iajs-3571	185	7	include	include	VERB
iajs-3571	185	8	any	any	DET
iajs-3571	185	9	funding	funding	NOUN
iajs-3571	185	10	or	or	CCONJ
iajs-3571	185	11	financial	financial	ADJ
iajs-3571	185	12	support	support	NOUN
iajs-3571	185	13	.	.	PUNCT
iajs-3571	186	1	ethical	ethical	ADJ
iajs-3571	186	2	clearance	clearance	NOUN
iajs-3571	186	3	this	this	DET
iajs-3571	186	4	study	study	NOUN
iajs-3571	186	5	was	be	AUX
iajs-3571	186	6	approved	approve	VERB
iajs-3571	186	7	by	by	ADP
iajs-3571	186	8	the	the	DET
iajs-3571	186	9	scientific	scientific	ADJ
iajs-3571	186	10	committee	committee	NOUN
iajs-3571	186	11	at	at	ADP
iajs-3571	186	12	the	the	DET
iajs-3571	186	13	department	department	NOUN
iajs-3571	186	14	of	of	ADP
iajs-3571	186	15	chemistry/	chemistry/	NUM
iajs-3571	186	16	college	college	NOUN
iajs-3571	186	17	of	of	ADP
iajs-3571	186	18	science	science	NOUN
iajs-3571	186	19	for	for	ADP
iajs-3571	186	20	women/	women/	NUM
iajs-3571	186	21	university	university	NOUN
iajs-3571	186	22	of	of	ADP
iajs-3571	186	23	baghdad	baghdad	PROPN
iajs-3571	186	24	.	.	PUNCT
iajs-3571	187	1	references	reference	NOUN
iajs-3571	187	2	1	1	NUM
iajs-3571	187	3	.	.	PUNCT
iajs-3571	188	1	abdullah	abdullah	PROPN
iajs-3571	188	2	a	a	PRON
iajs-3571	188	3	,	,	PUNCT
iajs-3571	188	4	salh	salh	ADJ
iajs-3571	188	5	d.	d.	PROPN
iajs-3571	188	6	determination	determination	NOUN
iajs-3571	188	7	of	of	ADP
iajs-3571	188	8	serum	serum	PROPN
iajs-3571	188	9	zinc	zinc	NOUN
iajs-3571	188	10	,	,	PUNCT
iajs-3571	188	11	manganese	manganese	NOUN
iajs-3571	188	12	,	,	PUNCT
iajs-3571	188	13	copper	copper	NOUN
iajs-3571	188	14	and	and	CCONJ
iajs-3571	188	15	cobalt	cobalt	NOUN
iajs-3571	188	16	traces	trace	NOUN
iajs-3571	188	17	in	in	ADP
iajs-3571	188	18	type	type	NOUN
iajs-3571	188	19	two	two	NUM
iajs-3571	188	20	diabetic	diabetic	ADJ
iajs-3571	188	21	patients	patient	NOUN
iajs-3571	188	22	in	in	ADP
iajs-3571	188	23	sulaimaniyah	sulaimaniyah	NOUN
iajs-3571	188	24	city	city	NOUN
iajs-3571	188	25	using	use	VERB
iajs-3571	188	26	icp	icp	PROPN
iajs-3571	188	27	technique	technique	NOUN
iajs-3571	188	28	.	.	PUNCT
iajs-3571	189	1	ihjpas	ihjpas	PROPN
iajs-3571	189	2	.	.	PUNCT
iajs-3571	190	1	2012	2012	NUM
iajs-3571	190	2	;	;	PUNCT
iajs-3571	190	3	25(3):220	25(3):220	PROPN
iajs-3571	190	4	-	-	PUNCT
iajs-3571	190	5	225	225	NUM
iajs-3571	190	6	.	.	PUNCT
iajs-3571	190	7	https://doi.org/	https://doi.org/	NOUN
iajs-3571	190	8	bim-382950	bim-382950	NOUN
iajs-3571	190	9	.	.	PUNCT
iajs-3571	191	1	2	2	X
iajs-3571	191	2	.	.	X
iajs-3571	191	3	logue	logue	PROPN
iajs-3571	191	4	j	j	PROPN
iajs-3571	191	5	,	,	PUNCT
iajs-3571	191	6	walker	walker	PROPN
iajs-3571	191	7	jj	jj	PROPN
iajs-3571	191	8	,	,	PUNCT
iajs-3571	191	9	colhoun	colhoun	PROPN
iajs-3571	191	10	hm	hm	INTJ
iajs-3571	191	11	,	,	PUNCT
iajs-3571	191	12	leese	leese	PROPN
iajs-3571	191	13	gp	gp	PROPN
iajs-3571	191	14	,	,	PUNCT
iajs-3571	191	15	lindsay	lindsay	PROPN
iajs-3571	191	16	]	]	PUNCT
iajs-3571	191	17	rs	rs	PROPN
iajs-3571	191	18	,	,	PUNCT
iajs-3571	191	19	mcknight	mcknight	PROPN
iajs-3571	191	20	ja	ja	PROPN
iajs-3571	191	21	,	,	PUNCT
iajs-3571	191	22	morris	morris	PROPN
iajs-3571	191	23	ad	ad	NOUN
iajs-3571	191	24	,	,	PUNCT
iajs-3571	191	25	pearson	pearson	PROPN
iajs-3571	191	26	dw	dw	PROPN
iajs-3571	191	27	,	,	PUNCT
iajs-3571	191	28	petrie	petrie	VERB
iajs-3571	191	29	jr	jr	PROPN
iajs-3571	191	30	,	,	PUNCT
iajs-3571	191	31	philip	philip	PROPN
iajs-3571	191	32	s	s	PROPN
iajs-3571	191	33	,	,	PUNCT
iajs-3571	191	34	wild	wild	PROPN
iajs-3571	191	35	sh	sh	PROPN
iajs-3571	191	36	.	.	PROPN
iajs-3571	191	37	do	do	AUX
iajs-3571	191	38	men	man	NOUN
iajs-3571	191	39	develop	develop	VERB
iajs-3571	191	40	type	type	NOUN
iajs-3571	191	41	2	2	NUM
iajs-3571	191	42	diabetes	diabetes	NOUN
iajs-3571	191	43	at	at	ADP
iajs-3571	191	44	lower	low	ADJ
iajs-3571	191	45	body	body	NOUN
iajs-3571	191	46	mass	mass	NOUN
iajs-3571	191	47	indices	index	NOUN
iajs-3571	191	48	than	than	ADP
iajs-3571	191	49	women	woman	NOUN
iajs-3571	191	50	.	.	PUNCT
iajs-3571	192	1	diabetologia	diabetologia	NOUN
iajs-3571	192	2	.	.	PUNCT
iajs-3571	193	1	2011	2011	NUM
iajs-3571	193	2	;	;	PUNCT
iajs-3571	193	3	54(12):3003	54(12):3003	NUM
iajs-3571	193	4	-	-	SYM
iajs-3571	193	5	3006	3006	NUM
iajs-3571	193	6	.	.	PUNCT
iajs-3571	194	1	https://doi.org/10.1007/s00125-011-2313-3	https://doi.org/10.1007/s00125-011-2313-3	NUM
iajs-3571	194	2	.	.	PUNCT
iajs-3571	195	1	3	3	X
iajs-3571	195	2	.	.	X
iajs-3571	195	3	galicia	galicia	PROPN
iajs-3571	195	4	-	-	PUNCT
iajs-3571	195	5	garcia	garcia	PROPN
iajs-3571	195	6	u	u	PROPN
iajs-3571	195	7	,	,	PUNCT
iajs-3571	195	8	benito	benito	PROPN
iajs-3571	195	9	-	-	PROPN
iajs-3571	195	10	vicente	vicente	PROPN
iajs-3571	195	11	a	a	PRON
iajs-3571	195	12	,	,	PUNCT
iajs-3571	195	13	jebari	jebari	PROPN
iajs-3571	195	14	s	s	PROPN
iajs-3571	195	15	,	,	PUNCT
iajs-3571	195	16	larrea	larrea	NOUN
iajs-3571	195	17	-	-	PUNCT
iajs-3571	195	18	sebal	sebal	PROPN
iajs-3571	195	19	a	a	PRON
iajs-3571	195	20	,	,	PUNCT
iajs-3571	195	21	siddiqi	siddiqi	PROPN
iajs-3571	195	22	h	h	PROPN
iajs-3571	195	23	,	,	PUNCT
iajs-3571	195	24	uribe	uribe	PROPN
iajs-3571	195	25	kb	kb	PROPN
iajs-3571	195	26	,	,	PUNCT
iajs-3571	195	27	ostolaza	ostolaza	ADJ
iajs-3571	195	28	h	h	PROPN
iajs-3571	195	29	,	,	PUNCT
iajs-3571	195	30	martín	martín	PROPN
iajs-3571	195	31	c.	c.	PROPN
iajs-3571	195	32	pathophysiology	pathophysiology	PROPN
iajs-3571	195	33	of	of	ADP
iajs-3571	195	34	type	type	NOUN
iajs-3571	195	35	2	2	NUM
iajs-3571	195	36	diabetes	diabetes	NOUN
iajs-3571	195	37	mellitus	mellitus	NOUN
iajs-3571	195	38	.	.	PUNCT
iajs-3571	196	1	int	int	PROPN
iajs-3571	196	2	j	j	PROPN
iajs-3571	196	3	mol	mol	ADP
iajs-3571	196	4	sci	sci	PROPN
iajs-3571	196	5	.	.	PROPN
iajs-3571	196	6	2020	2020	NUM
iajs-3571	196	7	;	;	PUNCT
iajs-3571	196	8	21(17):6275	21(17):6275	X
iajs-3571	196	9	.	.	X
iajs-3571	196	10	https://doi.org/10.3390/ijms21176275	https://doi.org/10.3390/ijms21176275	PROPN
iajs-3571	196	11	.	.	PUNCT
iajs-3571	197	1	4	4	X
iajs-3571	197	2	.	.	X
iajs-3571	197	3	chatterjee	chatterjee	PROPN
iajs-3571	197	4	s	s	PROPN
iajs-3571	197	5	,	,	PUNCT
iajs-3571	197	6	khunti	khunti	PROPN
iajs-3571	197	7	k	k	PROPN
iajs-3571	197	8	,	,	PUNCT
iajs-3571	197	9	davies	davies	PROPN
iajs-3571	197	10	mj	mj	PROPN
iajs-3571	197	11	.	.	PROPN
iajs-3571	197	12	type	type	NOUN
iajs-3571	197	13	2	2	NUM
iajs-3571	197	14	diabetes	diabetes	NOUN
iajs-3571	197	15	.	.	PUNCT
iajs-3571	198	1	lancet	lancet	NOUN
iajs-3571	198	2	.	.	PUNCT
iajs-3571	199	1	2017	2017	NUM
iajs-3571	199	2	;	;	PUNCT
iajs-3571	199	3	389(10085):2239–2251	389(10085):2239–2251	X
iajs-3571	199	4	.	.	PUNCT
iajs-3571	199	5	https://doi.org/10.1016/s0140-6736(17)30058-2	https://doi.org/10.1016/s0140-6736(17)30058-2	NOUN
iajs-3571	199	6	.	.	PROPN
iajs-3571	200	1	5	5	NUM
iajs-3571	200	2	.	.	X
iajs-3571	200	3	veit	veit	PROPN
iajs-3571	200	4	m	m	PROPN
iajs-3571	200	5	,	,	PUNCT
iajs-3571	200	6	van	van	PROPN
iajs-3571	200	7	asten	asten	VERB
iajs-3571	200	8	r	r	NOUN
iajs-3571	200	9	,	,	PUNCT
iajs-3571	200	10	olie	olie	NOUN
iajs-3571	200	11	a	a	PRON
iajs-3571	200	12	,	,	PUNCT
iajs-3571	200	13	prinz	prinz	PROPN
iajs-3571	200	14	p.	p.	NOUN
iajs-3571	201	1	the	the	DET
iajs-3571	201	2	role	role	NOUN
iajs-3571	201	3	of	of	ADP
iajs-3571	201	4	dietary	dietary	ADJ
iajs-3571	201	5	sugars	sugar	NOUN
iajs-3571	201	6	,	,	PUNCT
iajs-3571	201	7	overweight	overweight	ADJ
iajs-3571	201	8	,	,	PUNCT
iajs-3571	201	9	and	and	CCONJ
iajs-3571	201	10	obesity	obesity	NOUN
iajs-3571	201	11	in	in	ADP
iajs-3571	201	12	type	type	NOUN
iajs-3571	201	13	2	2	NUM
iajs-3571	201	14	diabetes	diabetes	NOUN
iajs-3571	201	15	mellitus	mellitus	NOUN
iajs-3571	201	16	:	:	PUNCT
iajs-3571	201	17	a	a	DET
iajs-3571	201	18	narrative	narrative	NOUN
iajs-3571	201	19	review	review	NOUN
iajs-3571	201	20	.	.	PUNCT
iajs-3571	202	1	eur	eur	PROPN
iajs-3571	202	2	j	j	PROPN
iajs-3571	202	3	clin	clin	PROPN
iajs-3571	202	4	nutr	nutr	PROPN
iajs-3571	202	5	.	.	PROPN
iajs-3571	202	6	2022	2022	NUM
iajs-3571	202	7	;	;	PUNCT
iajs-3571	202	8	76(11):1	76(11):1	X
iajs-3571	202	9	-	-	SYM
iajs-3571	202	10	5	5	NUM
iajs-3571	202	11	.	.	PUNCT
iajs-3571	203	1	https://doi.org/10.1038/s41430-022-01114-5	https://doi.org/10.1038/s41430-022-01114-5	NOUN
iajs-3571	203	2	.	.	PUNCT
iajs-3571	204	1	6	6	NUM
iajs-3571	204	2	.	.	X
iajs-3571	204	3	sanchez	sanchez	PROPN
iajs-3571	204	4	-	-	PUNCT
iajs-3571	204	5	garcia	garcia	PROPN
iajs-3571	204	6	a	a	PRON
iajs-3571	204	7	,	,	PUNCT
iajs-3571	204	8	rodriguez	rodriguez	NOUN
iajs-3571	204	9	-	-	PUNCT
iajs-3571	204	10	gutierrez	gutierrez	PROPN
iajs-3571	204	11	r	r	NOUN
iajs-3571	204	12	,	,	PUNCT
iajs-3571	204	13	mancillas	mancillas	ADJ
iajs-3571	204	14	-	-	PUNCT
iajs-3571	204	15	adame	adame	PROPN
iajs-3571	204	16	l	l	NOUN
iajs-3571	204	17	,	,	PUNCT
iajs-3571	204	18	gonzález	gonzález	PROPN
iajs-3571	204	19	-	-	PUNCT
iajs-3571	204	20	nava	nava	PROPN
iajs-3571	204	21	v	v	PROPN
iajs-3571	204	22	,	,	PUNCT
iajs-3571	204	23	díaz	díaz	PROPN
iajs-3571	204	24	gonzálezcolmenero	gonzálezcolmenero	PROPN
iajs-3571	204	25	a	a	PROPN
iajs-3571	204	26	,	,	PUNCT
iajs-3571	204	27	solis	solis	PROPN
iajs-3571	204	28	rc	rc	PROPN
iajs-3571	204	29	,	,	PUNCT
iajs-3571	204	30	alvarez	alvarez	PROPN
iajs-3571	204	31	-	-	PUNCT
iajs-3571	204	32	villalobos	villalobos	PROPN
iajs-3571	204	33	na	na	NOUN
iajs-3571	204	34	,	,	PUNCT
iajs-3571	204	35	gonzález	gonzález	PROPN
iajs-3571	204	36	-	-	PUNCT
iajs-3571	204	37	gonzález	gonzález	PROPN
iajs-3571	204	38	jg	jg	PROPN
iajs-3571	204	39	.	.	PUNCT
iajs-3571	205	1	diagnostic	diagnostic	ADJ
iajs-3571	205	2	accuracy	accuracy	NOUN
iajs-3571	205	3	of	of	ADP
iajs-3571	205	4	the	the	DET
iajs-3571	205	5	triglyceride	triglyceride	ADJ
iajs-3571	205	6	and	and	CCONJ
iajs-3571	205	7	glucose	glucose	NOUN
iajs-3571	205	8	index	index	NOUN
iajs-3571	205	9	for	for	ADP
iajs-3571	205	10	insulin	insulin	NOUN
iajs-3571	205	11	resistance	resistance	NOUN
iajs-3571	205	12	:	:	PUNCT
iajs-3571	205	13	a	a	DET
iajs-3571	205	14	systematic	systematic	ADJ
iajs-3571	205	15	review	review	NOUN
iajs-3571	205	16	.	.	PUNCT
iajs-3571	206	1	int	int	NOUN
iajs-3571	206	2	j	j	PROPN
iajs-3571	206	3	endocrinol	endocrinol	NOUN
iajs-3571	206	4	.	.	PUNCT
iajs-3571	207	1	2020	2020	NUM
iajs-3571	207	2	;	;	PUNCT
iajs-3571	207	3	2020	2020	NUM
iajs-3571	207	4	:	:	PUNCT
iajs-3571	207	5	4678526	4678526	NUM
iajs-3571	207	6	.	.	PUNCT
iajs-3571	208	1	https://doi.org/10.1155/2020/4678526	https://doi.org/10.1155/2020/4678526	NOUN
iajs-3571	208	2	.	.	PUNCT
iajs-3571	209	1	7	7	X
iajs-3571	209	2	.	.	X
iajs-3571	209	3	adamczak	adamczak	PROPN
iajs-3571	209	4	m	m	PROPN
iajs-3571	209	5	,	,	PUNCT
iajs-3571	209	6	ritz	ritz	PROPN
iajs-3571	209	7	e	e	PROPN
iajs-3571	209	8	,	,	PUNCT
iajs-3571	209	9	wiecek	wiecek	NOUN
iajs-3571	209	10	a.	a.	NOUN
iajs-3571	209	11	carbohydrate	carbohydrate	NOUN
iajs-3571	209	12	metabolism	metabolism	NOUN
iajs-3571	209	13	in	in	ADP
iajs-3571	209	14	chronic	chronic	ADJ
iajs-3571	209	15	renal	renal	ADJ
iajs-3571	209	16	disease	disease	NOUN
iajs-3571	209	17	.	.	PUNCT
iajs-3571	210	1	in	in	ADP
iajs-3571	210	2	book	book	NOUN
iajs-3571	210	3	:	:	PUNCT
iajs-3571	210	4	nutritional	nutritional	ADJ
iajs-3571	210	5	management	management	NOUN
iajs-3571	210	6	of	of	ADP
iajs-3571	210	7	renal	renal	ADJ
iajs-3571	210	8	disease	disease	NOUN
iajs-3571	210	9	.	.	PUNCT
iajs-3571	211	1	academic	academic	ADJ
iajs-3571	211	2	press	press	NOUN
iajs-3571	211	3	;	;	PUNCT
iajs-3571	211	4	2022	2022	NUM
iajs-3571	211	5	,	,	PUNCT
iajs-3571	211	6	p.29	p.29	NOUN
iajs-3571	211	7	-	-	SYM
iajs-3571	211	8	41	41	NUM
iajs-3571	211	9	.	.	PUNCT
iajs-3571	212	1	https://doi.org/10.1016/b978-0-12-818540-7.00005-7	https://doi.org/10.1016/b978-0-12-818540-7.00005-7	PROPN
iajs-3571	212	2	.	.	PUNCT
iajs-3571	213	1	https://doi.org/%20bim-382950	https://doi.org/%20bim-382950	PROPN
iajs-3571	213	2	https://doi.org/10.1007/s00125-011-2313-3	https://doi.org/10.1007/s00125-011-2313-3	NUM
iajs-3571	213	3	https://doi.org/10.3390/ijms21176275	https://doi.org/10.3390/ijms21176275	PROPN
iajs-3571	213	4	https://doi.org/10.1016/s0140-6736(17)30058-2	https://doi.org/10.1016/s0140-6736(17)30058-2	NOUN
iajs-3571	213	5	.	.	PUNCT
iajs-3571	214	1	https://doi.org/10.1038/s41430-022-01114-5	https://doi.org/10.1038/s41430-022-01114-5	NOUN
iajs-3571	214	2	https://doi.org/10.1155/2020/4678526	https://doi.org/10.1155/2020/4678526	NOUN
iajs-3571	214	3	https://doi.org/10.1016/b978-0-12-818540-7.00005-7	https://doi.org/10.1016/b978-0-12-818540-7.00005-7	PROPN
iajs-3571	214	4	ihjpas	ihjpas	PROPN
iajs-3571	214	5	.	.	PUNCT
iajs-3571	215	1	2025	2025	NUM
iajs-3571	215	2	,	,	PUNCT
iajs-3571	215	3	38(2	38(2	NUM
iajs-3571	215	4	)	)	PUNCT
iajs-3571	215	5	232	232	NUM
iajs-3571	215	6	8	8	NUM
iajs-3571	215	7	.	.	PUNCT
iajs-3571	216	1	ahmed	ahmed	PROPN
iajs-3571	216	2	b	b	PROPN
iajs-3571	216	3	,	,	PUNCT
iajs-3571	216	4	sultana	sultana	NOUN
iajs-3571	216	5	r	r	PROPN
iajs-3571	216	6	,	,	PUNCT
iajs-3571	216	7	greene	greene	PROPN
iajs-3571	216	8	mw	mw	PROPN
iajs-3571	216	9	.	.	PROPN
iajs-3571	216	10	adipose	adipose	NOUN
iajs-3571	216	11	tissue	tissue	NOUN
iajs-3571	216	12	and	and	CCONJ
iajs-3571	216	13	insulin	insulin	NOUN
iajs-3571	216	14	resistance	resistance	NOUN
iajs-3571	216	15	in	in	ADP
iajs-3571	216	16	obese	obese	NOUN
iajs-3571	216	17	biomed	biome	VERB
iajs-3571	216	18	.	.	PUNCT
iajs-3571	217	1	pharmacother	pharmacother	ADJ
iajs-3571	217	2	.	.	PUNCT
iajs-3571	218	1	2021	2021	NUM
iajs-3571	218	2	;	;	PUNCT
iajs-3571	219	1	137:111315	137:111315	NUM
iajs-3571	219	2	.	.	PUNCT
iajs-3571	220	1	https://doi.org/10.1016/j.biopha.2021.111315	https://doi.org/10.1016/j.biopha.2021.111315	PROPN
iajs-3571	220	2	.	.	PUNCT
iajs-3571	221	1	9	9	X
iajs-3571	221	2	.	.	X
iajs-3571	221	3	tan	tan	PROPN
iajs-3571	221	4	sy	sy	PROPN
iajs-3571	221	5	,	,	PUNCT
iajs-3571	221	6	wong	wong	PROPN
iajs-3571	221	7	jl	jl	PROPN
iajs-3571	221	8	,	,	PUNCT
iajs-3571	221	9	sim	sim	PROPN
iajs-3571	221	10	yj	yj	PROPN
iajs-3571	221	11	,	,	PUNCT
iajs-3571	221	12	wong	wong	PROPN
iajs-3571	221	13	ss	ss	PROPN
iajs-3571	221	14	,	,	PUNCT
iajs-3571	221	15	elhassan	elhassan	PROPN
iajs-3571	221	16	sa	sa	PROPN
iajs-3571	221	17	,	,	PUNCT
iajs-3571	221	18	tan	tan	PROPN
iajs-3571	221	19	sh	sh	PROPN
iajs-3571	221	20	,	,	PUNCT
iajs-3571	221	21	lim	lim	PROPN
iajs-3571	221	22	gp	gp	PROPN
iajs-3571	221	23	,	,	PUNCT
iajs-3571	221	24	tay	tay	PROPN
iajs-3571	221	25	nw	nw	PROPN
iajs-3571	221	26	,	,	PUNCT
iajs-3571	221	27	annan	annan	PROPN
iajs-3571	221	28	nc	nc	PROPN
iajs-3571	221	29	,	,	PUNCT
iajs-3571	221	30	bhattamisra	bhattamisra	ADJ
iajs-3571	221	31	sk	sk	ADP
iajs-3571	221	32	,	,	PUNCT
iajs-3571	221	33	candasamy	candasamy	NOUN
iajs-3571	221	34	m.	m.	NOUN
iajs-3571	221	35	type	type	NOUN
iajs-3571	221	36	1	1	NUM
iajs-3571	221	37	and	and	CCONJ
iajs-3571	221	38	2	2	NUM
iajs-3571	221	39	diabetes	diabetes	NOUN
iajs-3571	221	40	mellitus	mellitus	NOUN
iajs-3571	221	41	:	:	PUNCT
iajs-3571	221	42	a	a	DET
iajs-3571	221	43	review	review	NOUN
iajs-3571	221	44	on	on	ADP
iajs-3571	221	45	current	current	ADJ
iajs-3571	221	46	treatment	treatment	NOUN
iajs-3571	221	47	approach	approach	NOUN
iajs-3571	221	48	and	and	CCONJ
iajs-3571	221	49	gene	gene	NOUN
iajs-3571	221	50	therapy	therapy	NOUN
iajs-3571	221	51	as	as	ADP
iajs-3571	221	52	potential	potential	ADJ
iajs-3571	221	53	intervention	intervention	NOUN
iajs-3571	221	54	.	.	PUNCT
iajs-3571	222	1	diabetes	diabete	VERB
iajs-3571	222	2	metab	metab	ADJ
iajs-3571	222	3	syndr	syndr	NOUN
iajs-3571	222	4	:	:	PUNCT
iajs-3571	222	5	clin	clin	PROPN
iajs-3571	222	6	res	res	PROPN
iajs-3571	222	7	rev	rev	PROPN
iajs-3571	222	8	.	.	PROPN
iajs-3571	222	9	2019	2019	NUM
iajs-3571	222	10	;	;	PUNCT
iajs-3571	222	11	13(1):364	13(1):364	NUM
iajs-3571	222	12	-	-	SYM
iajs-3571	222	13	372	372	NUM
iajs-3571	222	14	.	.	PUNCT
iajs-3571	223	1	https://doi.org/10.1016/j.dsx.2018.10.008	https://doi.org/10.1016/j.dsx.2018.10.008	PROPN
iajs-3571	223	2	.	.	PUNCT
iajs-3571	224	1	10	10	NUM
iajs-3571	224	2	.	.	PUNCT
iajs-3571	224	3	kural	kural	PROPN
iajs-3571	224	4	c	c	PROPN
iajs-3571	224	5	,	,	PUNCT
iajs-3571	224	6	kocdogan	kocdogan	PROPN
iajs-3571	224	7	ak	ak	PROPN
iajs-3571	224	8	,	,	PUNCT
iajs-3571	224	9	şimşek	şimşek	PROPN
iajs-3571	224	10	gg	gg	PROPN
iajs-3571	224	11	,	,	PUNCT
iajs-3571	224	12	oguztuzun	oguztuzun	PROPN
iajs-3571	224	13	s	s	PROPN
iajs-3571	224	14	,	,	PUNCT
iajs-3571	224	15	kaygın	kaygın	PROPN
iajs-3571	224	16	p	p	PROPN
iajs-3571	224	17	,	,	PUNCT
iajs-3571	224	18	yılmaz	yılmaz	PROPN
iajs-3571	224	19	i	i	PROPN
iajs-3571	224	20	,	,	PUNCT
iajs-3571	224	21	bayram	bayram	PROPN
iajs-3571	224	22	t	t	PROPN
iajs-3571	224	23	,	,	PUNCT
iajs-3571	224	24	izci	izci	PROPN
iajs-3571	224	25	y.	y.	PROPN
iajs-3571	224	26	glutathione	glutathione	PROPN
iajs-3571	224	27	s	s	NOUN
iajs-3571	224	28	-	-	PUNCT
iajs-3571	224	29	transferases	transferase	NOUN
iajs-3571	224	30	and	and	CCONJ
iajs-3571	224	31	cytochrome	cytochrome	ADJ
iajs-3571	224	32	p450	p450	ADJ
iajs-3571	224	33	enzyme	enzyme	NOUN
iajs-3571	224	34	expression	expression	NOUN
iajs-3571	224	35	in	in	ADP
iajs-3571	224	36	patients	patient	NOUN
iajs-3571	224	37	with	with	ADP
iajs-3571	224	38	intracranial	intracranial	ADJ
iajs-3571	224	39	tumors	tumor	NOUN
iajs-3571	224	40	:	:	PUNCT
iajs-3571	224	41	preliminary	preliminary	ADJ
iajs-3571	224	42	report	report	NOUN
iajs-3571	224	43	of	of	ADP
iajs-3571	224	44	55	55	NUM
iajs-3571	224	45	patients	patient	NOUN
iajs-3571	224	46	.	.	PUNCT
iajs-3571	225	1	med	med	PROPN
iajs-3571	225	2	princ	princ	PROPN
iajs-3571	225	3	pract	pract	PROPN
iajs-3571	225	4	.	.	PUNCT
iajs-3571	226	1	2019	2019	NUM
iajs-3571	226	2	;	;	PUNCT
iajs-3571	226	3	28(1):56	28(1):56	PROPN
iajs-3571	226	4	-	-	SYM
iajs-3571	226	5	62	62	NUM
iajs-3571	226	6	.	.	PUNCT
iajs-3571	227	1	https://doi.org/10.1159/000494496	https://doi.org/10.1159/000494496	NOUN
iajs-3571	227	2	.	.	PUNCT
iajs-3571	228	1	11	11	NUM
iajs-3571	228	2	.	.	PUNCT
iajs-3571	228	3	prysyazhnyuk	prysyazhnyuk	PROPN
iajs-3571	228	4	v	v	NOUN
iajs-3571	228	5	,	,	PUNCT
iajs-3571	228	6	sydorchuk	sydorchuk	VERB
iajs-3571	228	7	l	l	NOUN
iajs-3571	228	8	,	,	PUNCT
iajs-3571	228	9	sydorchuk	sydorchuk	VERB
iajs-3571	228	10	r	r	NOUN
iajs-3571	228	11	,	,	PUNCT
iajs-3571	228	12	prysiazhniuk	prysiazhniuk	NOUN
iajs-3571	228	13	i	i	NOUN
iajs-3571	228	14	,	,	PUNCT
iajs-3571	228	15	bobkovych	bobkovych	PROPN
iajs-3571	228	16	k	k	PROPN
iajs-3571	228	17	,	,	PUNCT
iajs-3571	228	18	buzdugan	buzdugan	VERB
iajs-3571	228	19	i	i	PRON
iajs-3571	228	20	,	,	PUNCT
iajs-3571	228	21	dzuryak	dzuryak	PROPN
iajs-3571	228	22	,	,	PUNCT
iajs-3571	228	23	v	v	NOUN
iajs-3571	228	24	,	,	PUNCT
iajs-3571	228	25	and	and	CCONJ
iajs-3571	228	26	prysyazhnyuk	prysyazhnyuk	ADJ
iajs-3571	228	27	,	,	PUNCT
iajs-3571	228	28	p.	p.	NOUN
iajs-3571	228	29	glutathione	glutathione	NOUN
iajs-3571	228	30	-	-	PUNCT
iajs-3571	228	31	s	s	NOUN
iajs-3571	228	32	-	-	PUNCT
iajs-3571	228	33	transferases	transferase	NOUN
iajs-3571	228	34	genes	gene	NOUN
iajs-3571	228	35	-	-	PUNCT
iajs-3571	228	36	promising	promise	VERB
iajs-3571	228	37	predictors	predictor	NOUN
iajs-3571	228	38	of	of	ADP
iajs-3571	228	39	hepatic	hepatic	ADJ
iajs-3571	228	40	dysfunction	dysfunction	NOUN
iajs-3571	228	41	.	.	PUNCT
iajs-3571	229	1	world	world	NOUN
iajs-3571	229	2	j	j	PROPN
iajs-3571	229	3	hepatol	hepatol	ADV
iajs-3571	229	4	.	.	PUNCT
iajs-3571	230	1	2021	2021	NUM
iajs-3571	230	2	;	;	PUNCT
iajs-3571	231	1	13(6):620	13(6):620	NUM
iajs-3571	231	2	-	-	PUNCT
iajs-3571	231	3	633	633	NUM
iajs-3571	231	4	.	.	PUNCT
iajs-3571	232	1	https://doi.org/10.4254/wjh	https://doi.org/10.4254/wjh	PROPN
iajs-3571	232	2	.	.	PUNCT
iajs-3571	232	3	v13.i6.620	v13.i6.620	PROPN
iajs-3571	232	4	.	.	PROPN
iajs-3571	232	5	12	12	NUM
iajs-3571	232	6	.	.	PUNCT
iajs-3571	233	1	casadei	casadei	PROPN
iajs-3571	233	2	g	g	NOUN
iajs-3571	233	3	,	,	PUNCT
iajs-3571	233	4	filippini	filippini	PROPN
iajs-3571	233	5	m	m	PROPN
iajs-3571	233	6	,	,	PUNCT
iajs-3571	233	7	brognara	brognara	PROPN
iajs-3571	233	8	l.	l.	PROPN
iajs-3571	233	9	glycated	glycate	VERB
iajs-3571	233	10	hemoglobin	hemoglobin	NOUN
iajs-3571	233	11	(	(	PUNCT
iajs-3571	233	12	hba1c	hba1c	PROPN
iajs-3571	233	13	)	)	PUNCT
iajs-3571	233	14	as	as	ADP
iajs-3571	233	15	a	a	DET
iajs-3571	233	16	biomarker	biomarker	NOUN
iajs-3571	233	17	for	for	ADP
iajs-3571	233	18	diabetic	diabetic	ADJ
iajs-3571	233	19	foot	foot	NOUN
iajs-3571	233	20	peripheral	peripheral	ADJ
iajs-3571	233	21	neuropathy	neuropathy	ADJ
iajs-3571	233	22	.	.	PUNCT
iajs-3571	234	1	diseases	disease	NOUN
iajs-3571	234	2	.	.	PUNCT
iajs-3571	235	1	2021	2021	NUM
iajs-3571	235	2	;	;	PUNCT
iajs-3571	235	3	9(1):16	9(1):16	NUM
iajs-3571	235	4	.	.	PUNCT
iajs-3571	236	1	https://doi.org/10.3390/diseases9010016	https://doi.org/10.3390/diseases9010016	PROPN
iajs-3571	236	2	.	.	PUNCT
iajs-3571	237	1	13	13	NUM
iajs-3571	237	2	.	.	X
iajs-3571	237	3	alzahrani	alzahrani	PROPN
iajs-3571	237	4	sh	sh	PROPN
iajs-3571	237	5	,	,	PUNCT
iajs-3571	237	6	baig	baig	PROPN
iajs-3571	237	7	m	m	PROPN
iajs-3571	237	8	,	,	PUNCT
iajs-3571	237	9	aashi	aashi	PROPN
iajs-3571	237	10	mm	mm	PROPN
iajs-3571	237	11	,	,	PUNCT
iajs-3571	237	12	al	al	PROPN
iajs-3571	237	13	-	-	PUNCT
iajs-3571	237	14	shaibi	shaibi	PROPN
iajs-3571	237	15	fk	fk	INTJ
iajs-3571	237	16	,	,	PUNCT
iajs-3571	237	17	alqarni	alqarni	PROPN
iajs-3571	237	18	da	da	PROPN
iajs-3571	237	19	,	,	PUNCT
iajs-3571	237	20	bakhamees	bakhamee	NOUN
iajs-3571	237	21	wh	wh	PROPN
iajs-3571	237	22	.	.	PUNCT
iajs-3571	237	23	association	association	PROPN
iajs-3571	237	24	between	between	ADP
iajs-3571	237	25	glycated	glycate	VERB
iajs-3571	237	26	hemoglobin	hemoglobin	NOUN
iajs-3571	237	27	(	(	PUNCT
iajs-3571	237	28	hba1c	hba1c	PROPN
iajs-3571	237	29	)	)	PUNCT
iajs-3571	237	30	and	and	CCONJ
iajs-3571	237	31	the	the	DET
iajs-3571	237	32	lipid	lipid	NOUN
iajs-3571	237	33	profile	profile	NOUN
iajs-3571	237	34	in	in	ADP
iajs-3571	237	35	patients	patient	NOUN
iajs-3571	237	36	with	with	ADP
iajs-3571	237	37	type	type	NOUN
iajs-3571	237	38	2	2	NUM
iajs-3571	237	39	diabetes	diabetes	NOUN
iajs-3571	237	40	mellitus	mellitus	NOUN
iajs-3571	237	41	at	at	ADP
iajs-3571	237	42	a	a	DET
iajs-3571	237	43	tertiary	tertiary	ADJ
iajs-3571	237	44	care	care	NOUN
iajs-3571	237	45	hospital	hospital	NOUN
iajs-3571	237	46	:	:	PUNCT
iajs-3571	237	47	a	a	DET
iajs-3571	237	48	retrospective	retrospective	ADJ
iajs-3571	237	49	study	study	NOUN
iajs-3571	237	50	.	.	PUNCT
iajs-3571	238	1	diabetes	diabetes	NOUN
iajs-3571	238	2	metab	metab	ADJ
iajs-3571	238	3	syndr	syndr	NOUN
iajs-3571	238	4	obes	obe	NOUN
iajs-3571	238	5	.	.	PUNCT
iajs-3571	238	6	2019	2019	NUM
iajs-3571	238	7	;	;	PUNCT
iajs-3571	238	8	12:1640	12:1640	NUM
iajs-3571	238	9	-	-	SYM
iajs-3571	238	10	1644	1644	NUM
iajs-3571	238	11	.	.	PUNCT
iajs-3571	239	1	https://doi.org/10.2147/dmso.s222271	https://doi.org/10.2147/dmso.s222271	NOUN
iajs-3571	239	2	.	.	PUNCT
iajs-3571	240	1	14	14	NUM
iajs-3571	240	2	.	.	PUNCT
iajs-3571	241	1	galon	galon	NOUN
iajs-3571	241	2	-	-	PUNCT
iajs-3571	241	3	tilleman	tilleman	PROPN
iajs-3571	241	4	h	h	NOUN
iajs-3571	241	5	,	,	PUNCT
iajs-3571	241	6	yang	yang	PROPN
iajs-3571	241	7	h	h	PROPN
iajs-3571	241	8	,	,	PUNCT
iajs-3571	241	9	bednarek	bednarek	PROPN
iajs-3571	241	10	ma	ma	PROPN
iajs-3571	241	11	,	,	PUNCT
iajs-3571	241	12	spurlock	spurlock	PROPN
iajs-3571	241	13	sm	sm	PROPN
iajs-3571	241	14	,	,	PUNCT
iajs-3571	241	15	paavola	paavola	PROPN
iajs-3571	241	16	kj	kj	PROPN
iajs-3571	241	17	,	,	PUNCT
iajs-3571	241	18	ko	ko	PROPN
iajs-3571	241	19	b	b	PROPN
iajs-3571	241	20	,	,	PUNCT
iajs-3571	241	21	to	to	ADP
iajs-3571	241	22	c	c	NUM
iajs-3571	241	23	,	,	PUNCT
iajs-3571	241	24	luo	luo	PROPN
iajs-3571	241	25	j	j	PROPN
iajs-3571	241	26	,	,	PUNCT
iajs-3571	241	27	tian	tian	ADJ
iajs-3571	241	28	h	h	NOUN
iajs-3571	241	29	,	,	PUNCT
iajs-3571	241	30	jermutus	jermutus	PROPN
iajs-3571	241	31	l	l	PROPN
iajs-3571	241	32	and	and	CCONJ
iajs-3571	241	33	grimsby	grimsby	PROPN
iajs-3571	241	34	j	j	PROPN
iajs-3571	241	35	,	,	PUNCT
iajs-3571	241	36	apelin-36	apelin-36	PROPN
iajs-3571	241	37	modulates	modulate	VERB
iajs-3571	241	38	blood	blood	NOUN
iajs-3571	241	39	glucose	glucose	NOUN
iajs-3571	241	40	and	and	CCONJ
iajs-3571	241	41	body	body	NOUN
iajs-3571	241	42	weight	weight	NOUN
iajs-3571	241	43	independently	independently	ADV
iajs-3571	241	44	of	of	ADP
iajs-3571	241	45	canonical	canonical	ADJ
iajs-3571	241	46	apj	apj	NOUN
iajs-3571	241	47	receptor	receptor	NOUN
iajs-3571	241	48	signaling	signal	VERB
iajs-3571	241	49	.	.	PUNCT
iajs-3571	242	1	jbc	jbc	PROPN
iajs-3571	242	2	.	.	PROPN
iajs-3571	242	3	2017	2017	NUM
iajs-3571	242	4	;	;	PUNCT
iajs-3571	242	5	292(5):1925	292(5):1925	X
iajs-3571	242	6	-	-	SYM
iajs-3571	242	7	1933	1933	NUM
iajs-3571	242	8	.	.	PUNCT
iajs-3571	243	1	https://doi.org/10.1074/jbc.m116.748103	https://doi.org/10.1074/jbc.m116.748103	X
iajs-3571	243	2	.	.	NOUN
iajs-3571	243	3	15	15	NUM
iajs-3571	243	4	.	.	PUNCT
iajs-3571	243	5	suastika	suastika	PROPN
iajs-3571	243	6	k	k	PROPN
iajs-3571	243	7	,	,	PUNCT
iajs-3571	243	8	dwipayana	dwipayana	PROPN
iajs-3571	243	9	p	p	NOUN
iajs-3571	243	10	,	,	PUNCT
iajs-3571	243	11	semadi	semadi	PROPN
iajs-3571	243	12	ms	ms	PROPN
iajs-3571	243	13	,	,	PUNCT
iajs-3571	243	14	kuswardhani	kuswardhani	PROPN
iajs-3571	243	15	rt	rt	PROPN
iajs-3571	243	16	.	.	PUNCT
iajs-3571	243	17	age	age	PROPN
iajs-3571	243	18	is	be	AUX
iajs-3571	243	19	an	an	DET
iajs-3571	243	20	important	important	ADJ
iajs-3571	243	21	risk	risk	NOUN
iajs-3571	243	22	factor	factor	NOUN
iajs-3571	243	23	for	for	ADP
iajs-3571	243	24	type	type	NOUN
iajs-3571	243	25	2	2	NUM
iajs-3571	243	26	diabetes	diabetes	NOUN
iajs-3571	243	27	mellitus	mellitus	NOUN
iajs-3571	243	28	and	and	CCONJ
iajs-3571	243	29	cardiovascular	cardiovascular	ADJ
iajs-3571	243	30	diseases	disease	NOUN
iajs-3571	243	31	.	.	PUNCT
iajs-3571	244	1	glucose	glucose	NOUN
iajs-3571	244	2	tolerance	tolerance	NOUN
iajs-3571	244	3	.	.	PUNCT
iajs-3571	245	1	2012	2012	NUM
iajs-3571	245	2	;	;	PUNCT
iajs-3571	245	3	5:67	5:67	NUM
iajs-3571	245	4	-	-	SYM
iajs-3571	245	5	80	80	NUM
iajs-3571	245	6	.	.	PUNCT
iajs-3571	246	1	https://doi.org/10.5772/52397	https://doi.org/10.5772/52397	NOUN
iajs-3571	246	2	.	.	PUNCT
iajs-3571	247	1	16	16	NUM
iajs-3571	247	2	.	.	PUNCT
iajs-3571	248	1	taylor	taylor	PROPN
iajs-3571	248	2	r	r	PROPN
iajs-3571	248	3	,	,	PUNCT
iajs-3571	248	4	al	al	PROPN
iajs-3571	248	5	-	-	PUNCT
iajs-3571	248	6	mrabeh	mrabeh	PROPN
iajs-3571	248	7	a	a	PRON
iajs-3571	248	8	,	,	PUNCT
iajs-3571	248	9	sattar	sattar	PROPN
iajs-3571	248	10	n.	n.	PROPN
iajs-3571	248	11	understanding	understand	VERB
iajs-3571	248	12	the	the	DET
iajs-3571	248	13	mechanisms	mechanism	NOUN
iajs-3571	248	14	of	of	ADP
iajs-3571	248	15	reversal	reversal	NOUN
iajs-3571	248	16	of	of	ADP
iajs-3571	248	17	type	type	NOUN
iajs-3571	248	18	2	2	NUM
iajs-3571	248	19	diabetes	diabetes	NOUN
iajs-3571	248	20	.	.	PUNCT
iajs-3571	249	1	lancet	lancet	NOUN
iajs-3571	249	2	diabetes	diabetes	NOUN
iajs-3571	249	3	endocrinol	endocrinol	NOUN
iajs-3571	249	4	.	.	PUNCT
iajs-3571	250	1	2019	2019	NUM
iajs-3571	250	2	;	;	PUNCT
iajs-3571	250	3	7(9):726	7(9):726	NUM
iajs-3571	250	4	-	-	SYM
iajs-3571	250	5	736	736	NUM
iajs-3571	250	6	.	.	PUNCT
iajs-3571	251	1	https://doi.org/10.1016/s2213-8587(19)30076-2	https://doi.org/10.1016/s2213-8587(19)30076-2	PROPN
iajs-3571	251	2	.	.	PUNCT
iajs-3571	252	1	17	17	NUM
iajs-3571	252	2	.	.	X
iajs-3571	253	1	chang	chang	PROPN
iajs-3571	253	2	-	-	PUNCT
iajs-3571	253	3	rueda	rueda	PROPN
iajs-3571	253	4	c	c	NOUN
iajs-3571	253	5	,	,	PUNCT
iajs-3571	253	6	cañas	cañas	PROPN
iajs-3571	253	7	-	-	PUNCT
iajs-3571	253	8	urbina	urbina	PROPN
iajs-3571	253	9	a	a	PROPN
iajs-3571	253	10	,	,	PUNCT
iajs-3571	253	11	trujillo	trujillo	PROPN
iajs-3571	253	12	-	-	PUNCT
iajs-3571	253	13	murillo	murillo	PROPN
iajs-3571	253	14	k	k	PROPN
iajs-3571	253	15	,	,	PUNCT
iajs-3571	253	16	espinoza	espinoza	PROPN
iajs-3571	253	17	-	-	PUNCT
iajs-3571	253	18	ruiz	ruiz	PROPN
iajs-3571	253	19	m	m	PROPN
iajs-3571	253	20	,	,	PUNCT
iajs-3571	253	21	feliciano	feliciano	NOUN
iajs-3571	253	22	-	-	PUNCT
iajs-3571	253	23	díaz	díaz	PROPN
iajs-3571	253	24	j	j	PROPN
iajs-3571	253	25	,	,	PUNCT
iajs-3571	253	26	vázquez	vázquez	PROPN
iajs-3571	253	27	-	-	PUNCT
iajs-3571	253	28	moreno	moreno	PROPN
iajs-3571	253	29	m	m	PROPN
iajs-3571	253	30	,	,	PUNCT
iajs-3571	253	31	lugo	lugo	PROPN
iajs-3571	253	32	-	-	PUNCT
iajs-3571	253	33	trampe	trampe	VERB
iajs-3571	253	34	á	á	PROPN
iajs-3571	253	35	.	.	PUNCT
iajs-3571	253	36	correlation	correlation	NOUN
iajs-3571	253	37	of	of	ADP
iajs-3571	253	38	homa	homa	NOUN
iajs-3571	253	39	-	-	PUNCT
iajs-3571	253	40	ir	ir	PROPN
iajs-3571	253	41	with	with	ADP
iajs-3571	253	42	bmi	bmi	NOUN
iajs-3571	253	43	-	-	PUNCT
iajs-3571	253	44	for	for	ADP
iajs-3571	253	45	-	-	PUNCT
iajs-3571	253	46	age	age	NOUN
iajs-3571	253	47	percentile	percentile	NOUN
iajs-3571	253	48	in	in	ADP
iajs-3571	253	49	children	child	NOUN
iajs-3571	253	50	and	and	CCONJ
iajs-3571	253	51	adolescents	adolescent	NOUN
iajs-3571	253	52	from	from	ADP
iajs-3571	253	53	the	the	DET
iajs-3571	253	54	soconusco	soconusco	PROPN
iajs-3571	253	55	region	region	NOUN
iajs-3571	253	56	of	of	ADP
iajs-3571	253	57	chiapas	chiapas	PROPN
iajs-3571	253	58	,	,	PUNCT
iajs-3571	253	59	mexico	mexico	PROPN
iajs-3571	253	60	.	.	PUNCT
iajs-3571	254	1	revista	revista	PROPN
iajs-3571	254	2	de	de	X
iajs-3571	254	3	la	la	X
iajs-3571	254	4	facultad	facultad	PROPN
iajs-3571	254	5	de	de	PROPN
iajs-3571	254	6	medicina	medicina	PROPN
iajs-3571	254	7	.	.	PROPN
iajs-3571	255	1	2019	2019	NUM
iajs-3571	255	2	;	;	PUNCT
iajs-3571	255	3	67(4):447	67(4):447	PROPN
iajs-3571	255	4	-	-	PUNCT
iajs-3571	255	5	450	450	NUM
iajs-3571	255	6	.	.	PUNCT
iajs-3571	256	1	https://doi.org/10.15446/revfacmed.v67n4.67159	https://doi.org/10.15446/revfacmed.v67n4.67159	PROPN
iajs-3571	256	2	.	.	PROPN
iajs-3571	256	3	18	18	NUM
iajs-3571	256	4	.	.	X
iajs-3571	257	1	son	son	PROPN
iajs-3571	257	2	js	js	PROPN
iajs-3571	257	3	,	,	PUNCT
iajs-3571	257	4	kim	kim	PROPN
iajs-3571	257	5	hj	hj	PROPN
iajs-3571	257	6	,	,	PUNCT
iajs-3571	257	7	son	son	NOUN
iajs-3571	257	8	y	y	PROPN
iajs-3571	257	9	,	,	PUNCT
iajs-3571	257	10	lee	lee	PROPN
iajs-3571	257	11	h	h	PROPN
iajs-3571	257	12	,	,	PUNCT
iajs-3571	257	13	chae	chae	PROPN
iajs-3571	257	14	sa	sa	PROPN
iajs-3571	257	15	,	,	PUNCT
iajs-3571	257	16	seong	seong	PROPN
iajs-3571	257	17	jk	jk	PROPN
iajs-3571	257	18	,	,	PUNCT
iajs-3571	257	19	song	song	PROPN
iajs-3571	257	20	w.	w.	NOUN
iajs-3571	257	21	effects	effect	NOUN
iajs-3571	257	22	of	of	ADP
iajs-3571	257	23	exercise‐induced	exercise‐induce	VERB
iajs-3571	257	24	apelin	apelin	PROPN
iajs-3571	257	25	levels	level	NOUN
iajs-3571	257	26	on	on	ADP
iajs-3571	257	27	skeletal	skeletal	ADJ
iajs-3571	257	28	muscle	muscle	NOUN
iajs-3571	257	29	and	and	CCONJ
iajs-3571	257	30	their	their	PRON
iajs-3571	257	31	capillarization	capillarization	NOUN
iajs-3571	257	32	in	in	ADP
iajs-3571	257	33	type	type	NOUN
iajs-3571	257	34	2	2	NUM
iajs-3571	257	35	diabetic	diabetic	ADJ
iajs-3571	257	36	rats	rat	NOUN
iajs-3571	257	37	.	.	PUNCT
iajs-3571	258	1	muscle	muscle	NOUN
iajs-3571	258	2	&	&	CCONJ
iajs-3571	258	3	nerve	nerve	PROPN
iajs-3571	258	4	.	.	PUNCT
iajs-3571	259	1	2017	2017	NUM
iajs-3571	259	2	;	;	PUNCT
iajs-3571	259	3	56(6	56(6	NUM
iajs-3571	259	4	):	):	PUNCT
iajs-3571	259	5	1155	1155	NUM
iajs-3571	259	6	-	-	SYM
iajs-3571	259	7	1163	1163	NUM
iajs-3571	259	8	.	.	PUNCT
iajs-3571	260	1	https://doi.org/10.1002/mus.25596	https://doi.org/10.1002/mus.25596	PROPN
iajs-3571	260	2	.	.	NOUN
iajs-3571	260	3	19	19	NUM
iajs-3571	260	4	.	.	X
iajs-3571	261	1	alwan	alwan	PROPN
iajs-3571	261	2	lh	lh	PROPN
iajs-3571	261	3	,	,	PUNCT
iajs-3571	261	4	khaleel	khaleel	PROPN
iajs-3571	261	5	fm	fm	PROPN
iajs-3571	261	6	,	,	PUNCT
iajs-3571	261	7	hameed	hameed	PROPN
iajs-3571	261	8	as	as	ADP
iajs-3571	261	9	,	,	PUNCT
iajs-3571	261	10	al	al	PROPN
iajs-3571	261	11	-	-	PUNCT
iajs-3571	261	12	ghani	ghani	PROPN
iajs-3571	261	13	a.	a.	NOUN
iajs-3571	261	14	determination	determination	NOUN
iajs-3571	261	15	of	of	ADP
iajs-3571	261	16	polymorphism	polymorphism	NOUN
iajs-3571	261	17	of	of	ADP
iajs-3571	261	18	glutathione	glutathione	NOUN
iajs-3571	261	19	s	s	PART
iajs-3571	261	20	transferase	transferase	NOUN
iajs-3571	261	21	(	(	PUNCT
iajs-3571	261	22	gst	gst	NOUN
iajs-3571	261	23	)	)	PUNCT
iajs-3571	261	24	in	in	ADP
iajs-3571	261	25	the	the	DET
iajs-3571	261	26	iraqi	iraqi	ADJ
iajs-3571	261	27	(	(	PUNCT
iajs-3571	261	28	diabetic	diabetic	ADJ
iajs-3571	261	29	and	and	CCONJ
iajs-3571	261	30	non	non	ADJ
iajs-3571	261	31	-	-	ADJ
iajs-3571	261	32	diabetic	diabetic	ADJ
iajs-3571	261	33	)	)	PUNCT
iajs-3571	261	34	acromegalic	acromegalic	ADJ
iajs-3571	261	35	patients	patient	NOUN
iajs-3571	261	36	.	.	PUNCT
iajs-3571	262	1	biochem	biochem	PROPN
iajs-3571	262	2	cell	cell	PROPN
iajs-3571	262	3	arch	arch	NOUN
iajs-3571	262	4	.	.	PUNCT
iajs-3571	263	1	2020	2020	NUM
iajs-3571	263	2	;	;	PUNCT
iajs-3571	263	3	20(2):6709	20(2):6709	NUM
iajs-3571	263	4	-	-	PUNCT
iajs-3571	263	5	6714	6714	NUM
iajs-3571	263	6	.	.	PUNCT
iajs-3571	264	1	https://connectjournals.com/03896.2020.20.6709	https://connectjournals.com/03896.2020.20.6709	NOUN
iajs-3571	264	2	.	.	PROPN
iajs-3571	265	1	20	20	NUM
iajs-3571	265	2	.	.	X
iajs-3571	266	1	salmeron	salmeron	PROPN
iajs-3571	266	2	j	j	PROPN
iajs-3571	266	3	,	,	PUNCT
iajs-3571	266	4	hu	hu	PROPN
iajs-3571	267	1	fb	fb	INTJ
iajs-3571	267	2	,	,	PUNCT
iajs-3571	267	3	manson	manson	PROPN
iajs-3571	267	4	je	je	PROPN
iajs-3571	267	5	,	,	PUNCT
iajs-3571	267	6	stampfer	stampfer	PROPN
iajs-3571	267	7	mj	mj	PROPN
iajs-3571	267	8	,	,	PUNCT
iajs-3571	267	9	colditz	colditz	PROPN
iajs-3571	267	10	ga	ga	PROPN
iajs-3571	267	11	,	,	PUNCT
iajs-3571	267	12	rimm	rimm	PROPN
iajs-3571	267	13	eb	eb	PROPN
iajs-3571	267	14	,	,	PUNCT
iajs-3571	267	15	willett	willett	PROPN
iajs-3571	267	16	wc	wc	PROPN
iajs-3571	267	17	.	.	PROPN
iajs-3571	268	1	dietary	dietary	ADJ
iajs-3571	268	2	fat	fat	ADJ
iajs-3571	268	3	intake	intake	NOUN
iajs-3571	268	4	and	and	CCONJ
iajs-3571	268	5	risk	risk	NOUN
iajs-3571	268	6	of	of	ADP
iajs-3571	268	7	type	type	NOUN
iajs-3571	268	8	2	2	NUM
iajs-3571	268	9	diabetes	diabetes	NOUN
iajs-3571	268	10	in	in	ADP
iajs-3571	268	11	women	woman	NOUN
iajs-3571	268	12	.	.	PUNCT
iajs-3571	269	1	am	be	AUX
iajs-3571	269	2	j	j	PROPN
iajs-3571	269	3	clin	clin	PROPN
iajs-3571	269	4	nutr	nutr	PROPN
iajs-3571	269	5	.	.	PROPN
iajs-3571	269	6	2001	2001	NUM
iajs-3571	269	7	;	;	PUNCT
iajs-3571	269	8	1(736):1019	1(736):1019	NUM
iajs-3571	269	9	-	-	SYM
iajs-3571	269	10	1026	1026	NUM
iajs-3571	269	11	.	.	PUNCT
iajs-3571	270	1	https://doi.org/10.1093/ajcn/73.6.1019	https://doi.org/10.1093/ajcn/73.6.1019	PROPN
iajs-3571	270	2	.	.	PUNCT
iajs-3571	271	1	21	21	NUM
iajs-3571	271	2	.	.	PUNCT
iajs-3571	272	1	ohkuma	ohkuma	PROPN
iajs-3571	272	2	t	t	PROPN
iajs-3571	272	3	,	,	PUNCT
iajs-3571	272	4	komorita	komorita	PROPN
iajs-3571	272	5	y	y	PROPN
iajs-3571	272	6	,	,	PUNCT
iajs-3571	272	7	peters	peters	PROPN
iajs-3571	272	8	sa	sa	PROPN
iajs-3571	272	9	,	,	PUNCT
iajs-3571	272	10	woodward	woodward	PROPN
iajs-3571	272	11	m.	m.	NOUN
iajs-3571	272	12	diabetes	diabetes	NOUN
iajs-3571	272	13	as	as	ADP
iajs-3571	272	14	a	a	DET
iajs-3571	272	15	risk	risk	NOUN
iajs-3571	272	16	factor	factor	NOUN
iajs-3571	272	17	for	for	ADP
iajs-3571	272	18	heart	heart	NOUN
iajs-3571	272	19	failure	failure	NOUN
iajs-3571	272	20	in	in	ADP
iajs-3571	272	21	women	woman	NOUN
iajs-3571	272	22	and	and	CCONJ
iajs-3571	272	23	men	man	NOUN
iajs-3571	272	24	:	:	PUNCT
iajs-3571	272	25	a	a	DET
iajs-3571	272	26	systematic	systematic	ADJ
iajs-3571	272	27	review	review	NOUN
iajs-3571	272	28	and	and	CCONJ
iajs-3571	272	29	meta	meta	NOUN
iajs-3571	272	30	-	-	PUNCT
iajs-3571	272	31	analysis	analysis	NOUN
iajs-3571	272	32	of	of	ADP
iajs-3571	272	33	47	47	NUM
iajs-3571	272	34	cohorts	cohort	NOUN
iajs-3571	272	35	including	include	VERB
iajs-3571	272	36	12	12	NUM
iajs-3571	272	37	million	million	NUM
iajs-3571	272	38	individuals	individual	NOUN
iajs-3571	272	39	.	.	PUNCT
iajs-3571	273	1	diabetologia	diabetologia	NOUN
iajs-3571	273	2	.	.	PUNCT
iajs-3571	274	1	2019	2019	NUM
iajs-3571	274	2	;	;	PUNCT
iajs-3571	274	3	1(62):1550	1(62):1550	X
iajs-3571	274	4	-	-	SYM
iajs-3571	274	5	1560	1560	NUM
iajs-3571	274	6	.	.	PUNCT
iajs-3571	275	1	https://doi.org/	https://doi.org/	VERB
iajs-3571	275	2	10.1007	10.1007	NUM
iajs-3571	275	3	/	/	SYM
iajs-3571	275	4	s00125	s00125	NUM
iajs-3571	275	5	-	-	PUNCT
iajs-3571	275	6	019	019	NUM
iajs-3571	275	7	-	-	PUNCT
iajs-3571	275	8	4926	4926	NUM
iajs-3571	275	9	-	-	PUNCT
iajs-3571	275	10	x.	x.	NOUN
iajs-3571	275	11	22	22	NUM
iajs-3571	275	12	.	.	PUNCT
iajs-3571	276	1	zhang	zhang	PROPN
iajs-3571	276	2	y	y	PROPN
iajs-3571	276	3	,	,	PUNCT
iajs-3571	276	4	yang	yang	PROPN
iajs-3571	276	5	j	j	PROPN
iajs-3571	276	6	,	,	PUNCT
iajs-3571	276	7	guo	guo	PROPN
iajs-3571	276	8	q	q	PROPN
iajs-3571	276	9	,	,	PUNCT
iajs-3571	276	10	wang	wang	PROPN
iajs-3571	276	11	w	w	PROPN
iajs-3571	276	12	,	,	PUNCT
iajs-3571	276	13	sun	sun	PROPN
iajs-3571	276	14	y	y	PROPN
iajs-3571	276	15	,	,	PUNCT
iajs-3571	276	16	zeng	zeng	PROPN
iajs-3571	276	17	q.	q.	PROPN
iajs-3571	276	18	separate	separate	ADJ
iajs-3571	276	19	and	and	CCONJ
iajs-3571	276	20	combined	combined	ADJ
iajs-3571	276	21	associations	association	NOUN
iajs-3571	276	22	of	of	ADP
iajs-3571	276	23	physical	physical	ADJ
iajs-3571	276	24	activity	activity	NOUN
iajs-3571	276	25	and	and	CCONJ
iajs-3571	276	26	obesity	obesity	NOUN
iajs-3571	276	27	with	with	ADP
iajs-3571	276	28	lipid	lipid	NOUN
iajs-3571	276	29	-	-	PUNCT
iajs-3571	276	30	related	relate	VERB
iajs-3571	276	31	indices	index	NOUN
iajs-3571	276	32	in	in	ADP
iajs-3571	276	33	non	non	ADJ
iajs-3571	276	34	-	-	ADJ
iajs-3571	276	35	diabetic	diabetic	ADJ
iajs-3571	276	36	and	and	CCONJ
iajs-3571	276	37	diabetic	diabetic	ADJ
iajs-3571	276	38	patients	patient	NOUN
iajs-3571	276	39	.	.	PUNCT
iajs-3571	277	1	lipids	lipids	ADP
iajs-3571	277	2	health	health	NOUN
iajs-3571	277	3	dis	dis	PROPN
iajs-3571	277	4	.	.	PUNCT
iajs-3571	278	1	2019	2019	NUM
iajs-3571	278	2	;	;	PUNCT
iajs-3571	278	3	18(1):49	18(1):49	NUM
iajs-3571	278	4	.	.	PUNCT
iajs-3571	278	5	https://doi.org/10.1186/s12944-019-0987-6	https://doi.org/10.1186/s12944-019-0987-6	PROPN
iajs-3571	278	6	.	.	PUNCT
iajs-3571	279	1	https://doi.org/10.1016/j.biopha.2021.111315	https://doi.org/10.1016/j.biopha.2021.111315	PROPN
iajs-3571	279	2	https://doi.org/10.1016/j.dsx.2018.10.008	https://doi.org/10.1016/j.dsx.2018.10.008	PROPN
iajs-3571	279	3	https://doi.org/10.1159/000494496	https://doi.org/10.1159/000494496	NOUN
iajs-3571	279	4	https://doi.org/10.4254/wjh.%20v13.i6.620	https://doi.org/10.4254/wjh.%20v13.i6.620	PROPN
iajs-3571	279	5	https://doi.org/10.3390/diseases9010016	https://doi.org/10.3390/diseases9010016	PROPN
iajs-3571	279	6	.	.	PUNCT
iajs-3571	280	1	https://doi.org/10.2147/dmso.s222271	https://doi.org/10.2147/dmso.s222271	PROPN
iajs-3571	281	1	https://doi.org/10.1074/jbc.m116.748103	https://doi.org/10.1074/jbc.m116.748103	NOUN
iajs-3571	281	2	https://doi.org/10.5772/52397	https://doi.org/10.5772/52397	NOUN
iajs-3571	281	3	https://doi.org/10.1016/s2213-8587(19)30076-2	https://doi.org/10.1016/s2213-8587(19)30076-2	VERB
iajs-3571	281	4	https://doi.org/10.15446/revfacmed.v67n4.67159	https://doi.org/10.15446/revfacmed.v67n4.67159	X
iajs-3571	281	5	https://doi.org/10.1002/mus.25596	https://doi.org/10.1002/mus.25596	PROPN
iajs-3571	281	6	https://connectjournals.com/03896.2020.20.6709	https://connectjournals.com/03896.2020.20.6709	NOUN
iajs-3571	281	7	https://doi.org/10.1093/ajcn/73.6.1019	https://doi.org/10.1093/ajcn/73.6.1019	X
iajs-3571	281	8	https://doi.org/10.1093/ajcn/73.6.1019	https://doi.org/10.1093/ajcn/73.6.1019	VERB
iajs-3571	281	9	https://doi.org/%2010.1007/s00125-019-4926-x	https://doi.org/%2010.1007/s00125-019-4926-x	PRON
iajs-3571	281	10	https://doi.org/10.1186/s12944-019-0987-6	https://doi.org/10.1186/s12944-019-0987-6	NUM
iajs-3571	281	11	ihjpas	ihjpa	NOUN
iajs-3571	281	12	.	.	PUNCT
iajs-3571	282	1	2025	2025	NUM
iajs-3571	282	2	,	,	PUNCT
iajs-3571	282	3	38(2	38(2	NUM
iajs-3571	282	4	)	)	PUNCT
iajs-3571	282	5	233	233	NUM
iajs-3571	282	6	23	23	NUM
iajs-3571	282	7	.	.	PUNCT
iajs-3571	283	1	yang	yang	PROPN
iajs-3571	283	2	y	y	PROPN
iajs-3571	283	3	,	,	PUNCT
iajs-3571	283	4	zhang	zhang	PROPN
iajs-3571	283	5	y	y	PROPN
iajs-3571	283	6	,	,	PUNCT
iajs-3571	283	7	wang	wang	PROPN
iajs-3571	283	8	j	j	PROPN
iajs-3571	283	9	,	,	PUNCT
iajs-3571	283	10	ning	ning	PROPN
iajs-3571	283	11	x	x	PROPN
iajs-3571	283	12	,	,	PUNCT
iajs-3571	283	13	zhang	zhang	PROPN
iajs-3571	283	14	y	y	PROPN
iajs-3571	283	15	,	,	PUNCT
iajs-3571	283	16	zhao	zhao	PROPN
iajs-3571	283	17	t	t	PROPN
iajs-3571	283	18	,	,	PUNCT
iajs-3571	283	19	zhong	zhong	PROPN
iajs-3571	283	20	y	y	PROPN
iajs-3571	283	21	,	,	PUNCT
iajs-3571	283	22	liu	liu	PROPN
iajs-3571	283	23	z	z	PROPN
iajs-3571	283	24	,	,	PUNCT
iajs-3571	283	25	xia	xia	PROPN
iajs-3571	283	26	l	l	PROPN
iajs-3571	283	27	,	,	PUNCT
iajs-3571	283	28	li	li	PROPN
iajs-3571	283	29	w	w	PROPN
iajs-3571	283	30	,	,	PUNCT
iajs-3571	283	31	yao	yao	PROPN
iajs-3571	283	32	x.	x.	NOUN
iajs-3571	283	33	sex	sex	NOUN
iajs-3571	283	34	differences	difference	NOUN
iajs-3571	283	35	in	in	ADP
iajs-3571	283	36	the	the	DET
iajs-3571	283	37	association	association	NOUN
iajs-3571	283	38	of	of	ADP
iajs-3571	283	39	homa	homa	PROPN
iajs-3571	283	40	-	-	PUNCT
iajs-3571	283	41	ir	ir	NOUN
iajs-3571	283	42	index	index	NOUN
iajs-3571	283	43	and	and	CCONJ
iajs-3571	283	44	bdnf	bdnf	PROPN
iajs-3571	283	45	in	in	ADP
iajs-3571	283	46	han	han	PROPN
iajs-3571	283	47	chinese	chinese	PROPN
iajs-3571	283	48	patients	patient	NOUN
iajs-3571	283	49	with	with	ADP
iajs-3571	283	50	chronic	chronic	ADJ
iajs-3571	283	51	schizophrenia	schizophrenia	NOUN
iajs-3571	283	52	.	.	PUNCT
iajs-3571	284	1	front	front	ADJ
iajs-3571	284	2	psychiatry	psychiatry	NOUN
iajs-3571	284	3	.	.	PUNCT
iajs-3571	285	1	2021	2021	NUM
iajs-3571	285	2	;	;	PUNCT
iajs-3571	285	3	21(12):656230	21(12):656230	X
iajs-3571	285	4	.	.	NOUN
iajs-3571	285	5	https://doi.org/	https://doi.org/	PROPN
iajs-3571	285	6	10.3389	10.3389	NUM
iajs-3571	285	7	/	/	SYM
iajs-3571	285	8	fpsyt.2021.656230	fpsyt.2021.656230	VERB
iajs-3571	285	9	.	.	PUNCT
iajs-3571	286	1	24	24	NUM
iajs-3571	286	2	.	.	PUNCT
iajs-3571	286	3	abbas	abbas	PROPN
iajs-3571	286	4	km	km	PROPN
iajs-3571	286	5	,	,	PUNCT
iajs-3571	286	6	alaaraji	alaaraji	PROPN
iajs-3571	286	7	sf	sf	PROPN
iajs-3571	286	8	,	,	PUNCT
iajs-3571	286	9	alâ	alâ	VERB
iajs-3571	286	10	rs	rs	NOUN
iajs-3571	286	11	.	.	PUNCT
iajs-3571	287	1	a	a	DET
iajs-3571	287	2	study	study	NOUN
iajs-3571	287	3	of	of	ADP
iajs-3571	287	4	the	the	DET
iajs-3571	287	5	association	association	NOUN
iajs-3571	287	6	between	between	ADP
iajs-3571	287	7	il-17	il-17	ADV
iajs-3571	287	8	and	and	CCONJ
iajs-3571	287	9	homa	homa	NOUN
iajs-3571	287	10	-	-	PUNCT
iajs-3571	287	11	ir	ir	PROPN
iajs-3571	287	12	in	in	ADP
iajs-3571	287	13	iraqi	iraqi	ADJ
iajs-3571	287	14	type	type	NOUN
iajs-3571	287	15	2	2	NUM
iajs-3571	287	16	diabetic	diabetic	ADJ
iajs-3571	287	17	patients	patient	NOUN
iajs-3571	287	18	.	.	PUNCT
iajs-3571	288	1	iraqi	iraqi	PROPN
iajs-3571	288	2	j	j	PROPN
iajs-3571	288	3	sci	sci	PROPN
iajs-3571	288	4	.	.	PROPN
iajs-3571	288	5	2020	2020	NUM
iajs-3571	288	6	;	;	PUNCT
iajs-3571	288	7	61(3):491	61(3):491	NOUN
iajs-3571	288	8	-	-	PUNCT
iajs-3571	288	9	498	498	NUM
iajs-3571	288	10	.	.	PUNCT
iajs-3571	289	1	https://doi.org/10.24996/ijs.2020.61.3.4	https://doi.org/10.24996/ijs.2020.61.3.4	NOUN
iajs-3571	289	2	.	.	PROPN
iajs-3571	290	1	25	25	NUM
iajs-3571	290	2	.	.	PUNCT
iajs-3571	291	1	delaney	delaney	PROPN
iajs-3571	291	2	kz	kz	PROPN
iajs-3571	291	3	,	,	PUNCT
iajs-3571	291	4	santosa	santosa	PROPN
iajs-3571	291	5	s.	s.	PROPN
iajs-3571	291	6	sex	sex	NOUN
iajs-3571	291	7	differences	difference	NOUN
iajs-3571	291	8	in	in	ADP
iajs-3571	291	9	regional	regional	ADJ
iajs-3571	291	10	adipose	adipose	ADJ
iajs-3571	291	11	tissue	tissue	NOUN
iajs-3571	291	12	depots	depot	NOUN
iajs-3571	291	13	pose	pose	VERB
iajs-3571	291	14	different	different	ADJ
iajs-3571	291	15	threats	threat	NOUN
iajs-3571	291	16	for	for	ADP
iajs-3571	291	17	the	the	DET
iajs-3571	291	18	development	development	NOUN
iajs-3571	291	19	of	of	ADP
iajs-3571	291	20	type	type	NOUN
iajs-3571	291	21	2	2	NUM
iajs-3571	291	22	diabetes	diabetes	NOUN
iajs-3571	291	23	in	in	ADP
iajs-3571	291	24	males	male	NOUN
iajs-3571	291	25	and	and	CCONJ
iajs-3571	291	26	females	female	NOUN
iajs-3571	291	27	.	.	PUNCT
iajs-3571	292	1	obes	obes	PROPN
iajs-3571	292	2	rev	rev	VERB
iajs-3571	292	3	.	.	PROPN
iajs-3571	292	4	2022	2022	NUM
iajs-3571	292	5	;	;	PUNCT
iajs-3571	293	1	23(3):e13393	23(3):e13393	X
iajs-3571	293	2	.	.	PUNCT
iajs-3571	293	3	https://doi.org/10.1111/obr.13393	https://doi.org/10.1111/obr.13393	PROPN
iajs-3571	293	4	.	.	PROPN
iajs-3571	294	1	26	26	NUM
iajs-3571	294	2	.	.	PUNCT
iajs-3571	295	1	nordstrom	nordstrom	PROPN
iajs-3571	295	2	a	a	PRON
iajs-3571	295	3	,	,	PUNCT
iajs-3571	295	4	hadrévi	hadrévi	PROPN
iajs-3571	295	5	j	j	PROPN
iajs-3571	295	6	,	,	PUNCT
iajs-3571	295	7	olsson	olsson	PROPN
iajs-3571	295	8	t	t	PROPN
iajs-3571	295	9	,	,	PUNCT
iajs-3571	295	10	franks	frank	NOUN
iajs-3571	295	11	pw	pw	PROPN
iajs-3571	295	12	,	,	PUNCT
iajs-3571	295	13	nordström	nordström	NOUN
iajs-3571	295	14	p.	p.	NOUN
iajs-3571	295	15	higher	high	ADJ
iajs-3571	295	16	prevalence	prevalence	NOUN
iajs-3571	295	17	of	of	ADP
iajs-3571	295	18	type	type	NOUN
iajs-3571	295	19	2	2	NUM
iajs-3571	295	20	diabetes	diabetes	NOUN
iajs-3571	295	21	in	in	ADP
iajs-3571	295	22	men	man	NOUN
iajs-3571	295	23	than	than	ADP
iajs-3571	295	24	in	in	ADP
iajs-3571	295	25	women	woman	NOUN
iajs-3571	295	26	is	be	AUX
iajs-3571	295	27	associated	associate	VERB
iajs-3571	295	28	with	with	ADP
iajs-3571	295	29	differences	difference	NOUN
iajs-3571	295	30	in	in	ADP
iajs-3571	295	31	visceral	visceral	ADJ
iajs-3571	295	32	fat	fat	ADJ
iajs-3571	295	33	mass	mass	NOUN
iajs-3571	295	34	.	.	PUNCT
iajs-3571	296	1	j	j	PROPN
iajs-3571	296	2	clin	clin	PROPN
iajs-3571	296	3	endocrinol	endocrinol	PROPN
iajs-3571	296	4	metab	metab	NOUN
iajs-3571	296	5	.	.	PUNCT
iajs-3571	297	1	2016	2016	NUM
iajs-3571	297	2	;	;	PUNCT
iajs-3571	298	1	101(10):3740	101(10):3740	NOUN
iajs-3571	298	2	-	-	SYM
iajs-3571	298	3	3746	3746	NUM
iajs-3571	298	4	.	.	PUNCT
iajs-3571	299	1	https://doi.org/10.1210/jc.2016-1915	https://doi.org/10.1210/jc.2016-1915	NOUN
iajs-3571	299	2	.	.	PUNCT
iajs-3571	300	1	27	27	NUM
iajs-3571	300	2	.	.	PUNCT
iajs-3571	300	3	tramunt	tramunt	PROPN
iajs-3571	300	4	b	b	PROPN
iajs-3571	300	5	,	,	PUNCT
iajs-3571	300	6	smati	smati	PROPN
iajs-3571	300	7	s	s	PART
iajs-3571	300	8	,	,	PUNCT
iajs-3571	300	9	grandgeorge	grandgeorge	NOUN
iajs-3571	300	10	n	n	CCONJ
iajs-3571	300	11	,	,	PUNCT
iajs-3571	300	12	lenfant	lenfant	ADJ
iajs-3571	300	13	f	f	PROPN
iajs-3571	300	14	,	,	PUNCT
iajs-3571	300	15	arnal	arnal	PROPN
iajs-3571	300	16	jf	jf	PROPN
iajs-3571	300	17	,	,	PUNCT
iajs-3571	300	18	montagner	montagner	NOUN
iajs-3571	300	19	a	a	NOUN
iajs-3571	300	20	,	,	PUNCT
iajs-3571	300	21	gourdy	gourdy	ADJ
iajs-3571	300	22	p.	p.	NOUN
iajs-3571	300	23	sex	sex	NOUN
iajs-3571	300	24	differences	difference	NOUN
iajs-3571	300	25	in	in	ADP
iajs-3571	300	26	metabolic	metabolic	NOUN
iajs-3571	300	27	regulation	regulation	NOUN
iajs-3571	300	28	and	and	CCONJ
iajs-3571	300	29	diabetes	diabetes	NOUN
iajs-3571	300	30	susceptibility	susceptibility	NOUN
iajs-3571	300	31	.	.	PUNCT
iajs-3571	301	1	diabetologia	diabetologia	NOUN
iajs-3571	301	2	.	.	PUNCT
iajs-3571	302	1	2020	2020	NUM
iajs-3571	302	2	;	;	PUNCT
iajs-3571	302	3	63(3):453	63(3):453	NOUN
iajs-3571	302	4	-	-	SYM
iajs-3571	302	5	461	461	NUM
iajs-3571	302	6	.	.	PUNCT
iajs-3571	303	1	https://doi.org/10.1007/s00125-019-05040-3	https://doi.org/10.1007/s00125-019-05040-3	NUM
iajs-3571	303	2	.	.	PUNCT
iajs-3571	304	1	28	28	NUM
iajs-3571	304	2	.	.	PUNCT
iajs-3571	305	1	ohkuma	ohkuma	PROPN
iajs-3571	305	2	t	t	PROPN
iajs-3571	305	3	,	,	PUNCT
iajs-3571	305	4	komorita	komorita	PROPN
iajs-3571	305	5	y	y	PROPN
iajs-3571	305	6	,	,	PUNCT
iajs-3571	305	7	peters	peters	PROPN
iajs-3571	305	8	sa	sa	PROPN
iajs-3571	305	9	,	,	PUNCT
iajs-3571	305	10	woodward	woodward	PROPN
iajs-3571	305	11	m.	m.	NOUN
iajs-3571	305	12	diabetes	diabetes	NOUN
iajs-3571	305	13	as	as	ADP
iajs-3571	305	14	a	a	DET
iajs-3571	305	15	risk	risk	NOUN
iajs-3571	305	16	factor	factor	NOUN
iajs-3571	305	17	for	for	ADP
iajs-3571	305	18	heart	heart	NOUN
iajs-3571	305	19	failure	failure	NOUN
iajs-3571	305	20	in	in	ADP
iajs-3571	305	21	women	woman	NOUN
iajs-3571	305	22	and	and	CCONJ
iajs-3571	305	23	men	man	NOUN
iajs-3571	305	24	:	:	PUNCT
iajs-3571	305	25	a	a	DET
iajs-3571	305	26	systematic	systematic	ADJ
iajs-3571	305	27	review	review	NOUN
iajs-3571	305	28	and	and	CCONJ
iajs-3571	305	29	meta	meta	NOUN
iajs-3571	305	30	-	-	PUNCT
iajs-3571	305	31	analysis	analysis	NOUN
iajs-3571	305	32	of	of	ADP
iajs-3571	305	33	47	47	NUM
iajs-3571	305	34	cohorts	cohort	NOUN
iajs-3571	305	35	including	include	VERB
iajs-3571	305	36	12	12	NUM
iajs-3571	305	37	million	million	NUM
iajs-3571	305	38	individuals	individual	NOUN
iajs-3571	305	39	.	.	PUNCT
iajs-3571	306	1	diabetologia	diabetologia	NOUN
iajs-3571	306	2	.	.	PUNCT
iajs-3571	307	1	2019	2019	NUM
iajs-3571	307	2	;	;	PUNCT
iajs-3571	307	3	62(9):1550	62(9):1550	NUM
iajs-3571	307	4	-	-	SYM
iajs-3571	307	5	1560	1560	NUM
iajs-3571	307	6	.	.	PUNCT
iajs-3571	308	1	https://doi.org/10.1007/s00125-019-4926-x	https://doi.org/10.1007/s00125-019-4926-x	PROPN
iajs-3571	308	2	.	.	PROPN
iajs-3571	309	1	29	29	NUM
iajs-3571	309	2	.	.	PUNCT
iajs-3571	310	1	viigimaa	viigimaa	PROPN
iajs-3571	310	2	m	m	PROPN
iajs-3571	310	3	,	,	PUNCT
iajs-3571	310	4	sachinidis	sachinidi	NOUN
iajs-3571	310	5	a	a	DET
iajs-3571	310	6	,	,	PUNCT
iajs-3571	310	7	toumpourleka	toumpourleka	NOUN
iajs-3571	310	8	m	m	PROPN
iajs-3571	310	9	,	,	PUNCT
iajs-3571	310	10	koutsampasopoulos	koutsampasopoulos	PROPN
iajs-3571	310	11	k	k	PROPN
iajs-3571	310	12	,	,	PUNCT
iajs-3571	310	13	alliksoo	alliksoo	PROPN
iajs-3571	310	14	s	s	PROPN
iajs-3571	310	15	,	,	PUNCT
iajs-3571	310	16	titma	titma	NOUN
iajs-3571	310	17	t.	t.	PROPN
iajs-3571	310	18	macrovascular	macrovascular	PROPN
iajs-3571	310	19	complications	complication	NOUN
iajs-3571	310	20	of	of	ADP
iajs-3571	310	21	type	type	NOUN
iajs-3571	310	22	2	2	NUM
iajs-3571	310	23	diabetes	diabetes	NOUN
iajs-3571	310	24	mellitus	mellitus	NOUN
iajs-3571	310	25	.	.	PUNCT
iajs-3571	311	1	curr	curr	PROPN
iajs-3571	311	2	vasc	vasc	PROPN
iajs-3571	311	3	pharmacol	pharmacol	PROPN
iajs-3571	311	4	.	.	PUNCT
iajs-3571	311	5	2020	2020	NUM
iajs-3571	311	6	;	;	PUNCT
iajs-3571	311	7	18(2):110116	18(2):110116	NUM
iajs-3571	311	8	.	.	PUNCT
iajs-3571	312	1	https://doi.org/10.2174/1570161117666190405165151	https://doi.org/10.2174/1570161117666190405165151	NOUN
iajs-3571	312	2	.	.	PUNCT
iajs-3571	313	1	30	30	NUM
iajs-3571	313	2	.	.	PUNCT
iajs-3571	314	1	sattar	sattar	PROPN
iajs-3571	314	2	n	n	PROPN
iajs-3571	314	3	,	,	PUNCT
iajs-3571	314	4	rawshani	rawshani	X
iajs-3571	314	5	a	a	DET
iajs-3571	314	6	,	,	PUNCT
iajs-3571	314	7	franzén	franzén	X
iajs-3571	314	8	s	s	PROPN
iajs-3571	314	9	,	,	PUNCT
iajs-3571	314	10	rawshani	rawshani	PROPN
iajs-3571	314	11	a	a	PROPN
iajs-3571	314	12	,	,	PUNCT
iajs-3571	314	13	svensson	svensson	PROPN
iajs-3571	314	14	am	be	AUX
iajs-3571	314	15	,	,	PUNCT
iajs-3571	314	16	rosengren	rosengren	PROPN
iajs-3571	314	17	a	a	PROPN
iajs-3571	314	18	,	,	PUNCT
iajs-3571	314	19	mcguire	mcguire	PROPN
iajs-3571	314	20	dk	dk	PROPN
iajs-3571	314	21	,	,	PUNCT
iajs-3571	314	22	eliasson	eliasson	NOUN
iajs-3571	314	23	b	b	PROPN
iajs-3571	314	24	,	,	PUNCT
iajs-3571	314	25	gudbjörnsdottir	gudbjörnsdottir	PROPN
iajs-3571	314	26	s.	s.	PROPN
iajs-3571	314	27	age	age	NOUN
iajs-3571	314	28	at	at	ADP
iajs-3571	314	29	diagnosis	diagnosis	NOUN
iajs-3571	314	30	of	of	ADP
iajs-3571	314	31	type	type	NOUN
iajs-3571	314	32	2	2	NUM
iajs-3571	314	33	diabetes	diabetes	NOUN
iajs-3571	314	34	mellitus	mellitus	NOUN
iajs-3571	314	35	and	and	CCONJ
iajs-3571	314	36	associations	association	NOUN
iajs-3571	314	37	with	with	ADP
iajs-3571	314	38	cardiovascular	cardiovascular	ADJ
iajs-3571	314	39	and	and	CCONJ
iajs-3571	314	40	mortality	mortality	NOUN
iajs-3571	314	41	risks	risk	NOUN
iajs-3571	314	42	:	:	PUNCT
iajs-3571	314	43	findings	finding	NOUN
iajs-3571	314	44	from	from	ADP
iajs-3571	314	45	the	the	DET
iajs-3571	314	46	swedish	swedish	PROPN
iajs-3571	314	47	national	national	PROPN
iajs-3571	314	48	diabetes	diabetes	PROPN
iajs-3571	314	49	registry	registry	NOUN
iajs-3571	314	50	.	.	PUNCT
iajs-3571	315	1	circulation	circulation	NOUN
iajs-3571	315	2	.	.	PUNCT
iajs-3571	316	1	2019	2019	NUM
iajs-3571	316	2	;	;	PUNCT
iajs-3571	316	3	139(19	139(19	NUM
iajs-3571	316	4	):	):	PUNCT
iajs-3571	316	5	2228	2228	NUM
iajs-3571	316	6	-	-	SYM
iajs-3571	316	7	2237	2237	NUM
iajs-3571	316	8	.	.	PUNCT
iajs-3571	317	1	https://doi.org/10.1161/circulationaha.118.037885	https://doi.org/10.1161/circulationaha.118.037885	NOUN
iajs-3571	317	2	.	.	PROPN
iajs-3571	317	3	31	31	NUM
iajs-3571	317	4	.	.	PUNCT
iajs-3571	318	1	balaky	balaky	PROPN
iajs-3571	318	2	hm	hm	PROPN
iajs-3571	318	3	,	,	PUNCT
iajs-3571	318	4	kakey	kakey	PROPN
iajs-3571	318	5	is	be	AUX
iajs-3571	318	6	.	.	PUNCT
iajs-3571	319	1	indications	indication	NOUN
iajs-3571	319	2	of	of	ADP
iajs-3571	319	3	liver	liver	NOUN
iajs-3571	319	4	and	and	CCONJ
iajs-3571	319	5	kidney	kidney	NOUN
iajs-3571	319	6	functions	function	NOUN
iajs-3571	319	7	innon	innon	NOUN
iajs-3571	319	8	-	-	PUNCT
iajs-3571	319	9	insulin	insulin	ADJ
iajs-3571	319	10	dependent	dependent	ADJ
iajs-3571	319	11	diabetic	diabetic	ADJ
iajs-3571	319	12	patients	patient	NOUN
iajs-3571	319	13	.	.	PUNCT
iajs-3571	320	1	iraqi	iraqi	PROPN
iajs-3571	320	2	j	j	PROPN
iajs-3571	320	3	sci	sci	PROPN
iajs-3571	320	4	.	.	PROPN
iajs-3571	320	5	2021	2021	NUM
iajs-3571	320	6	;	;	PUNCT
iajs-3571	320	7	62(3):769	62(3):769	PROPN
iajs-3571	320	8	-	-	PUNCT
iajs-3571	320	9	778	778	NUM
iajs-3571	320	10	.	.	PUNCT
iajs-3571	321	1	https://doi.org/10.24996/ijs.2021.62.3.7	https://doi.org/10.24996/ijs.2021.62.3.7	NOUN
iajs-3571	321	2	.	.	PUNCT
iajs-3571	322	1	32	32	NUM
iajs-3571	322	2	.	.	PUNCT
iajs-3571	323	1	ahmed	ahmed	PROPN
iajs-3571	323	2	sy	sy	PROPN
iajs-3571	323	3	.	.	PUNCT
iajs-3571	324	1	a	a	DET
iajs-3571	324	2	study	study	NOUN
iajs-3571	324	3	of	of	ADP
iajs-3571	324	4	hepcidin	hepcidin	ADJ
iajs-3571	324	5	levels	level	NOUN
iajs-3571	324	6	and	and	CCONJ
iajs-3571	324	7	other	other	ADJ
iajs-3571	324	8	biochemical	biochemical	ADJ
iajs-3571	324	9	parameters	parameter	NOUN
iajs-3571	324	10	in	in	ADP
iajs-3571	324	11	woman	woman	NOUN
iajs-3571	324	12	with	with	ADP
iajs-3571	324	13	osteoporosis	osteoporosis	NOUN
iajs-3571	324	14	with	with	ADP
iajs-3571	324	15	type	type	NOUN
iajs-3571	324	16	2	2	NUM
iajs-3571	324	17	diabetes	diabetes	NOUN
iajs-3571	324	18	mellitus	mellitus	NOUN
iajs-3571	324	19	.	.	PUNCT
iajs-3571	325	1	ihjpas	ihjpas	PROPN
iajs-3571	325	2	.	.	PUNCT
iajs-3571	326	1	2022	2022	NUM
iajs-3571	326	2	;	;	PUNCT
iajs-3571	326	3	35(4):183	35(4):183	NUM
iajs-3571	326	4	-	-	SYM
iajs-3571	326	5	193	193	NUM
iajs-3571	326	6	.	.	PUNCT
iajs-3571	327	1	https://doi.org/10.30526/35.4.2867	https://doi.org/10.30526/35.4.2867	X
iajs-3571	327	2	.	.	PUNCT
iajs-3571	328	1	33	33	NUM
iajs-3571	328	2	.	.	PUNCT
iajs-3571	329	1	zhang	zhang	PROPN
iajs-3571	329	2	y	y	PROPN
iajs-3571	329	3	,	,	PUNCT
iajs-3571	329	4	pan	pan	PROPN
iajs-3571	329	5	xf	xf	PROPN
iajs-3571	329	6	,	,	PUNCT
iajs-3571	329	7	chen	chen	PROPN
iajs-3571	329	8	j	j	PROPN
iajs-3571	329	9	,	,	PUNCT
iajs-3571	329	10	xia	xia	PROPN
iajs-3571	329	11	l	l	PROPN
iajs-3571	329	12	,	,	PUNCT
iajs-3571	329	13	cao	cao	PROPN
iajs-3571	329	14	a	a	X
iajs-3571	329	15	,	,	PUNCT
iajs-3571	329	16	zhang	zhang	PROPN
iajs-3571	329	17	y	y	PROPN
iajs-3571	329	18	,	,	PUNCT
iajs-3571	329	19	wang	wang	PROPN
iajs-3571	329	20	j	j	PROPN
iajs-3571	329	21	,	,	PUNCT
iajs-3571	329	22	li	li	PROPN
iajs-3571	329	23	h	h	PROPN
iajs-3571	329	24	,	,	PUNCT
iajs-3571	329	25	yang	yang	PROPN
iajs-3571	329	26	k	k	PROPN
iajs-3571	329	27	,	,	PUNCT
iajs-3571	329	28	guo	guo	PROPN
iajs-3571	329	29	k	k	PROPN
iajs-3571	329	30	,	,	PUNCT
iajs-3571	329	31	he	he	PRON
iajs-3571	329	32	m.	m.	VERB
iajs-3571	329	33	combined	combine	VERB
iajs-3571	329	34	lifestyle	lifestyle	NOUN
iajs-3571	329	35	factors	factor	NOUN
iajs-3571	329	36	and	and	CCONJ
iajs-3571	329	37	risk	risk	NOUN
iajs-3571	329	38	of	of	ADP
iajs-3571	329	39	incident	incident	NOUN
iajs-3571	329	40	type	type	NOUN
iajs-3571	329	41	2	2	NUM
iajs-3571	329	42	diabetes	diabetes	NOUN
iajs-3571	329	43	and	and	CCONJ
iajs-3571	329	44	prognosis	prognosis	NOUN
iajs-3571	329	45	among	among	ADP
iajs-3571	329	46	individuals	individual	NOUN
iajs-3571	329	47	with	with	ADP
iajs-3571	329	48	type	type	NOUN
iajs-3571	329	49	2	2	NUM
iajs-3571	329	50	diabetes	diabetes	NOUN
iajs-3571	329	51	:	:	PUNCT
iajs-3571	329	52	a	a	DET
iajs-3571	329	53	systematic	systematic	ADJ
iajs-3571	329	54	review	review	NOUN
iajs-3571	329	55	and	and	CCONJ
iajs-3571	329	56	meta	meta	ADJ
iajs-3571	329	57	-	-	PUNCT
iajs-3571	329	58	analysis	analysis	NOUN
iajs-3571	329	59	of	of	ADP
iajs-3571	329	60	prospective	prospective	ADJ
iajs-3571	329	61	cohort	cohort	NOUN
iajs-3571	329	62	studies	study	NOUN
iajs-3571	329	63	.	.	PUNCT
iajs-3571	330	1	diabetologia	diabetologia	NOUN
iajs-3571	330	2	.	.	PUNCT
iajs-3571	331	1	2020	2020	NUM
iajs-3571	331	2	;	;	PUNCT
iajs-3571	331	3	63(1):21	63(1):21	NUM
iajs-3571	331	4	-	-	SYM
iajs-3571	331	5	33	33	NUM
iajs-3571	331	6	.	.	PUNCT
iajs-3571	332	1	https://doi.org/10.1007/s00125-019-04985-9	https://doi.org/10.1007/s00125-019-04985-9	NUM
iajs-3571	332	2	.	.	PUNCT
iajs-3571	333	1	https://doi.org/%2010.3389/fpsyt.2021.656230	https://doi.org/%2010.3389/fpsyt.2021.656230	X
iajs-3571	333	2	https://doi.org/10.24996/ijs.2020.61.3.4	https://doi.org/10.24996/ijs.2020.61.3.4	NOUN
iajs-3571	333	3	https://doi.org/10.1111/obr.13393	https://doi.org/10.1111/obr.13393	PROPN
iajs-3571	333	4	https://doi.org/10.1111/obr.13393	https://doi.org/10.1111/obr.13393	PROPN
iajs-3571	333	5	https://doi.org/10.1210/jc.2016-1915	https://doi.org/10.1210/jc.2016-1915	NOUN
iajs-3571	333	6	.	.	PUNCT
iajs-3571	334	1	https://doi.org/10.1007/s00125-019-05040-3	https://doi.org/10.1007/s00125-019-05040-3	PROPN
iajs-3571	334	2	.	.	PUNCT
iajs-3571	335	1	https://doi.org/10.1007/s00125-019-4926-x	https://doi.org/10.1007/s00125-019-4926-x	PROPN
iajs-3571	335	2	https://doi.org/10.2174/1570161117666190405165151	https://doi.org/10.2174/1570161117666190405165151	PROPN
iajs-3571	335	3	https://doi.org/10.1161/circulationaha.118.037885	https://doi.org/10.1161/circulationaha.118.037885	VERB
iajs-3571	335	4	https://doi.org/10.24996/ijs.2021.62.3.7	https://doi.org/10.24996/ijs.2021.62.3.7	PRON
iajs-3571	335	5	https://doi.org/10.24996/ijs.2021.62.3.7	https://doi.org/10.24996/ijs.2021.62.3.7	NOUN
iajs-3571	335	6	.%20https:/doi.org/10.30526/35.4.2867	.%20https:/doi.org/10.30526/35.4.2867	PUNCT
iajs-3571	335	7	.%20https:/doi.org/10.30526/35.4.2867	.%20https:/doi.org/10.30526/35.4.2867	PUNCT
iajs-3571	336	1	https://doi.org/10.1007/s00125-019-04985-9	https://doi.org/10.1007/s00125-019-04985-9	NUM